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Abstract
A series of cholesterol analogues possessing side chains with
either more or less carbon atoms than cholesterol were synthesised
from hyodesoxycholic acid and fully characterised by nuclear magnetic
resonance, mass spectrometry, and infra red analysis. These analogues
were used in (a) physical studies of cholesterol phospholipid interactions
and (b) experiments to investigate the substrate specificities of
cholesterol 7a"hydroxylase from rat liver and the adrenal mitochondrial
cholesterol side chain cleavage enzyme.
(a) The physical properties of cholesterol and a series of cholesterol
side chain analogues were investigated by incorporating them into
liposomes prepared from lipid films containing the sterol and a series
of saturated or unsaturated phospholipids in the required molar
proportions. A series of spin labels (3-nitroxy octane, Tempo, 25
nitroxy cholestane, and 3 nitroxy cholestane) were incorporated into the
sterol phospholipid liposomes and the effect of each analogue on each
spin label mobility was observed. In addition the effect of each
analogue on water permeability across the liposomal membrane was determined.
The results of both sets of experiments showed that the cholesterol molecule
with its iso-octane side chain was optimally adapted for maximal interaction
with phospholipid. This specificity was not observed in monolayer
studies of cholesterol phospholipid interactions.
(b) The involvement of the cholesterol side chain in cholesterol
oxidation by the liver microsomal enzyme, cholesterol 7a~hydroxylase
was determined using an established assay based on the oxidation of
added radioactive cholesterol. Using phenobarbitone pretreated rats
it was shown that the metabolism of short side chain analogues was
stimulated whereas 7a~hydroxylase activity was unaffected. Thus it is
postulated that the side chain of cholesterol determines its metabolic
fate and that the shorter side chain analogues are metabolised by the
inducible hepatic drug metabolising enzyme system. A new G.L.C.
assay which measures the production of 7a-hydroxy cholesterol
from endogenous microsomal cholesterol has been developed and
used to investigate the problem of substrate supply for the 7a-
hydroxylase enzyme. This involved the addition of cholesterol in
detergents in sonicated and unsonicated liposomes containing different
molar proportions of sterol and in organic solvents to a cholesterol
depleted form of the enzyme.
The involvement of a soluble protein isolated from the 100,000 x g
supernatant of rat liver by ammonium sulphate fractionation, gel
filtration and ion exchange chromatography has also been demonstrated.
The molecular weight of the protein has been determined by S.D.S.
polyacrylamide gel electrophoresis, and its means of action investigated.
The cholesterol side chain cleavage enzyme of rat adrenal
mitochondria has been shown to possess an absolute requirement for
cholesterol as substrate by use of a radio-immuno-assay that measures
pregnenolone production from the exogenous cholesterol side chain
analogues.
The results of both the physical measurements and the enzyme
assays show that the side chain of cholesterol plays a major role
in determining the extent of the interaction between cholesterol and
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Cholesterol is found in all mammalian cell membranes in
varying quantities depending on the source. It is not present in
any bacterial cells, but derivatives are present in plants and fungi
of yeast. These sterols possess a double bond in the side chain
at C^2 and/or a methyl or ethyl group at C^ and include stigmasterol
and sitosterol (plant) and ergosterol (fungi and yeast) (Fig. 1.1).
In the mammalian system the cholesterol originates either from
cholesterol newly synthesised in the animal or it may be obtained
in the diet. In this introduction the dual role that cholesterol
plays as a component of cellular membranes and as a substrate for
cholesterol oxidising systems is considered.
The liver has a major role to play in the regulation of the
amount of cholesterol that is present in animal$. Dietary cholesterol,
lipoprotein cholesterol and cholesterol synthesised in situ may
increase the liver cholesterol content, whereas the excretion of
cholesterol in faeces as neutral sterols such as cholestanol and
coprostanol, the conversion of cholesterol to bile acid, the re-export
of lipoproteins and the metabolism of cholesterol to steroid hormones
and their catabolites decrease the liver content. Of the catabolic
processes the conversion of cholesterol to the bile acids is
quantitatively the most important and accounts for 50 per cent of
the excreted cholesterol while the conversion to steroid hormones is
of minor importance. The transformation of cholesterol to the bile
acids requires many chemical modifications involving two hydroxylations
of the sterol nucleus at the 7 and 12 positions, oxidation of the 33
hydroxyl group, saturation of the double bond and reduction of the
3 oxo group to a 3a hydroxyl. The side chain is reduced in length by
a three carbon fragment by a series of hydroxylations and oxidations
Figure 1.2 Pathways for formation of bile acids. I, cholesterol; 11, 7a-hydroxycholesterol
(5-cholestene-3/^, 7a-diol); III, 7a-hydroxy-4-cholesten-3-one; IV. 5/i-cholestane-3a, 7a-diol;
V, 7 a, 12a-dihydroxy-4-cholesten-3-one; VI, 5/j-cholestane-3a, 7a, 12a-triol; VII, 5/?-
cholestane-3a, 7a, 12a, 26-tetrol; VIII, 5/i-cholestane-3a, 7a, 26-triol; IX, 3a, 7a, 12a-tri-
hydroxy-5/f-cholestanoic acid; X, 3a, 7a-dihydroxy-5/l-cholestanoic acid; XI, cholic acid;
XII, chenodeoxycholic acid; XIII, deoxycholic acid; XIV, lithocholic acid. reactions
catalyzed by liver enzymes; —reactions catalyzed by microbial enzymes.
(Fig. 1.2). The bile acids so formed are converted into their CoA
derivatives in the liver and are condensed with glycine or taurine
in the hepatocytes to give bile salts. Bile salts themselves are
anionic detergents which emulsify fat in the duodenum prior to
digestion by pancreatic lipase. Unlike the partially hydrolysed
fats, the bile salts themselves are not absorbed by the proximal
small intestine but pass onto the ileum. When absorption occurs
they are recirculated in the portal blood to the liver and then
to the bile for re-entry at the duodenum. This is known as
enterohepatic circulation. The bile salts may also be further
metabolised by bacteria in the intestinal tract to secondary bile
acids which are also returned to the liver and rehydroxylated to
primary bile acids. It is estimated that 90 per cent of the bile
acids are reabsorbed in the region of the lower ileum.
The first step in the production of bile acids from cholesterol
was deduced to be the 7a-hydroxylation of cholesterol (1).
Cannulation of the bile duct or treatment with the anion exchange
resin, cholestyramine, interrupts the enterohepatic circulation and
increases the cholesterol 7a-hydroxylase activity 10 fold. Not
only is this activity increased but the output of both cholic and
chenodeoxycholic acid is increased. As the proposed pathways for
the production of these two primary bile acids diverge after the 7a
hydroxylation and no enzyme is stimulated by cholestyramine treatment
nor is there any noticeable build up of intermediates in the pathway
leading to bile acids, cholesterol 7a-hydroxylase is considered to
be the first and rate limiting step in the conversion of cholesterol
to bile acids.
The decrease in the bile acid concentration in the enterohepatic
circulation caused by cholestyramine feeding precedes the rise in
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cholesterol 7a-hydroxylase activity. As puromycin, actinomycin D
and cycloheximide all inhibit the rise in activity (2,3), most
workers are agreed that the increase in cholesterol 7a hydroxylase
is not due to relief of inhibition of this enzyme by the reduction
in concentration of the portal bile salts (4,5,6). As there is a
delay of at least 24 hours in the rise in cholesterol 7a hydroxylase
activity upon interruption of the enterohepatic circulation (7)
and since the rise is prevented by actinomycin D the increase in
enzyme activity is thought to be due to induction of some component
of the enzyme system or of some factor required for providing the
enzyme with a supply of cholesterol rather than activation of the
pre-existing enzyme.
The cholesterol 7a-hydroxylase has certain features in common
with several hepatic mixed function oxidases in that it requires
NADPH and molecular oxygen and cytochrome P450 for its activation
and it is located in the microsomal fraction. The NADPH provides
a source of electrons and the flavoprotein, NADPH cytochrome P450
reductase catalyses the transfer of electrons from the NADPH to
cytochrome P450. The cholesterol 7a hydroxylation system resembles
other hepatic microsomal mixed function oxidases in not requiring
an ironsulphur protein which is essential for cytochrome P450
dependent hydroxylations occurring in the adrenal mitochondria.
The iron sulphur protein is situated between the flavoprotein and
cytochrome P450 (Fig. 1.3).
Although the cholesterol 7a-hydroxylase has been shown to be
P450 linked, no direct evidence has been presented to show that
cholesterol interacts with microsomal P450 during the hydroxylation
process. However the adrenal cytochrome P450 that catalyses the
cleavage of the cholesterol side chain (P450scc) has been obtained
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in a state of purity sufficient to show that cholesterol is
interacting directly with the cytochrome (8).
The cholesterol 7a-hydroxylase mixed function oxidase system
also has certain differences from the rest of the hepatic mixed
function oxidases. Drug treatment of the animal increases the
hepatic cytochrome P450 levels with a consequent increase in
the activity of mixed function oxidases that are associated with
drug metabolism but this treatment has no effect on the activity
of the cholesterol 7ot hydroxylase (9). This finding illustrates
the problem that although the cholesterol 7a-hydroxylase enzyme
is dependent on cytochrome P450 for its activity there does not
seem to be a direct relationship between hepatic cytochrome P450
concentration and cholesterol 7a-hydroxylase activity. Perhaps
this is explained by stating that there is a specific cytochrome
P450 in liver associated with the cholesterol 7a-hydroxylase
enzyme system and that small alteration in its concentration cannot
be detected in the presence of the general hepatic cytochrome P450.
Further indications of the specificity of the cholesterol 7a-
hydroxylase was provided by adding radioactive cholesterol analogues
to the microsomal suspension. Alteration of the A5 double bond
did not alter the ability of the microsomal system to 7a-hydroxylate
the sterol (4) but alteration of the cholesterol side chain by
removing the terminal methyl group reduced the rate of 7a-hydroxylation
to about half that for cholesterol (10). This last result implied
that the side chain of cholesterol played an important part in
determining the metabolism of the whole molecule. This aspect of
the enzyme action was chosen for further study and chapter 3 describes
the synthesis of cholesterol analogues with longer side chains than
cholesterol which were used to further define the role of the cholesterol
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side chain in the metabolism of cholesterol by the liver and the
adrenal mitochondria.
Traditionally, cholesterol 7a-hydroxylase activity has been
measured by a method which involved the addition of radioactive
substrate to the microsomes and isolation of the metabolites.
As the microsomes are relatively rich in cholesterol an assay
based on the conversion of a small amount of exogenous cholesterol
can give an indication of the activity of the enzyme but is not
entirely suitable due to problems of substrate supply. This is
due to the fact that the cholesterol in the microsomes exists in
different pools and it is not known how interchangeable the pool
contents are, or if a pool exists whose sole function is to supply
substrate for the enzyme. The added tracer cholesterol could
enter a pool of cholesterol that does not provide substrate and
thus the calculations of a percentage conversion to 7a-hydroxy
cholesterol could only give an approximation of the percentage of
the radioactivity accessible to the enzyme and not of the actual
enzyme activity. A much improved method of measuring the activity
of the enzyme would be to estimate the actual mass of product
formed by the endogenous cholesterol in the microsome. This
involved the use of gas liquid chromatography and mass spectrometry
and has been successfully used in other laboratories (11,12).
This is the obvious assay to use for study of the effect of
alteration of microsomal cholesterol and an example of a similar
assay is described in chapter 6.
The previously mentioned difficulty in explaining the regulation
of cholesterol 7a-hydroxylase by bile salts in terms of an effect on
any of the known components of the enzyme system indicated that the
production of 7a-hydroxycholesterol from cholesterol may be '
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increased by increasing the supply of substrate to the enzyme.
Indirect evidence of this came from the report of a 100,000 g
supernatant protein which was capable of stimulating the
activity of the cholesterol 7a-hydroxylase (13).
No possible mode of action of this protein is included in
the report although it may act to transport cholesterol to the
enzyme. A transport role for this protein implies that an
interaction between the cholesterol and protein is occurring.
Although there is evidence for a specific cholesterol binding
protein,it is not unequivocal, Klappauf and Schubert (14)
reported results of experiments with monlayers prepared from
phosphatidylcholine, phosphatidylethanolamine, sphingomyelin,
phosphatidylserine and cholesterol respectively that show that
Band 3 protein isolated from the erythrocyte specifically
interacted with cholesterol.
Binding proteins have also been isolated from the cytosol
of L cell cultures that are capable of distinguishing between
cholesterol and 25 hydroxycholesterol (15). The findings raise
the possibility that the activity of the cholesterol 7a-hydroxylase
might be regulated by a protein capable of supplying substrate to
the enzyme. If cholesterol could be relocated in the microsomes to
a site adjacent to the enzyme active site by such a protein,
then perhaps the effect of cholestyramine feeding could be
estimated in terms of the increased synthesis of such a cytosolic
protein. A similar cytosolic protein has been described by
Bell (16) which enhances transfer of cholesterol from the mitochondria
to the microsomes. This implies that the cholesterol pools of the
various cellular organelles may be capable of mutual interconversion.
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The actual function of cholesterol in a membrane has been
the subject of much study in the past few years. Cellular
membranes such as liver plasma membranes (17) and erythrocytes (18)
contain high levels of cholesterolthe molar ratios of
cholesterol to phospholipid of 0.83, 0.90 respectively while
relatively low cholesterol concentrations are found in plasma
membranes and subcellular membranes of nuclei, mitochondria, and
microsomes from liver. The cholesterol:phospholipid ratio
ranges from 0.11 to 0.33 (18) in these intracellular organelles
and only free cholesterol is present in a membrane. The functions
of the sterols in many biological membranes and the possible
interactions with other membrane components including phospholipid
and protein cannot really be studied in the intact cell due to
the complexity of the system. For this reason the initial studies
of the interaction of cholesterol with membrane components
especially phospholipid have been performed on artificial membranes
and natural membranes whose sterol content has been manipulated in
some way. The model systems developed have included monolayers
and liposomes and the role of cholesterol in these model membranes
has been studied by several physical techniques including electron
paramagnetic resonance (epr) (14), nuclear magnetic resonance
spectroscopy (nmr) (20), X-ray diffraction (21), and differential
scanning calorimetry (22).
When membrane lipids are spread on a film of water the q'mf4i«*pathic
nature of membrane lipids gives rise to forces at the lipid-water
interface due to hydrophilic and hydrophobic interactions. The
phospholipid head group is oriented in the water phase with the
hydrophobic fatty acyl chains in the air. In sterols the hydroxyl










attached side chain, the hydrophobic part. The interaction between
cholesterol and phospholipid can be monitored by measuring the reduction
in area of a mixed film of cholesterol and phospholipid when the film
is compressed by means of a moveable barrier (23, 24). The results
of these experiments showed that a planar sterol structure and a side
chain of undefined length were required for the interaction of a sterol
with a phospholipid and supported the view that hydrophobic inter¬
actions played an important role in cholesterol phospholipid inter¬
action.
Closed lamellar structures (liposomes) consisting of layers of
lipid separated by aqueous layers containing an electrolyte can be
spontaneously formed after suspending dry lipid material in an aqueous
solution (25). When the electrolyte containing liposomes are
challenged with a hypo- or hypertonic solution the liposomes swell
or shrink. Stopped flow light scattering measurements have been
made on these liposomes and the optical changes observed represented
the permeability of water through the outer layers of the liposome
(26). A similar set of experiments have been performed by preparing
liposomes containing different proportions of sterol in the presence
of glucose and noting the glucose leakage by an enzymatic assay.
In both sets of experiments cholesterol caused a strong reduction in
the permeability of those liposomes for which an interaction of
phospholipid with cholesterol was demonstrated (27, 28, 29).
Lathosterol and 7 - dehydrocholesterol showed similar effect&to that
of cholesterol, whereas stigmasterol and ergosterol were somewhat
less effective. The decrease in permeability was generally
proportional to the cholesterol concentration and was explained to
be due to the increased packing and decreased mobility of the hydro¬





phospholipid interaction as the 3a hydroxysterol, epicholesterol,
was not able to reduce the lipsome permeability (27). In agreement
with the monolayer results no effect is found for compounds lacking
the side chain (androstan-3g-ol) or with a non-planar sterol
nucleus (coprostanol).
The importance of the side chain in cholesterol phospholipid
interaction has been confirmed by Suckling and Boyd (30) using epr
spectroscopy. Their results suggested that the steroid side chain
exerted a very strong effect on its immediate environment, but
were only based on experiments performed with cholesterol analogues
with shorter side chains than cholesterol. It should be possible
to further define the role of the cholesterol side chain in
cholesterol phospholipid interaction and to determine if the iso-
octane side chain confers special properties on the cholesterol
molecule. Epr spectroscopy is a technique which requires the use
of an external reporter group in order to adapt it to the study of
membrane structure. The most common spin labels contain nitroxyl
radicals which indicate the molecular motion of liposomal phospho¬
lipids. By the use of spin labelled phospholipids in which the
spin label was attached at different points in the hydrocarbon
chain, Hubbell and McConnell were able to show that a fluidity
gradient existed in a phospholipid bilayer (31). Near the polar
edge of the bilayer the motion of the phospholipid hydrocarbon chain
was restricted, making this region of the membrane comparatively
rigid whereas the membrane interior was in a highly fluid state with
an apparent microviscosity comparable to that of a light oil. The
fluidity gradient arises because the overall motion of the chain is
composed of rotations about the individual C-C bonds. These
rotations are transitions between trans and gauche conformations
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with the gauche being of higher energy than the trans. If it is
assumed that the phospholipid chains are anchored at the polar
interface the chances of gauche configuration in the C-C bond
increases with the length of hydrocarbon chain with a consequent
increase in membrane fluidity at the bilayer centre.
The effect of cholesterol on the motion of the phospholipid
chains can also be observed using epr spectroscopy and differential
scanning calorimetry. Lipid bilayers composed of a single phospho¬
lipid type undergo a well defined phase transition at a characteristic
temperature (phase transition temperature) from a low temperature
state in which the lipid chains are in a rigid pseudo crystalline
state to a high-temperature form in which the chains are in a
fluid state (32). Introduction of cholesterol into fluid lipid
bilayers decreases the probability of gauche conformations in the
lipid chains until at equimolar amounts the lipid chains are almost
completely rigid in the all trans conformation (33). For non-fluid
bilayers e.g. dipalmitoyl phosphatidylcholine below its phase
transition, the hydrocarbon chains are in the all trans configuration
and the introduction of cholesterol actually introduces gauche
conformations into the chains fluidising the membrane. Thus below
the transition temperature in the presence of cholesterol the lipid
chains are more mobile than in the absence of cholesterol and above
the transition temperature they are less mobile. The overall effect
of the incorporation of cholesterol in phospholipid bilayers is to
produce a state of intermediate fluidity (32). In differential
scanning calorimetry, (22) the parameter that is measured is the
heat absorbed by the lipid chains to induce the phase change.
Although a transition from a gel to liquid crystalline state is not
detectable in the presence of equimolar amounts of cholesterol by
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examination of the DSC endotherm, laser Raman evidence indicates
that a transition still takes place though over a very wide temper¬
ature range and it is now a non co-operative phenomenon (34).
The precise phase transition temperature for each phospholipid
is a function of the unsaturation and fatty acid chain length of
the phospholipid (35). When cholesterol is added to a mixture
of phospholipids with different transition temperatures the cholesterol
partitions with the fluid phospholipid irrespective of the nature of
the other components (36). However using DSC Demel et al. (37) have
shown that the cholesterol affinity for phospholipid is in the order
sphingomyelin >, phosphatidylcholine > phosphatidylethanolamine.
This is consistent with the observations that biological membranes
containing phosphatidylethanolamine (mitochondria) contain little
or no cholesterol. This is considered to be due to the fact
that cholesterol and phosphatidylethanolamine cannot coexist in a
bilayer structure (38). The high levels of cholesterol and
sphingomyelin formed in the erythrocyte reflect the ability of
cholesterol to interact with sphingomyelin. In addition the
phospholipids with the highest affinity for cholesterol are located
on the outer side of the membrane whereas most of the phosphatidyl¬
ethanolamine and all of the phosphatidylserine is located on the
inner side (39). A combination of the different affinities of the
phospholipids for cholesterol and their distribution might produce
cholesterol rich areas in membranes.
Recently a related study has appeared which used cholesterol
oxidase (EC 11 26) to probe the organisation of a membrane.
Cholesterol oxidase was found not to be capable of oxidising
cholesterol present in erythrocytes and resealed erythrocyte ghosts
but could gain access to the cholesterol when inside out vesicles
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were prepared (40). Predominance of choline phospholipids with
bulky headgroups in the outer layer of erythrocytes was suggested
to provide steric hindrance to the cholesterol oxidase, whereas
inner layer phospholipids did not protect the hydroxyl group of
cholesterol.
The location of cholesterol in an egg yolk phosphatidylcholine
liposome is suggested to be concentration dependent (41). Below
31 mole per cent the cholesterol molecules partition homogeneously
into large liposomes, whereas abowe 31 mole per cent the cholesterol
molecules with their smaller molecular dimensions pack preferentially
into the areas of the bilayer with high radius of curvature (centre
of bilayer).
The various physical techniques already mentioned have been
used to provide information on the molecular architecture of the
cholesterol phospholipid complex. Darke et al. (42) used n.m.r.
to study the cholesterol phospholipid interaction and proposed that
the cholesterol and phospholipid formed an equimolar complex in
which apolar interactions between the steroid molecule and the first
ten methylene groups of each fatty acyl chain severely restrict their
motion. Under these conditions the motion of the terminal methyl
groups of the fatty acyl chain was essentially unrestricted. Their
model also implied that the cholesterol hydroxyl group may be hydrogen
bonded to the phosphatidylcholine phosphate grouping. This binding
is now considered improbable since the ester groupings of the
phospholipids must be hydrated and cholesterol incorporation does
31
not affect the P n.m.r. spectrum of various phosphatidylcholine
groupings (43). The observed ability of the cholesterol to affect
the motion of a section of the hydrocarbon chain has been incorporated
into a model of the interaction of cholesterol and phospholipid which
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does not propose the existence of a specific 1:1 complex (44).
This model proposes that the interactions between cholesterol
and phospholipid fatty acyl chains in a lipid bilayer are primarily
steric in nature. The carbonyl end of the fatty acyl chain
parallels the cholesterol nucleus whereas the lower region of the
chain terminal methyl end parallels the narrower cholesterol tail.
The cholesterol molecule can limit the number of possible > chain
conformations along the upper part of the fatty acyl chain while
simultaneously increasing the number of conformation of the lower
part of the chain. Thus the intermediate fluidity previously
described (32) results due to a gradation in the steric interaction
of the fatty acyl chains with the cholesterol molecule.
The motion of the isopropyl tail of the cholesterol molecule
has been studied by various applications of n.m.r. spectroscopy
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including C n.m.r. and H n.m.r. While the results of both
investigations indicate that the isopropyl tail undergoes rapid motion
there is no agreement regarding the ability of the fatty acyl ch,ain
to restrict the cholesterol isopropyl tail motion. Opella et al.
(45) regard the fact that 4G of proton irradiation was required to
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remove a H- C dipolar interaction as an indication that the motion
of the isopropyl tail group cannot be essentially unrestricted as
indicated by the "'"H n.m.r. studies of Kroon et al. (46). However
both studies suggest that the 1:1 complex of phospholipid and
cholesterol proposed by Darke et al. (42) is unlikely to exist.
The model of Rothman and Engelman (44) explained the observation
regarding the effect of cholesterol on the molecular motion of the
phospholipid fatty acyl chains but did not include a consideration of
the effect of cholesterol on the phospholipid head groups. The
phosphorylcholine portion of the phospholipid head group is thought
/
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to orient parallel to the surface of the bilayer so that the
positively charged N-methyl group is located close to the
negatively charged phosphate on a neighbouring phospholipid
in an intermolecular interaction (47). Addition of cholesterol
is shown to disrupt the intermolecular interaction without altering
the conformation of the polar head group that is found in pure
phospholipid bilayers (48).
The spatial relationship between the cholesterol molecules
has been most extensively studied by n.m.r. and X-ray diffraction
(49). The best fit between the model and the measured electron
density profile was obtained when the phosphorUatom was at
23 ± iX from the bilayer centre and the cholesterol molecule was
located such that its hydroxyl group was 19.5 ± 1.5$ from the
bilayer centre. Assuming that the phospholipid head group is in
the bilayer plane this result placed the hydroxyl group in the
region of the bilayer adjacent to the ester carbonyl oxygen.
The involvement of hydrogen bonds between the cholesterol hydroxyl
group and the carbonyl group has been implicated in cholesterol:
phospholipid interactions, but was recently conclusively proved by
Schwarz and Paltauf (50) by comparison of the passive diffusion of
Na+, CI and glucose across the membrane of single walled liposomes
formed from cholesterol and diether phosphatidylcholine (which
contains no ester carbonyl group), I-ether-2-ester phosphatidyl¬
choline and diester phosphatidylcholine. The replacement of
the ester groups by ether groups which cannot hydrogen bond removed
the cholesterol mediated reduction in the glucose permeability
previously observed by Demel et al. (27). The hydrogen bonding
can only take place when the sterol contains an equatorial hydroxyl
group (38)• An axial hydroxyl group (3a) cannot hydrogen bond with
15.
carbonyl oxygen because the O-H-O bond angle is not consistent
with hydrogen bond formation.
The most recent model of the interaction between cholesterol
and phospholipid has been proposed by Huang (51). As in the
model proposed by Rothman and Engelman the interaction is seen
as being primarily hydrophobic in nature. In addition the nature
of the phospholipid involved in the interaction is defined as
consisting of two fatty acyl chains with the saturated acid at
position (I) and the unsaturated acid at position (2). of
cholesterol is placed about the same level of of the adjacent
fatty acid in order to allow the possib ility of hydrogen bonds
between the cholesterol and the phospholipid molecules. In the
model of Brockerhoff (52), which implies that hydrogen bonds are
the most important feature in defining the interaction between
cholesterol and phospholipid, membranes are visualised as
bond
consisting of a hydrophobic core, two hydrogen belts and two polar
zones. This model suggests that cholesterol forms a hydrogen
bond with the carbonyl group at position 2 whereas the Huang model
indicates a hydrogen bond in this position is unlikely because
the unsaturation ensures that this chain is packed preferentially
to the f3 surface of the cholesterol nucleus rendering the hydroxyl
on the a face unavailable for bonding.
The saturated fatty acyl chain of the phosphatidylcholine is
proposed to pack in close contact with the a face of the steroid
nucleus. The unsaturated C^g.^ chain at position 2 of phospholipid
in the bilayer appears to consist of two linear parallel straight
segments linked by a A trans-gauche kink, the length of each segment
depending on the position of the gauche conformation. A 9, 10 trans-










A schematic diagram to show the relative location of




the fatty acid generating a loX hydrophobic pocket which is
sufficient to fit the packing requirements of the 2 angular
methyl groups at C^g and on the B face of the cholesterol
nucleus.
Thus the model visualises that the cholesterol is fitting in
between the fatty acyl chains in a very precise manner which
allows maximum hydrogen bonding and steric interaction between
the cholesterol and the phospholipid molecules. This apparent
precision of interaction between the two molecules would tend
to suggest that alteration of either molecule would result in a
decrease in the interaction. Fig. 1.4 gives an indication of spatial
relationship of sterol and phospholipid. As the sterol has an
absolute requirement for a planar nucleus and a 3BOH group for
interaction but the side chain requirement is not so rigorously
defined, we propose that alteration of the side chain should
disrupt the precise interaction visualised by Huang. Experiments
designed to test this hypothesis are described in chapters 4 and 5.
This thesis describes
(1) The synthesis of cholesterol analogues with altered side chains
in order to further investigate the side chain dependence of
cholesterol 7a-hydroxylase and the adrenal mitochondrial side chain
cleavage enzyme.
(2) An investigation of the role of the cholesterol side chain in
the interaction of cholesterol with phospholipid by a selection of
physical techniques.
(3) An attempt to gain more information regarding the supply of substrates
for the cholesterol 7a-hydroxylase.
(4) An investigation of the differences that exist between the




2.1 Animals and their diets
Male and female rats of the Wistar strain were used and
weighed approximately 150 g. They were obtained from the Bush
Small Animal Breeding Centre of Edinburgh University. Control
diets consisted of 70% wholemeal flour, 25% skimmed milk powder
and 5% dried yeast. Except where statements to the contrary are
made, this basic diet was supplemented with the bile acid
sequestering resin cholestyramine at a level of 4% w/w.
Phenobarbitone (Pb) 3-methyl cholanthrene (3 MC) and pregnenolone
16a-carbonitrile (PCN) were administered to increase the amount
of cytochrome P450 present in the microsomes. The phenobarbitone
was added to the drinking water at a concentration of 1 mg/ml for
five days prior to sacrifice whereas the PCN and 3 MC were injected
intraperitoneally.
2.2 Perfusion of the livers
In order to reduce the amount of haemoglobin present in the
microsomal fraction, the rats were subjected to ether anaesthesia,
and a needle connected to a reservoir of cold isotonic potassium
chloride was inserted into the hepatic portal vein. The perfusion
was completed in 2 minutes.
2.3 Preparation of microsomes
The protocol followed was essentially that described by
Ernster et al. (53). The perfused liver was excised and diced
with scissors and homogenised by four passes of a 'Teflon' pestle
in 0.154 M potassium chloride (4 vols/g wet weight tissue).
The homogenate was centrifuged for 20 minutes at 17,500 x g to
remove large particles. The supernatant from this centrifugation
was recentrifuged at 100,000 x g for 1 hour. The pellet formed
contained the endoplasmic reticulum and a large amount of glycogen,































Lipid extraction procedure used in the cholesterol 7a hydroxylase
assay.
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and was resuspended in distilled water, freeze dried, and stored
at -20°C.
2.4 Preparation of a butanol powder of rat liver microsomes
About 2 g of the lyophilised powder were homogenised in
400 ml of n-butanol cooled to -20°C. The homogenate was centrifuged
at 17,500 x g rpm in an MSE 1800 at -20°C, in a rotor, which had
been precooled overnight at -20°C, for 5 minutes. The supernatant
was discarded and the pellet was resuspended in 400 ml acetone at
-20°C and recentrifuged at 17,500 x g for 5 minutes. The resulting
pellet was once more resuspended in 100 ml of acetone at -20°C and
filtered on a Buchner Funnel. The powder was washed with 50 ml cold
(~20°C) acetone and dried under vacuo at room temperature for 1 hour.
A powder thus prepared could be stored at -20°C for two months with
no apparent loss of cholesterol 7a-hydroxylase activity, whereas
freezing the microsomal pellet itself results in a complete loss of
activity on thawing. Vore et al. (54) found that this procedure
removes all of the neutral lipid including cholesterol, 80% of
the phosphatidylcholine and phosphatidylethanolamine( and 75% of the
phospholipid phosphorus. In addition the anhydrous conditions
employed ensured a minimal loss of cytochrome P450 and NADPH cytochrome
P450 reductase.
2.5 Assay of cholesterol 7«-hydroxylase
(a) The cholesterol 7a-hydroxylase assay
P 14 1
[_4- Cl cholesterol (specific activity 50 mCi per mmole) was
purified ty T.L.C. using a solvent system of petroleum etherrdi-
isopropyl ether:acetic acid 30:70,2, prior to use. About 1 mg
(0.1 yCi) radioactive cholesterol, dissolved in 50 ttl acetone was
added to the incubation medium of 7 ml. of 0.1 M potassium phosphate
buffer pH 7.4 containing 10 mM g-mercaptoethylamine (cysteamine),
iy.
5 pmoles NADP, 50 ymoles glucose-6-phosphate and 1 unit of
glucose-6-phosphate dehydrogenase and approximately 10 mg
microsomal protein, which is approximately equivalent to 1 g
wet weight of liver. These are the optimal conditions for
the assay as described by Boyd et al. (9). Cysteamine acts to
prevent autoxidation of substrate cholesterol. After incubation
for 1 hour at 37°C with constant agitation, the reaction was
terminated by the addition of 5 ml of methanol. The methanolic
incubation solution was then transferred to lipid extraction tubes
and the incubation tubes were rinsed with a further 5 ml of methanol
and the two solutions were combined together. The radioactive
sterols were then extracted by a neutral lipid extraction scheme
presented in Fig. 2.1. The organic extracts were evaporated
under a stream of air and the residues applied to Keiselgel H
Type 60 thin layer chromatography plates. The reaction products
were separated from the substrate by developing in a solvent
system of benzene:ethyl acetate (7:13) and the exact location of
the radioactive metabolites was identified by scanning with a
Panax thin layer scanner. In the absence of cysteamine, 7-keto-
cholesterol, 73 and 7a hydroxycholesterol and cholestan-33, 5a,
63 triols are formed (55), but under the conditions described,
only one major metabolite is formed. The silica gel corresponding
to radioactive peaks was scraped into counting vials and 5 ml of
scintillants added (20 g PPO, 150 mg P0P0P in 5 litres toluene).
Radioactivity was then quantitatively determined in a Packard
Tri-Carb liquid scintillation counter. The presence of silica gel
does not cause significant quenching, and the efficiency of counting
14
C is approximately 80 per cent.
Typical recoveries of (4"^C cholesterol ) from
an incubation.
— c.p.m. recovery
Standard 4^0 cholesterol 15,000 100
After a lipid extraction 14,100 94
After T.L.C. 11,400 'jG




When the metabolism of the tritiated cholesterol side chain
analogues by the 7a-hydroxylase system was measured, the radioactive
metabolites formed were separated by thin layer chromatography.
As this procedure yields many products the chromatograms were
scraped in centimetre bands.
(b) The determination of 7a-hydroxycholesterol
Incubations of liver microsomes or cholesterol depleted
microsomes were conducted as previously described but without
r 14 ~i
the addition of 4- Cl-cholesterol. After stopping the
reactions with methanol ^7^h| -7a hydroxycholesterol was added to
each flask. Lipids were extracted and subjected to TLC and
standard 7a hydroxycholesterol was run at the edge of each plate.
This was located by spraying with phosphomolybdic acid. A bright
turquoise colour is obtained on gentle heating. The areaof the
plate corresponding to 7a-hydroxycholesterol was removed into a
centrifuge tube and the silica gel was extracted twice with methanol.
An aliquot of the methanol was transferred to a scintillation vial,
evaporated, and counted in a Packard liquid scintillation spectrometer.
This gave an estimation of the recovery process. The remainder
was taken to dryness under nitrogen and a known quantity of
cholesterol was added as an internal standard for gas liquid
chromatography (GLC). A sample of this mixture was injected onto
the GLC column in redistilled acetone (the conditions for chromato¬
graphy are described below). The 7a-hydroxycholesterol in the sample
was quantified by comparing the ratio of the heights of the peaks
obtained for the 7a-hydroxycholesterol and cholesterol with a
standard curve of mass ratio versus peak height ratio. This value
is corrected for recovery losses and hence the mass of 7a-hydroxy-











(c) Conditions for 7a-hydroxycholesterol determinations by GLC
All gas chromatographic work was carried out on a Pye 104
gas chromatograph equipped with a flame ionisation detector.
The columns used were 1.75 metres long of 4 mm internal diameter
glass tubing silanised with dichloro-dimethylsilane. The liquid
phase used was 1% SE 30 on 100-120 mesh gas chrom Q. The
column oven temperature was 205°C, the injection port temperature
was 220°C, and the detector oven temperature was 240°C.
Nitrogen was used as a carrier gas at a flow rate of 30 ml per
minute. Using these conditions and an attenuation setting of
2
20 x 10 , a full scale deflection of the pen recorder represented
the presence of 0.8 yg of 7a-hydroxycholesterol.
2.6 Cholesterol assay
The levels of cholesterol in microsomal preparation were
measured in one of two ways:
(a) by gas liquid chromatography
(b) by the use of cholesterol oxidase prepared from Nocardia species
(a) This procedure involved a lipid extraction, similar to
that described by Folch (56), thin layer chromatography in petroleum
ether:di-iso-propyl ether:acetic acid (70:30:2v/v) and elution
of the cholesterol (located by including a sample of radioactive
cholesterol in the microsomal solution prior to the lipid extraction)
from the gel with methanol. After removal of an aliquot of the
methanol to measure the recovery of label, this final extract was
evaporated to dryness and then redissolved in redistilled acetone
in the presence of pregnenolone as an internal standard. Average
recoveries are noted on the opposite page (Table 2.1). The sample
was then applied to a column of 100-120 mesh gas chrom Q on which








injection heater at 300°C and a nitrogen flow of 30 cm/minute
the amounts of cholesterol present in the sample were determined
by comparison of the peak height ratios forthe unknown cholesterol
and known pregnenolone acetate with standard mixtures of the
two components.
(b) Cholesterol oxidase is an oxygen oxidoreductase which
.45
reacts specifically with A - or A - 38-hydroxycholestanes.
4
Cholesterol is metabolised to A - cholestenone by this enzyme with
the release of hydrogen peroxide as a by-product. This is measured
by monitoring at 500 nm the pink colour produced by a hydrogen
peroxide, phenol, 4-aminophinazone, peroxidase complex (57).
The presence of high levels of peroxidase activity and sodium
azide ensure that catalase does not interfere with colour
production.
100 yl of microsomal suspension (10-100 yg cholesterol) or
water were added to 2.5 ml of a solution prepared by mixing equal volumes
of 0.4 M Tris HC1 buffer pH 7.0 containing phenol, (0.144 % w/v),
and Triton X-100, (0.5 %), and 0.05 M Tris HC1 buffer pH 7.0 con¬
taining 4-amino-phenazone (0.022 % w/v). To this solution, was
added cholesterol oxidase (0.025 E.U.) and reaction was promoted by
a 15 minute incubation at 37°C. The solutions were read against
a reagent blank, correcting for turbidity, and the absolute amounts
of cholesterol present determined by comparison with standards.
Fig. 2.2 shows a typical calibration curve for cholesterol
determination by cholesterol oxidase.
2.7 Phospholipid determination
Phospholipid was measured in two ways:
(1) by a modification cfthe methods of Zilvers it and Davis (58)
(2) by the method of McClare (59)
23.
(a) Phospholipids, proteins and nucleic acids were precipitated
from the sample by the addition of a 10% (w/v) solution of
trichloracetic acid and a subsequent 30 min incubation at 4°C.
Centrifugation of the precipitate yielded a pellet which was
separated from the supernatant and vortexed with a chloroform:
methanol solution (2:1) to separate the lipids from the rest
of the material. The organic phase thus obtained was blown
down to dryness under nitrogen. The extract was then digested
for an hour by boiling with (1) 1 ml perchloric acid or (2) 0.5 ml
perchloric acid respectively.
(b) The method of detection of the phosphate liberated by this
procedure differed in both cases.
(1) Zilvers pv* tit added 3.5 ml water followed by 0.5 ml
8.3% ammonium molybdate and 1 ml of 1% amidol in 20 percent
sodium metabisulphite. After exactly 10 minutes the absorbance
at 720 nm against a perchloric acid boiled water blank was
determined. This colour reaction was useful in the range 1 to
25 yg phosphorus.
(2) The McClare method used triphenyl phosphine instead of
Na2HP0^ and involved the^use of a freshly prepared colorimetric
reagent containing 8% perchloric acid, 1% ammonium molybdate and
0.2% ascarbic acid. 9.5 ml of this reagent were added to each
digest tube which then covered and heated for 40 minutes in
a 50°C water bath. The phosphate content was measured by absorbance
against a reagent blank at 825 nm and converted to yg phospholipid
by multiplication by 25. This colour reaction was useful in the
range 1-7 yg phosphorus. Fig. 2.3 shows an example of a standard
curve for phosphate determination.
24.
Of the two methods McClare's was preferable due to its
greater sensitivity, its reproducibility and the stability of
the coloured complex produced.
2.8 SDS polyacrylamide gel electrophoresis was performed according
to Weber and Osborn (60).
2.9 Protein was assayed either according to the method of Lowry (61)
or by the biuret method (62). Fig. 2.4 shows a typical Lowry
calibration curve.
2.10 E thylmorphine-N-derne thylase assay
Ethylmorphine is N-demethylated hy liver microsomes in the
presence of an NADPH generating system with the concomitant
release of formaldehyde.
Liver microsomes were suspended at a final concentration of
2 mg microsomal protein per ml in a final total volume of 10 ml
of 50 mM Tris, 150 mM KC1, and 10 mM MgC^, pH 7.4 containing 8 mM
ethylmorphine. After equilibration at 37°C for two minutes,
0.2 ml of a NADPH generator (7.5 mg/ml NADP+, 25 mg/ml glucose
phosphate and 5 iu/ml glucose-6-phosphate dehydrogenase) was
added to the flask to initiate the reaction. 2 ml samples were
taken at zero time, 5 minutes and 10 minutes and immediately added
to centrifuge tubes containing 2.0 ml 15% trichloracetic acid.
After a 10 minute centrifugation 2.0 ml of the supernatant was
transferred into 2 ml of Nash reagent (2 M ammonium acetate,
50 mM acetic acid and 20 mM acetyl acetone) and colour development
was promoted by an eight minute incubation at 58°C. The absorbance
at 412 nm was measured and converted into the concentration of
formaldehyde present by use of an absorbance coefficient of 8 mM ^cm
25.
2.11 Assay of cytochrome P450
Cytochrome P450 concentration was determined essentially
as described by Omura and Sato (63) in a Pye Unicam SP 800
double beam spectrophotometer. Thus to approximately 6 ml of
sample (12 mg protein) were added a few crystals of sodium
dithionite and the suspension was split into two fractions,
a sample and reference fraction which were initially balanced
at 500 nm. After recording a base line of equal absorbance,
carbon monoxide was gently bubbled through the cuvette for about
30 seconds. A recording was then made of the CO reduced minus
reduced difference spectrum and the concentration of cytochrome P450
calculated by measuring the absorbance at 450 nm calculated by
measuring the absorbance at 450 nm relative to 490 nm using an
extinction coefficient of 91 mM ''"cm \
2.12 Measurement of cytochrome b^
The cytochrome b,. concentration was determined by observing
the difference in absorbance between the peak at 424 nm and the
trough at 409 nm obtained when a few grains of NADPH are added to
the sample cuvette. Using this reduced minus oxidised spectrum
and an extinction coefficient of 185 mM ^"cm ^ the cytochrome b,.
concentration present was calculated.
2.13 Assay of NADPH-cytochrome c oxidoreductase
To 218 ml of 0.1 potassium phosphate buffer pH 7.7 were added
50 pi i.e. 1 mg cytochrome c, 100 pi of NADPH generator (0.5 pmoles
NADP+, 5 pmoles glucose-6-phosphate dehydrogenase). The reaction
performed at 25°C was started by addition of the flavoprotein
containing sample. The velocity of reaction was measured in a
Pye-Unicam SP 800 double beam spectrophotometer in the dual wavelength
mode. The difference in absorbance between 551 nm and 540 nm was
zt>.
recorded as a function of time. An extinction coefficient of
19 mM ^cm ^ was used as the difference between reduced and
oxidised cytochrome c.
2.14 Preparation of single walled liposomes
Liposomes were prepared by the evaporation of a chloroform
solution of the lipids to form a thin film. The vessel containing
this film was then placed in a vacuum dessicator for two hours
during which time any residual chloroform was removed. The lipid
film was converted into multilayered liposomes by vortexing for 5
minutes with sufficient 10 mM Tris HC1 pH 7.4, 1 mM EDTA to prepare
a 3 mg/ml lipid dispersion. In order to prepare single walled
liposomes 5 ml of the multilayered liposomes (3 mg/ml) were subjected
to a sonication step (using a Rapidus 150 sonicator, output 20 w).
This involved a 40 minute treatment (16 x 2 minute bursts with 30
seconds between each burst) at power level 8 to 9 with a 9 mM
diameter titanium probe. The solution to be sonicated was placed
in a standard ice jacketed bottle (2 cm diameter, length 9 cm).
After the sonication step the single walled liposomes were separated
from titanium fragments and undispersed lipid by centrifugation of
the optically clear preparation at 100,000 g for 30 minutes. The
liposomes thus obtained were shown to be free of lysolecithin and
could be stored for a week at 4°C without any visible precipitation
occurring.
Using this sonication procedure the liposomes were shown to form
a homogeneous population as judged by the elution profile from a











Spin label spectra at 25 NC in the presence (40 mole % ( ))
or absence ( ) of cholesterol. The order parameter (S) is
calculated thus
s = 2A11 ~ 2A1
25
Fig. 2.6 (b)
Spin label spectra of 3 NC in the presence (40 mole% ( )) or




2.15 Preparation of egg yolk phosphatidylcholine
Phosphatidylcholine was prepared from egg yolks by the method
of Pangborn (65), which involved an initial acetone extraction which
removed all of the neutral lipids leaving a cake of protein and
phospholipids. A 95 per cent ethanol extraction of the cake
separated the protein from phospholipids which were subdivided by
a combination of solvent extraction methods and the formation of
cadmium adducts of the phosphatides. Sphingomyelin was retained
with the phosphatidylcholine during this preparation but was
eventually removed by precipitation from a cold ether solution of
phosphatidylcholine. Using this procedure it has been shown that the
phosphatidylcholine thus obtained contained a trace amount of
cadmium detectable by microelectrophoresis (66) (but not by 5%
Ag NO^), however this was not thought to be of critical importance.
Thin layer chromatography shows only one spot when the chromato-
gram was developed by chloroformrmethanol:water (65, 35, 5 v/v).
2.16 Electron spin resonance
Spin labelling experimental details
(a) 3NC and 25NC spin labels (for structure see Figure 2.5)
Multilayered liposomes were prepared as previously described using
0.154 M KC1 (20 yl) instead of 10 mM Tris-HCl-lmM EDTA. They
contained the required proportions of sterol, egg yolk phosphatidyl¬
choline and 1 mole % of the steroid spin label. (As a high concen¬
tration of spin label masks the spectrum it was essential to use a
-3
spin label concentration of less than 10 M). Electron spin
resonance spectra were recorded on a Varian E4 spectrometer (at
the X band (3272 G) with scan range 100 G, modulation frequency
100 kHz, modulation amplitude 1.25 G, time constant 1 second, at a
power input of 20 mW, with the klystron tuned at 9.15 GHz) within
two hours of preparation at 30°C with the samples in haematocrit
capillary tubes sealed at one end. Order parameters for 3NC
were calculated according to Griffith et al. (67) and Smith (68).
The three line spectrum obtained in both cases is the result of
averaging of the orientations of the principal axes of the
spin label group relative to the applied magnetic field, Fig. 2.6
shows representative spin label spectra. In one orientation along
the Z axes of the nitroxide an ESR spectrum of three narrow lines
separated by 32 G would be observed whereas along the x and y axes a
sharp three lines spectrum separated by approximately 6 G would be
recorded. The order parameter (S) is given by the equation
which is uncorrected for polarity effects.
c c
(S) = (A max - A min)/ Azz - | (A xx + A yy)
= A max - A min/25 G.
For (25NC) ACzz - { (ACxx + A yy)
is also estimated to be 25 G from its spectrum in chloroform at
-172°C (68). 25 G is the figure used to calculate (S) in Chapter 4.
(b) 2,2,6,6 Tetramethylpiperidine-I-oxyl (Tempo)
A chloroform solution of sterol and a saturated phosphatidyl¬
choline (dipalmitoylphosphatidylcholine) was evaporated under nitrogen
forming a film on the sides of a 3 ml test tube. The remaining
solvent was removed by a 2 hour vacuum dessication, 0.154 M KC1
(40 pi) was added and the solution was heated to 60°C for 30 seconds
in order to melt the saturated phospholipid. The resulting solution
was vortexed for 30 seconds and the process was repeated 4 times.
~8
Tempo (1 pi in aqueous solution 4 x 10 M) was then added, and the
mixture was reheated to 60°C for 15 seconds, vortexed for 1 minute
and placed in a flat cell. The plane of the cell was placed transverse
to the length of cavity so as to locate the whole of the sample in a
region of minimum electric and maximum magnetic field thus minimising
Fig. 2.7
Fig- 2.7
The effect of solvent polarity on the epr spectrum of 3N8
-4
(4.7 x 10 M) dissolved in (a) distilled water, (b) petroleum
ether and (c) in egg yolk phosphatidylcholine liposomes.
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Principles of Stopped Flow
The experimental method known as stopped flow spectrophotometer}^
is used to determine the kinetics and rates of reactions which
result from "ts|ie mixing of two samples, A and B. These samples
are contained in two syringes which are driven by a single
piston mechanism. The solutions therefore leave the two
syringes with equal flow velocities and enter the mixing cell
where the mixing occurs and the reaction
A + B C starts.
The mixed solution in which the reaction is now proceeding then
enters a third syringe, the piston of which is driven back until
it hits a stop which arrests the flow abruptly.
P marks the position of the mixing chamber.
dielectric absorption and maximising magnetic absorption. The
spectra were recorded in the x-band region (3500 G) with a modulation
amplitude of 1.25 G, a modulation frequency of 100 kHz, a time
constant of 0.3 sec and a power input of 5 MW. The klystron was
tuned at a frequency of 9.145 GHz. The spectra were obtained as
a function of temperature with heating rates of about 10°C per hour
controlled by a Varian E 257/WL 257 variable temperature accessory.
The structure of Tempo is shown in Fig. 2.5.
The experimental design was based on the differential penetration
of Tempo into lipid in the gel and liquid crystalline states. Thus
the nitroxide solubility parameter, (f), can be measured from the
partially resolved high field hyperfine spectral line and is
approximately equal to the mole fraction of spin label in the hydro¬
phobic region of the lipids (69) (Fig. 4.3).
(c) 3-(N-oxyl-4',4,-dimethyloxazolidine)-octane (3N8)
Experimental details were identical to those for Tempo. Fig. 2.7
shows the effect of the polarity of the medium on the spectrum and
the splitting ofthe high fii'd line. Fig. 2.5 shows 3N8 structure.
The relative position of each spin label in the phospholipid bilayer
was estimated in the following way.
(d) A solution of nickel chloride or ascorbate was added to
preformed egg yolk lecithin liposomes (4 mg/20 ml) containing 50 nmoles
spin label and the reduction in the spectral central line at room
temperature was measured over a fixed time which varied from 10 to
20 minutes.
2.17 Stopped flow spectrophotometry of liposomes
Multilayered liposomes were prepared in 0.05 M KC1 pH 7.2
(2 mg lipid/ml) from a lipid film containing 4 mole % dicetyl
phosphate by the method described in section 2.13. The dicetyl
phosphate gave the liposomes a negative charge and increased their
overall diameter but did not cause an increase in salt leakage.
The liposomes were introduced into one chamber.of a Nortech SF3A
stopped flow spectrophotometer equipped with a Datalab DL901
Transient Recorder and a recording oscilloscope. The other
chamber was filled with 0.18 M KC1 pH 7.2 and equal amounts of
both solutions were mixed in the path of a 450 nm light source.
The initial rate of shrinking over the first second was
calculated using the data collected over the first second of the
reaction expressed as a fraction of the total transmittance change
occurring over a 50 second period (26). As the incorporation of
dicetyl phosphate has been shown to increase both the initial rate
of shrinking over 1 second and the total amount of shrinking over
50 seconds, then this treatment of the data eliminated any dicetyl
phosphate mediated change. Fig. 2.8 shows a diagram of the stopped
flow spectrophotometer.
2.18 Measurement of the force area curve for mixed films of cholesterol
analogues and egg yolk phosphatidylcholine
The surface pressure-area relationship was determined for mono¬
layers spread at the air-water interface using a Langmuir trough
made of PTFE. The lipids were dissolved in chloroform and injected
on to the surface of a film of doubly distilled water maintained
at 22.5°C. Compression of the monolayer was continuous at a rate
of 4 cm min ^ and a pressure of 12 dynes cm ^ and the pressure curve
was recorded automatically in a period no greater than 5 minutes.
2.19 Assay of the cholesterol side chain enzyme from adrenal mitochondria
The rats were either given (a) a 10 minute period of ether
anaesthesia or (b) 10 IU ACTH (i.p.) 30 minutes prior to sacrifice.
The adrenals were excised and homogenised in 0.25 M sucrose con¬
taining 10 mM Tris pH 7.4 and 0.1 mM EDTA. Mitochondria were
prepared by centrifuging the homogenate at 500 x g for 15 minutes,
discarding the pellet and recentrifuging the supernatant at 6,000 x g
rpm for a further 15 minutes. The pellet thus obtained was once
washed with buffered sucrose and centrifuged at 6,000 x g for 15
minutes. The pellet was taken up in buffered sucrose (3 ml) and
resuspended by repeated mixture in a 10 ml pipette. The mitochondrial
suspension (0.2 ml of 4 mg/ml) was added to an incubation mixture
comprising NADP+ (20 pi from 7.5 mg/ml, Ca^C^ (20 pi from 0.05 M) ,
cyanoketone (5 pi from 1 mg/ml), sterol (10 pi from 4 mg/ml) in
0.8 ml of a buffer consisting of 0.25 M sucrose (47.5 ml), IMKC1
(1.0 ml), 1 M triethanolamine 0.75 ml), 1 M potassium phosphate pH 7.4
(0.5 ml), IM MgC^ (0.25 ml), essentially fat free BSA (50 mg) and
0.1 M EDTA (50 pi). The mixture was preincubated for 15 minutes
at 37°C before the reaction was initiated with 5 pi isocitrate.
0.2 ml sample was removed from each incubation after 0,2,5 and 10
minutes and added to methanol (4 ml). The amount of pregnenolone
present was assayed using a previously developed radioimmunoassay.
Materials
All common reagents were purchased from BDH or Sigma and
were of Analar grade.
Glucose-6-phosphate, NADP, NADH, glucose-6-phosphate dehydro¬
genase, were obtained from Boehringer GmbH, Mannheim.
Dicetyl phosphate, cytochrome c, trypsin, horse radish
peroxidase, ascfisxribjic acid, DEAE cellulose, and blue dextran were
supplied by Sigma (London).
Nonidet P42, ammonium sulphate, phenobarbitone, ammonium
molybdate, coomassie blue G250, cholesterol oxidase, Triton X-100,
aminophenazone, and phenol were purchased from BDH Chemicals,
Poole, England.
Pregnenolone-16a-carhonitrile was the generous gift of
Dr. J. Babcock, Upjohn Ltd., Kalamazoo, Michigan, U.S.A.
Ethyl morphine hydrochloride was obtained from McFarlane
Smith, Edinburgh.
Sephadex G75 and Sepharose 4B were supplied by Pharmacia,
Uppsala, Sweden.
PPO, PPOP, L-a-lecithin (B, dipalmitoyl), L-a-lecithin
(3- -dimyristoyl), acrylamide, methylene-bis-acrylamide, and
dihydropyran were purchased from Koch-Light, England.
Cholestyramine resin (Cuemid), Kieselgel H, and K'teselgel 60
(for column chromatography) were products of Merck, Sharp and Dohme.
[4-^^cj cholesterol (specific activity 50 mCi/mmol) , l,2(n)-"^H
(10-25 mCi/mmole) , were purchased from The Radiochemical Centre,
Amersham.
Other radioactive steroids were synthesised by Dr. K.E. Suckling
in this laboratory.
cholesterol (specific activity 40-60 mCi/mmol),
32.(eT)
3~spiro-(2'-(N-oxyl-4',4'-dimethyloxazolidine)) cholestane
(3NC) was purchased from Synvar Associates, Palo Alto, California.
3B-hydroxy-26-25- (2' - (N-oxyl-4' , 4' dimethyloxazolidine) ) cholestane
(25NC) was synthesised from 3f3-hydroxy-26-nor-25-cholestane by
Dr. K.E. Suckling.
CHAPTER 3




The synthetic scheme for the production of cholesterol analogues
with altered side chains falls into 2 basic parts
(a) Conversion of a bile acid steroid ring system to a cholestane
ring system with a bile acid side chain
(b) Extension of the five carbon unit side chain of the bile acid by
one, three, four carbon atoms by the use of the appropriate Grignard
reagent.
The starting material chosen for the synthetic scheme was the
major swine bile acid hyodesoxycholic acid which in common with all
bile acids has a cis A/B ring junction but exclusively possesses
equatorial hydroxyl groups at the 3a and 6a positions. The hydroxyl
groups are thus situated on the same side of the molecule and oriented
in the correct manner to assist conversion of the A/B ring junction
from a cis to a trans with a consequent inversion of configuration
at the 3a position.
3.1 Esterification of hyodesoxycholic acid
This was achieved by the use of diazomethane prepared by the
method of De Boer and Backer (70) which specifically reacts with
carboxylic acids leaving the alcohols untouched (71). The diazomethane
was reacted with hyodesoxycholic acid (Fig. 3.1) in the presence of a
small amount of methanol to enhance the reaction. The resulting methyl
ester (Fig. 3.2) was formed in quantitative yield.
3.2 5a-Cholanic acid-3a,6a-diol methyl ester di-p-toluene sulphonate
The activation of the equatorial hydroxyl groupings for elimination
was readily accomplished by the reaction at 4°C in dry pyridine
containing a 2 fold molar excess of p-toluene-sulphonylchoride (72)
with the hyodesoxycholic acid methyl ester (Fig. 3.2). There are
three points to note in this procedure.
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(a) If wet pyridine was used the yield was very poor.
(b) The ratio of methyl ester to pyridine was important (1 g per 4 ml
gave the best yield).
(c) The ditosylate formed by the reaction was very labile and decomposed
on mild heating.
Using this method a less polar homogeneous product with an
infrared spectrum identical to the methyl ester apart from the
presence of an aromatic absorbance at 1600 cm \ was obtained in
quantitative yield.
The points raised in this section apply equally well to the
preparation of tosyl esters of the various Grignard products
(3.16) (3.20) (3.10) and the hydroxy sterol (3.15).
3.3 3g-Hydroxy-5-cholenic acid methyl ester
The conversion of the 3a, 6a-ditosylate to the 36-secondary alcohol
was attempted in two ways.
(a) The ditosylate was dissolved in dimethyl formamide containing
potassium acetate (73), and water and heated at 105° for three hours
in an oil bath with constant stirring. The dimethyl formamide
solution was then poured into water. Silica gel thin layer chromatography
of the extracted reaction mixture showed that six products were
present, of which the 3f?-hydroxy cholenic acid methyl ester when
purified from the others by column chromatography was shown to be
present in approximately sixteen per cent yield.
(b) In outline (b) resembles (a) in the basic solvolysis reaction
(pouring dimethyl formamide into dilute acid instead of water)
and included a subsequent overnight alkaline hydrolysis of the un-
purified, chloroform extracted, steroidal derivatives. Purification
of the reaction products by column chromatography, eluting with
chloroform followed by ethyl acetate and methanol, yielded a material
o
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which was more polar than reference characterised 33~hydroxy cholenic
acid methyl ester. This polar product which crystallised from ethyl
acetate to give a white powder (Fig. 3.6) in a yield which varied
from 50-75% acid was converted to 33-hydroxy-5-cholenic acid methyl
ester (Fig. 3.7) by treatment with diazomethane. n.m.r. analysis shows
the presence of a double bond and a methyl ester.
The reason why a hydrolysis step increases the yield is explained
in the paper by Bharuca et al. (73). During the dehydrotosylation of
3a,6a ditosyloxy steroids having a ring A/B cis junction, several
reactions can take place.
There is an S^2 mechanism operative at C-3 with complete inversion
of the a hydroxyl group. This is accompanied by an El elimination
reaction in the B ring at C-6 to form the double bond. The same
elimination may also occur at the C-3 instead of substitution,
with the formation of a heteroannular diene impurity. The yield of
the 33~hydroxy steroid is increased with a concomitant decrease in
diene formation when the reaction is performed at an alkaline pH,
which inhibits the El reaction as the ratio of diene to 33-hydroxy
steroid is only determined by the relative rates of substitution and
elimination processes. Alkaline hydrolysis of a heteroannular diene
converts it to the corresponding 33 hydroxy-5a-compound.
3.A The protection of the 33 hydroxyl grouping
This was attempted in one of 2 ways, either by reaction with
(a) triphenylchloromethane to give 33-triphenyl-methoxy-5-cholenic
acid methyl ester (Fig. 3.4) or (b) dihydropyran yielding 33-2-
tetrahydropyranyloxy-5-cholenic acid methyl ester (3.3).
(a) Helferich et al. (74) showed that primary and secondary alcohols
can be converted into their respective trityl ethers by reaction with




3|3-hydrnxy-5-cholenic acid methyl ester and triphenylchloromethane,
previously purified by recrystallisation in the presence of acetyl
chloride (72), were reacted in dry apparatus in an oil bath at
110°C in the presence of catalytic amounts of phosphorous oxychloride.
Any trace of water results in the liberation of hydrochloric acid
which would cleave any adduct formed. The products were extracted
with dichloromethane and isolated by column chromatography.
Due to difficulty in separating the protected methyl ester from
the impurity triphenylhydroxymethane the yield was very variable
but was less than 47% (b) 2-3 dihydropyran is a reagent which
reacts under mild acid catalysis with primary and secondary alcohols
to form tetrahydropyranyl ethers which are stable to bases,
Grignard reagents, lithium aluminium hydride, and to oxidation
(72). Due to its high reactivity with carboxylic acids, it was
essential that the acid at was esterified prior to its
exposure to dihydropyran.
The method used was based on those developed by Greenhalgh
et al. (75) and Dasgupta et al. (76) for the protection of cholesterol
and 3B-hydroxy-24-nor-cholen-23-al respectively and is very clean
as judged by TLC. The tetrahydropyranyl ether was formed by
reaction of the secondary alcohol with a 3 fold molar excess of
freshly distilled dihydropyran in dry chloroform in the presence
of catalytic amounts of phosphorus oxychloride. The apparatus and
chemicals must be dry because the presence of water can cause the
liberation of hydrogen chloride which can cleave any adduct formed.
The reaction was allowed to proceed overnight and the protected
product isolated by silica gel column chromatography on elution
with ethyl acetate:chloroform (5:95 v/v). The yield of this reaction






3.5 Lithium aluminium hydride reduction
are
There^two steps in the synthetic scheme that involve the use
of lithium aluminium hydride.
(a) Conversion of the carboxylate methyl ester grouping to a primary
alcohol (3(3-2'-tetrahydropyranyloxy-5-cholen-24 ol) (Fig. 3.2).
This is a well characterised reaction involving the addition of a
large excess (2-4 mole ratio) of lithium aluminium hydride to a
solution of dry methyl ester. The reduction of esters is described
as an initial nucleophilic displacement which in effect amounts to
an addition-elimination step followed by a reduction step.
After a four hour reflex in dry apparatus fitted with a calcium
chloride guard tube the excess reagent was destroyed and the
product was isolated by column chromatography. The yield obtained
by this procedure is 70% (85% in (72)) IR analysis cannot detect
the presence of a carboxyl group consistent with its conversion to
an alcohol.
(b) The second reaction in the synthetic s.cheme that required the
use of lithium aluminium hydride was the reduction of a primary
p-toluene-sulphonyl-ester to the corresponding methyl compound.
This is common to the synthesis of the protected C^g (Fig. 3.12).
C25 (Fig. 3.17), (Fig. 3.14) and C29 (Fig. 3.21), and is
/
readily accomplished with a quoted median yield of 65% (72).
The actual conditions for the conversion were identical to those
described above and the reaction proceeded in approximately 50-60%
yield (90% in (72)).
3.6 Production of 5-cholen-3(3-ol
The synthesis of 5-cholen-3(3-ol was accomplished using
3-2'^tetrahydropyranyloxy-5-cholen-24-ol as starting material.
The synthetic scheme involved (a) an initial activation of the
JO,
primary alcohol on by reaction with p-toluene sulphonyl chloride
followed by (b) a lithium aluminium hydride mediated reduction.
5-cholen-33~ol was then easily prepared by (c) acidic cleavage of
the 33tetrahydropyranyl ether.
(a) The p-toluene sulphonyl ester was prepared by reaction of
the free alcohol with an excess of p-toluene sulphonyl chloride
following the method previously described in this chapter.
Infra red analysis of the concentrated reaction mixture detected
the presence of an aromatic ring and thin layer chromatography
indicated that a single, less polar, product had been formed.
(b) This procedure has already been described in detail in a
separate section. Crystalline 33tetrahydropyranyl ether was
obtained from the acetone solution of a Keiselgel 60 column eluate.
Infra red analysis showed that the aromatic group had been
removed and mass spectrometry gave the major peak at 328.
This was consistent with loss of the tetrahydropyran and the
sterol 33 hydroxyl group from the desired compound.
(c) Acid hydrolysis of 33~2'-tetrahydropyranyloxy-5-cholene
yielded 5-cholen~33-ol as needle like crystals from methanol with
a molecular ion of 344.
3.7 33-2'-tetrahydropyranyloxy-5-cholen-24-ol (Fig. 3.9)
The foregoing alcohol was oxidised to an aldehyde in one of
two following ways
(1) By oxidation with chromium trioxide pyridine complex (77) and
(2) By reaction with a silver oxidercelite (78).
(1) After reaction with the Collins reagent (77), TLC of the crude
material showed that four products had been formed, one of which
was separated in 25% yield.
Using this procedure Collins obtained cholestenone from cholesterol
in 64% yield, however there are two problems associated with this
procedure.
jy.
(a) The oxidation will proceed beyond the aldehyde with formation
of a carboxylic acid impurity.
(b) As it is an acidic reagent it tends to cleave the 3(3 tetrahydropy-
ranyl ether linkage.
(2) Essentially this method is that of (78) and involved the
preparation of a silver oxide:celite reagent formed by the combination
of silver nitrate (0.117 M), potassium carbonate (2 mmoles), and
celite (1.5 g) . This gave sufficient oxidation complex to react
with 1 mmole of alcohol during an overnight reflux. The aldehyde
formed was easily isolated by column chromatography due to the large
difference in polarity of starting material and product was found
to be present in greater amounts (40-70% yield as compared to 25%
with (1)).
The silver oxide gave a much cleaner conversion to product and
proceeds to completion with no further conversion of the aldehyde.
In both (a) and (b) the appearance of a sharp peak in the IR
trace at 1707 cm * was indicative of the presence of a carboxyl
group. In common with all tetrahydropyranyl ethers no molecular
ion was detected, but assuming that the molecular weight was 442,
the disintegration pattern was explained in terms of removal of
dihydropyran and a hydroxy 1 group (M+-102) . The major peak has a
molecular weight of 340.
3.8 Extension of the bile acid five carbon side chain by addition of
the appropriate Grignard reagent
The synthesis of (3.10), (3.20) and (3.16) were achieved using
3f3-2,-tetrahydropyranyloxy-5-cholen-24-ol and a Grignard prepared
from purified l-bromo-2-methyl propane, 1-iodo-pentane, and
iodomethane respectively. The method employed was similar in all
cases and was based on those of Petrov and Stuart-Webb (79) and
40.
Dasgupta et al. (76). The alcohol formed from 38-2'-tetrahydro-
pyranyloxy-5-cholen-24~ol was isolated by column chromatography of
the concentrated reaction mixture on Kieselgel 60 prepared in
dichloromethane and eluted with 5% ethyl acetate:95% chloroform.
Using this procedure the yield of product was 60-70% which is
comparable with the 80% of Dasgupta et al. (76) and 45% of Petrov (79).
The procedures required for the activation of the secondary
alcohol at and its subsequent reduction by lithium aluminium
hydride have already been mentioned.
3.9 Synthesis of 26,27-dinor-cholestane (3.18), 26,27-dinor-25-isopropyl-
cholest-5-en-38~ol (3.13), and 26,27-dinor-25-butyl-cholest-5-en-3B-ol
(3.19)
The final step in the synthetic scheme was the removal of the
tetrahydropyranyl group at the 38 position to give the free secondary
steroid alcohols (<^25' ^28' anc^ ^29 resPect^ve-'-y^ • ^he method used
was essentially a combination of those of Dasgupta (76) and
Greenhalgh et al. (75) and involved the addition of ethanol containing
a few drops of concentrated hydrochloric acid to a suspension of
the compound in ethanol. Warming to 50°C gave a clear solution from
which a crystalline, unprotected, product was obtained by evaporation
of the ethanol under a slow stream of nitrogen. It was cooled,
filtered, and recrystallised from methanol giving an average 65%
yield of product which had thin layer chromatographic properties and
infra red spectra similar to those of cholesterol.
As a final check of their side chain lengths the analogues were
injected as the free sterol, on to a column of 100-120 mesh gas
chrom Q with 1 per cent SE 30 adsorbed to it. The G.L.C. column
oven was maintained at 238°C and attached to a flame ionisation




and a plot of the log of each sterol's retention time relative to
that of cholesterol, which was given the value (1), against the
number of carbon atoms in each analogue was constructed. Using this
hydrophobic column material it has been shown to he possible to
separate a mixture of fatty acids according to their chain lengths.
The absolute retention time of each fatty acid varied in direct
proportion to the number of carbon atoms in the chain. In the same
way the side chain analogues possessed relative retention times
which were consistent with proposed side chain structure.
The C-^g> ^21 anc* ^26 3*23) previously prepared by
Dr. Keith Suckling were included to give a better estimate of the
graph. Fig. 3.24 shows the calibration curve.
Thus the sequential elution from a G.L.C. column taken in
combination with the other properties of the intermediates and
final products indicates that the synthetic scheme described is
capable of producing a set of cholesterol side chain analogues based
on the 5 carbon unit of the bile acid side chain.
3
3.10 Synthesis of (7~ H}- 7ahydroxycholesterol
This was achieved using the procedures of Malinow et al. (80)
and Johnson and Lack (81) . Although the starting materials were
different both methods used tritium labelled NaBH. to reduce a
4
keto group at the 7 position in the steroid ring system. The reduction
yielded a mixture of sterols hydroxylated at the B and a positions.
Using the method of Malinow, 7-keto-cholesterol (0.02 mole)
was dissolved in 9 ml of methanol, 5 ml of freshly prepared ethanolic
tritiated. NaBH^ (100 mCi of 156 mCi/mg specific activity) was added,
and the solution was incubated for 3 days at 4°C. Any borohydride
remaining was destroyed by the addition of water (8 ml) and the
steroids extracted with petroleum ether (2 x 30 ml, 60°C) .
 
4Z.
The extracts were combined and evaporated to dryness under nitrogen.
To ensure that all remaining tritium was stably linked to the
steroid residue was dissolved in methanol (5 ml). The solvent was
distilled, collected by evaporation and assayed for tritium in a
liquid scintillation spectrometer. The procedure was repeated
three times until negligible radioactivity was present in the
distillate. The 73-and 7a-hydroxycholesterol isomers in the residue
were isolated by TLC on (20 x 20 x 0.2 cm) silica gel plates with
authentic standards in adjacent lanes. Ethyl acetate:benzene (13.7
v/v) was used as the developing solvent and the radioactive peaks
correspond with those of the authentic standards. The reaction was
very inefficient in my hands, with a recovery of 1 per cent of
added radioactivity. 7oi-Hydroxycholesterol accounted for a quarter
of the recovered material the remaining threequarters being
73 hydroxycholesterol.
3.11 Synthesis of 7a-hydroxycholesterol (82)
Recrystallised cholesterol (300 mg) was dissolved in chloroform
containing haematoporphyrin methyl ester (1 mg) and placed in a
photo-oxygenation chamber. Oxygen was bubbled through the solution
during the subsequent eighteen hour incubation and the progress of
the reaction was monitored by TLC. Phosphomolybdic acid spray
revealed that the blue cholesterol spot disappeared and a turquoise
spot corresponding to cholesterol-7-hydroperoxide appeared in its place.
The hydroperoxide was transformed to 7a-hydroxycholesterol by
a 45 minute reduction with potassium iodide (1.5 g) in a refluxing
solution of ether; ethanol (1*.5 v/v) containing 4 drops of 10%
acetic acid. The solvent was evaporated and the excess iodine was
removed by washing with sodium thiosulphate. 7a-Hydroxycholesterol











Synthetic route for production of 7a hydroxycholesterol.
<o.
plate developed with benzene; ethyl acetate (7:13 v/v) by comparison
with standard 7a-hydroxycholesterol. The two step reaction produced
white crystals from methanol (80 mg; 27% yield compared to a
literature value of 32%).
Fig. 3.25 describes the synthetic route.
3.12 Experimental
General directions
Organic extracts were dried over anhydrous sodium sulphate unless
otherwise stated. Solutions were evaporated under reduced pressure
using a rotary evaporator. The purity of all compounds was established
using thin layer chromatography (TLC) on Cam. Lab. POLYGRAM SILG/UV 254.
precoated plates. Radiochemical purity of all radioactive products
was monitored using a Panax phin layer scanner R.T.L.S.(I.A.).
Analytical samples were dried in vacuo prior to analysis. Melting
points, which are uncorrected, were determined on a Kofler Micro
Hot Stage. Infra-red spectra (I.R.) were recorded on a Perkin
Elmer 257 grating IR spectrometer using chloroform solutions.
Frequencies of IR peaks are quoted in cm ^.
Nuclear magnetic resonance spectra (n.m.r.) were obtained by
Mr. John Miller of the University of Edinburgh Chemistry Department
on a Varian HA lOOor XA 100. Chemical shifts are quoted in 6
values and the following abbreviations are used,
s = singlet d = doublet t = triplet
q = quartet m = multiplet
Fig. 3.22 describes the numbering system adopted for H resonances.
Gas liquid chromatography (GLC) was carried out using a
Pye Unicam Series 100 GLC fitted with a 1% SE 30 on 100/120
Gas Chrom. Q column and using a flame ionisation detector. Mass spectra
were obtained by Dr. Norman Chalmers of the University of Edinburgh
44.
Department of Pharmacology on a LKB 9000 MGSS spectrometer using
trimethylsilyl derivatives of the compounds, except in case of
tetrahydropyran ethers, and a 1.5% SE 30 column. The organic extracts
were purified by chromatography on Merck Keiselgel 60.
Hydodesoxycholic acid methyl ester
Diazomethane (1 g) was prepared by the dropwise addition of a
solution of N-methyl-N-nitrosotoluene-4-sulphonamide (7.0 g) in
anhydrous ether (100 ml sodium dtjed) to an ethanolic solution
(30 ml) containing potassium hydroxide (1.6 g) and a few drops of
water to enhance the solution of potassium hydroxide. The ethanol
was heated to at least 50°C and the diazomethane evolved collected
over a half hour period by condensation of the yellow etherate.
The closed collecting vessel was surrounded by an ice jacket and
fitted with an outlet tube which was immersed in a further open
conical flask containing dry ether to collect any escaped
diazomethane. After all the N-methyl-N-nitrosotoluene-4-sulphonamide
solution was added, the procedure was repeated with a further 50 ml
of dry ether in order to ensure that no diazomethane remained in
the apparatus. The solutions in the main and secondary collecting
flasks were combined and stored in ice.
Hyodesoxycholic acid (9 g) was added to anhydrous ether
(400 ml) containing methanol (5 ml) to enhance (a) the methylation
reaction and (b) the solubility of hyodesoxycholic acid,and placed
in ice. The diazomethane was added in 10 ml portions and the
solution swirled. After all the diazomethane had been added the
mixture was then tested for the presence of excess diazomethane by
acetic acid in ethanol (1;1).
<o.
The resulting methylated steroid was obtained by evaporation
of the solvent yielding a light yellow oil which formed 11.4 g
of a yellowish-white powder after drying under vacuo (100% yield).
No further purification was required as TLC showed one product.
IR C=0 1720, vC-OH. 3400, vC=H 2850.
5ct~Cholanic acid-3a,6a-diol methyl ester-di-p-toluene sulphonate
5a-Cholanic acid-3a,6a-diol methyl ester (11.4 g) was dissolved
in dry pyridine (44 ml, dried by storing over a molecular sieve)
and placed in ice. To this solution was added, gradually with
swirling, p-toluene sulphonyl chloride (12 g) and the resulting
solution placed at 4°C for 18 hours during which time colourless
needles of pyridine hydrochloride were formed and the solution became
yellow. The mixture was then poured into an ice cold solution of
dilute hydrochloric acid (100 ml) and either a white crystalline
mass or a yellow oil was deposited on the ice. In both cases the
acidic solution was extracted with dichloromethane (3 x 50 ml) and
evoporabc4
the excess solvent was by an initial rotary evaporation
step at room temperature.
(b) Residual solvent was removed by a stream of nitrogen and
addition of methanol to the residue.
(c) The methanol was removed by a further exposure to the nitrogen,
and evaporation under vacuo using an oil pump.
A caramel gum (15 g) resulted from the procedure, TLC of which in
dichloromethane showed that only one product was present. No further
purification due to lability of tosylates.
IR vC20 1720, v aromatic 1600, and vC-H 2850.
4 b.
3g-Hydroxy cholenic acid
5ct-Cholanic acid-3a,6cc-diol methyl ester di-p-toluene sulphonate
(15 g) was placed in a conical flask in an oil bath, which was in
turn placed on a magnetic stirrer hot plate. Dimethylformamide
(120 ml) , water (12 ml) , and potassium acetate (25 g) , were added
and the solution heated to 105°C with constant stirring.
After 4 hours the mixture was poured into dilute hydrochloric acid
without cooling and the resulting yellow-white precipitate was
filtered, washed with water, and immediately saponified by refluxing
overnight with 4% (w/v) methanolic potassium hydroxide. The yellow
liquid was cooled and poured into dilute hydrochloric acid once again.
The white water-saturated precipitate was filtered and extracted with
chloroform:methanol (2:1).
In addition the same extraction procedure was carried out on
the gum formed on the sides of the flask after acidification and
the 2 extracts combined and caicentrated by rotary evaporation.
Recrystallising the material from ethyl acetate yielding 9 g of a
white powder. TLC showed it contained one major product and two
minor less polar contaminants (64% yield).
3g-Hydroxy-cholenic acid methyl ester
The foregoing 3(3-hydroxy cholenic acid (9 g) was dissolved in
dry ether (400 ml) containing methanol (5 ml) and reacted with
diazomethane (1 g) in ether solution. The reaction mixture was
concentrated by rotary evaporation and dried under vacuo using an
oil pump. The contaminating upper two spots were removed by
chromatography on Kieselgel 60 (270 g) prepared in dichloromethane.
Sequential elution with dichloromethane, dichlormethane:chloroform
A
(1:1),and chloroform gave the pure 3S~hydroxy cholenic acid methyl
ester which crystallised from methanol to give a white powder (6.92 g)
m.
78% from ditosylate mp 144°C (lit 145-146°C) IR v C=0 1720, vC-H 2930.
n.m.r. 3.64 6 (CO^CH^ at ^) > 5.33 6 C,. attached to A"* double bond.
M.S. M+ 461.
3g-Triphenylmethoxy-5-cholenic acid methyl ester
3g-Hydroxy-5—cholenic acid methyl ester (2.5 g) was dissolved
in dry pyridine (6 ml) and mixed *AfllrV> triphenylchlorometharie(purified
by recrystallisation from benzene containing 20% acetyl chloride and by
washing with light petrol containing acetyl chloride). The reaction
was initiated by heating the mixture on an oil bath for 10 hrs at 110°C.
After cooling the pyridine was removed by rotary evaporation, water
was added to the resulting oil and the mixture was heated to
convert the triphenylchloromethane to triphenylhydroxymethane.
The solution was cooled, extracted with dichlorbmethane (3 x 30 ml),
and concentrated by rotary evaporation. The mixture was chromatographed
on Kieselgel 60 (70 g) made up in dichloromethane, and elution with
same solvent removed the non-polar product and a portion of the
triphenylhydroxymethane which proved impossible to separate from
the product using chromatographic techniques and differing elution
systems (such as petroleum ether:dichloromethane 100;0 to 0:100)
1.5 g of triphenylmethane derivative: tripheny1 hydroxymethane
mixture <47% yield.
-1 -1 -1
vC-H 2900 cm ; vC=0 1720 cm , vC-C (aromatic) 1600 cm
3g—2'-1etrahydropyranyloxy-5~cho 1 enic acid methyl ester
3g-Hydroxy-5-cholenic acid methyl ester (6.92 g) was dissolved
in dry chloroform (20 ml dried by passage down a column of roasted
Kieselgel H and subsequently over sodium sulphate) and placed in a
dried flask with a calcium chloride guard tube. Freshly distilled
dihydropyran (6 ml) and 10 drops of phosphorus oxychloride were
added, the guard tube was replaced and the yellow solution was left
overnight at room temperature. The mixture became dark green during
the reaction and the coupling was stopped by dilution with dry
chloroform and addition of chilled sodium bicarbonate. The chloroform
layer was separated, the water layer extracted with chloroform
(2 x 20 ml) and the extracts concentrated to give a reddish brown
oil which was purified by column chromatography on Kieselgel 60
(200 g) . The column was prepared in CH„C1„, and elut^c^ with 5%
3<>ve ct
ethyl acetate;95% chloroform^purified product (which crystallises
from methanol from more polar impurities).
5.62 g (70% yield) m.p. 110-111°C.
IR vC-H 2880, 2440, 2620, 2710; vC=0 1720.
n.m.r. 5.3t(C=C), 4.62o (2), 3.92 (6a, 3).s q
3.65 (CO^CH^ at 24) 1 m (saturated alkyl).
M.S. M+ 472.
3g~2'-tetrahydropyranyloxy-5-cholen-24-ol
The foregoing 3g-2'-tetrahydropyranyloxy-5-cholenic acid methyl
ester (5.6 g) was dissolved in tetrahydrofuran (25 ml) which had
been freshly distilled into dry glassware from a solution of
tetrahydrofuran containing a few milligrams of lithium aluminium
hydride to minimise the formation of hydroperoxides. Lithium aluminium
hydride (450 mg) was then added and the flask fitted with a condenser
topped by a calcium chloride guard tube. The reaction proceeded
during a 4 hour reflux after which the catalyst was destroyed by
the sequential addition of water (0.45 ml) followed by 15% sodium
hydroxide (0.45 ml) and finally a further amount of water (1.35 ml).
A light grey complex was formed by this process, and this was
placed in a filter funnel and washed with chloroform (100 ml) to
remove anyadhering steroid. The complex was discarded and the
chloroform extract concentrated, dried under vacuum and applied to a
column of Kieselgel 60 (180 g) made up in dichloromethane. When the
column was eluted with chloroform and then 5% ethyl acetate:95%
chloroform a colourless oil was formed which on leaving overnight
was transformed into a white opaque solid which crystallised into
transparent needle like crystals from ethyl acetate. 4.0 g 78% yield,
m.p. 134-135°C.
IR vC-OH 3400, vC-H 2860, 2440, 2620, 2710.
n.m.r. 5.3 d (C=C), 4.7 s (H at 2a), 3.9 q (2 J *1 Ja) , 3.55 d (®2°H ),ri at J at .
24
9 t (saturated alyl), 4.9 s (OH at ^) .
M.S. M-102 = 414.
38-~2 '-tetrahydropyranyloxy-cholen-24-'-ol
The oxidising reagent used in this reaction wTas prepared by
rapidly mixing acid washed celite (3.0 g) with an aqueous silver
nitrate solution (2 g in 100 ml) and potassium carbonate (0.8 g)
for 15 minutes. The mixture was filtered, sucked dry in air on a
Buchner flask, and further dried in a vacuum desiccator for 5 hours.
The yellow filter cake was then transferred to a round bottomed
flask containing dry benzene, 10 ml of which was evaporated off
to ensure the complete absence of water. The 38-2'-tetrahydro-
pyranyloxy-cholen-24-ol (1 g) in dry benzene was mixed with the
t-Ve.
oxidising reagent and solution was refluxed overnight using a
A
condenser with a calcium chloride guard tube, cooled, and filtered
through celite. The resulting yellow solution was evaporated and
purified by column chromatography on Kieselgel 60 (30 g) prepared
in dichloromethane. Elution with 5% ethyl acetate:95% chloroform
yielded white needles from ethyl acetate solution. The yield of the
aldehyde seemed very variable from preparation to preparation and
is probably due to the presence of water in the oxidising agent,
m.p. 125-126°C.
50.
IR vC-H 2860; vC=0 1707.
M.S. No molecular ion M-THP = M-102 = 340.
Calculated molecular weight = 442.
26,27-Dinor-25-isopropy1-38-2'tetrahydropyranyloxy-cholest^5-en-24-ol
In order to prepare the appropriate Grignard reagent for the
desired side chain analogue of cholesterol, dry ether washed
magnesium turnings (240 mg, 10 mmole) were added to a crystal of
iodine in a dry round bottomed flask. This was gently warmed until
iodine vapour filled it. The flask was cooled and fitted with a
condenser, a CaCl^ guard tube, and an addition funnel. The magnesium
was then covered with dry ether (5 ml) and the addition funnel was
filled with dry ether (5 ml) and freshly distilled l-bromo-2-methylpropane
(2 ml, 18 mmoles). 1 ml of the mixture was introduced into the
reaction flask whose contents were magnetically stirred. The remainder
of the halide was added dropwise over a ninety minute period with
constant stirring and this was followed by a 30 min. reflux of the
mixture to destroy any residual magnesium.
The 38~2'-tetrahydropyranyloxy-5-cholen-24-ol (0.45 g) was
dissolved in dry benzene (15 ml) and added to the excess of Grignard
and the mixture was heated to 78°C with the condenser switched off
to remove the ether. The benzene remaining was refluxed overnight
with the condenser fitted with a calcium chloride guard tube,
after which it was cooled and the Grignard complex was decomposed
by the addition of saturated ammonium chloride (3.8 g in 10 ml).
The Grignard product was isolated by ether extraction of the aqueous
layer, and subsequent evaporation of the ether. The purified product
was eluted by 95% chloroform:5% ethyl acetate from a Kieselgel 60
column (13 g) made up in dichloromethane.
300 mg product 70% yield.
IR vC-OH 3400; vC-H 2840, 2440, 2620, 2710.





en-24-p-toluene sulphonate was prepared in a similar manner to the
5-cholenic acid 3a,6a-diol methyl ester di-p-toluene sulphonate.
26,27-dinor^25-isopropyl-3B~2' -^tetrahydropyranyloxy-choles t^5-en-24~ol
was dissolved in dry pyridine (1.2 ml and p-toluene sulphonyl
chloride (.300 mg) added as before. After extraction of the
ditosylate the chloroform was removed by a nitrogen stream and
vacuum desiccation. The purity of the tosylate was checked by TLC
and the one spot material utilised in the subsequent reduction step
without any further purification.
IR vC-H 2920; vC-C 1580
C-H deformation 1420, 1350.
26,27-dinor-25-isopropyl-3i3~2' ^tetrahydropyranyloxy-cholest-5-^ene
The reduction of the tosylate with lithium aluminium hydride
was accomplished in a similar way to that of the methyl ester.
Approximately 400 mg of 26,27-dinor-25-isopropyl-3f3-2'-^tetrahydro-
pyranyloxy-cholest-5—en-24-p—toluene sulphonate was reduced with
lithium aluminium hydride (40 mg) in tetrahydrofuran. The reaction
product was isolated from the chloroform extract by column chromatography
on Kieselgel 60 (12 g) prepared in dichloromethane. Sequential
elution with dichloromethane and 5% ethyl acetate:95% chloroform
separated the protected C2g (Fig. 3.12) which crystallised from
acetone to give white crystals (160 mg) . The yield of product is
variable and gives 50~60% yield mp 115-119°C.
dz.
IR vC-H at 1420 vC-H 2840, 2440, 2620, 2710.
at 1350
•f #
M no molecular ion was detected.
M- Dihydropyran (400) and M- dihydropyran and a hydroxyl group
(382) were major bands visualised.
26,27-dinor-25-isopropyl-cholest-5-en-36-ol Fig» 3.13)
26,27-dinor-25~isopropy 1-3(3-2'-tetrahydropyranyloxy-^cholest-5-ene
(150 mg) was added to ethanol (10 ml) containing 5 drops of
concentrated hydrochloric acid. The solution was heated to 50°C
when the protected product dissolved leaving a colourless solution.
The heating process was continued for 30 minutes then a few drops
of water were added and the volume of the ethanol was reduced under
nitrogen. Colourless needle-like crystals were deposited during
this time, which were further purified by recrystallisation from
methanol.
110 mg (88% yield) m.p. 130°C.
IR vC-OH 3400; vC-H 2880.
n.m.r. 5.4 t (C,.), 4.0 s (OH at 3), 9m (saturated alkyl).
MS M+ 400.
26,27-dinor-3g-2' -tetrahydropyranyloxycholest-5-en-24-ol
This synthesis is similar to the Grignard reaction described
previously. It only differs in the alkyl halide used to prepare
the Grignard reagent. 3(3-2'-Tetrahydropyranyloxy—5-cholen-24-ol
(620 mg) was added in dry benzene (15 ml) to methyl magnesium iodide
prepared from freshly distilled iodomethane (2 ml) and magnesium
(240 mg) . The Grignard product was isolated and subjected to
column chromatography on silica gel, whence it was isolated by
elution with dichloromethaue followed by 5% ethyl acetate:95%
chloroform.
53.
0.5 g (78% yield).
IR vC-OH 3400; -'vC-H 2840, 2440, 2620, 2710.
n.m.r. 0.9 t (saturated alkyl), 3.55 g (OH at C2^),5.33 d (C^) .
26,27-Dinor-3g-2' -tetrahydropyranyloxy-cholest-5-ene
The hydroxyl group of 26,27-dinor-3g-2'-tetrahydropyranyloxy-
cholest-5-en-24-ol (500 mg) was activated by the formation of a
p-toluene sulphonate ester by reaction with an equal amount of
p-toluene-sulphonyl chloride in pyridine (2 ml). The method used
is identical to that for the methyl ester and the extracted steroid
is concentrated and dried. Following the synthetic scheme for
production of 3f3-2,-tetrahydropyranyloxy-cholest-5-en-24-ol, the
p-toluene sulphonate ester grouping is eliminated by reduction
with lithium aluminium hydride (100 mg) and the compound is isolated
by column chromatography on Kieselgel 60. Elution with 5% ethyl
acetate:95% chloroform gives a material which crystallises from
acetone (220 mg) yield of 50%.
m.p. 104°C.
IR vC-H, 2840, 2710, 2620, 2440.
n.m.r. 5.35 6 (C at 5), 4.7 (H at 2a), 1 (saturated alkyl).
26,27-Dinor-cholest-5-en-3g-ol (C^g? fig- 3.18)
The free sterol was liberated by acid hydrolysis as described
previously, 200 mg yielding 105 mg (60%) of 26,27-dinor-cholest-5-en^
33~ol which recrystallised from methanol giving a white powder,
m.p. 132-133°C.
IR vC-0H 3400; vC-H 2840.




The Grignard addition reaction was performed as for the addition
of the 1 bromopentane with the following differences: 26,27-dinof-25-
butyl-3B~2'-tetrahydropyranyl cholest-5-en-24-ol was prepared by
the addition of 3(3-2'-tetrahydropyranyloxy-5-cholen-24-ol (700 mg)
to a Grignard complex prepared from freshly distilled 1-iodopentane
(2 ml) and foasted magnesium turnings (240 mg) . The addition product
formed was isolated by column chromatography as previously described,
and 500 mg was isolated (60% yield) .
IR vC-OH 3400, vC-H 2850, 2440, 2620, 2710.
26,27-Dinor-25-butyl-3B-2 '-tetrahydropyranyloxy-cholest-5-ene
The foregoing alcohol was converted to 26,27-dinor-25~butyl-3(3-
2'-tetrahydropyranyloxy-cholest-5-ene by an initial protection step
followed by lithium aluminium hydride reduction.
The routine tosylation with 450 mg of starting material gave
a heat labile product which was difficult to weigh accurately.
Infra red analysis showed that it contained an aromatic group
(v C=C 1600) and had lost a C-0H grouping. In all other respects
it resembled the starting material (pure by thin layer chromatography
but with a greater R f value). The conversion to 26,27-dinor-25-butyl-
3-2'-tetrahydropyranyloxy-cholest-5-ene was accompanlished by 50 mg
of lithium aluminium hydride. Extraction by chloroform and silica
cKlorO-fcx-ws
column chromatography produced in the 5% ethyl acetate:95%)Seluent
a material which crystallises from acetone to give white transparent
needles. 200 mg (44% yield of product from 26,27-dinor-25-butyl-3f3-2
tetrahydropyrayloxy-cholest-5-ene) .
m.p. 116-117°C.
IR v-C-H 2860, 2440, 2620, 2710.
n.m.r. 5.35 t (C,_) , 4.7 s (H 2a), 0.96 m (saturated alkyl).
26,27-Dinor-25-butyl-cholest-5-en~3g-ol Fig* 3.19)
The free sterol was prepared by acid hydrolysis of the tetra-
hydropyranyl ether (180 mg) in a similar manner to that previously
described. The resultft^needles were crystallised from methanol.
90 mg 64% yield,
m.p. 115-119°C.
IR vC-OH 3400; vC-H 2850.
n.m.r. 5.38 t (C^); 9 m (saturated alkyl), 3.5 s (OH at 3).
M.S. M+ 414.
3g-2'-Tetrahydropyranyloxy-5-cholen-24-p-toluene sulphonate
3g-2'-Tetrahydropyranyloxy-5-cholen-24-ol (300 mg) was converted
to the corresponding p-toluene sulphonate by the addition of excess
p-toluene sulphonyl chloride (300 mg) in 1.2 ml of dry pyridine.
The method used was identical to that described in the synthesis
of 5g-cholanic acid 3a,6a-diol methyl ester di-p-toluene sulphonate.
The product was concentrated from a chloroform extract by evaporation
under nitrogen and the residual solvent was removed by vacuum
desiccation. Thin layer chromatography of the sterol mixture showed
the presence of a single non-polar material (330 mg) in 80% yield,
infra red analysis of which showed that it possessed (a) an aromatic
group (1600 cm ^) and (b) C-H bonds (2850 cm \ 2440, 2620, 2710) .
Due to the reported lability of tosylates (72) it was considered to
be of sufficient purity for the subsequent reduction step.
The primary tosyl ester formed in the reaction was reduced by
lithium aluminium hydride with the formation of the corresponding
saturated alkane. 5a-Cholen-3g-tetrahydropyranyloxy-24-p-toluene
sulphonate (330 mg) were reacted with an excess of lithium aluminium
hydride (40 mg) in freshly distilled tetrahydrofuran (20 ml) by
refluxing the solution for four hours in dry apparatus containing a
56.
calcium chloride capped condenser. The product was isolated in tHt
previously described manner and the mixture of three products was
resolved by column chromatography on silica gel. The column was
prepared in dichloromethane and the mixture was resolved by elution
with chloroform and 230 mg (99% yield) of white crystals were
prepared from acetone,
m.p. 118-120°C.
IR v-G-H 2880, 2440, 2620, 2710.
n.m.r. 5.35 t (C^), 4.7 s (H at 2a), 9 m (saturated alkyl).
Mass spectrometry - no molecular ion is detected. The major
peak observed has a molecular weight of 328. This value could be
obtained by cleavage at the 3 position with loss of the dihydropyran
and the hydroxyl group.
5ot-Cholen-3g-ol (C^' ^ig» 3.23)
The foregoing tetrahydropyranyl ether (230 mg) was hydrolysed
by reflux with ethanolic hydrochloric acid as described in the
production of anc* '"'29* Evaporation of excess solvent
under nitrogen and caused the precipitation of needle-like
crystals which were recrystallised from methanol. 120 mg (65%).
m.p. 129-132°C.
IR vC-H 2820, vC-OH 3400.
n.m.r. 5.35 t (C,.); 4.0 s (H at 2), 9 m (saturated alkyl).
M.S. M+ 344.
CHAPTER 4




Electron paramagnetic^(epr) is a technique that has been
widely used in determining intermolecular relationships in
membranes. One application of this physical method to the
study of membrane structure is by incorporating a spin labelled
molecule, formed by attaching a stable free radical to a membrane
component, into the membrane. Information regarding the spin
label's immediate environment can be derived from the first
derivative epr spectrum of a spin label thus incorporated.
For example, if the spin labelled molecule is rotating rapidly
and randomly in its environment, then a sharp 3 line spectrum
is obtained whereas if the molecule is rotating more slowly
then the spectrum is increasingly broadened due to a restricted
motion of the spin label (83).
Epr has been used to define the role of cholesterol in
membranes, particularly model membranes, composed of defined
proportions of spin label, cholesterol and phospholipid. A
quantitative method for determining the effect of the incorporation
of a sterol on the nature of the surrounding phospholipid has been
employed by Suckling and Boyd (30) following Hubbell and McConnell
(84). Using the 3NC spin label they incorporated an increasing
proportion of cholesterol into egg yolk phosphatidylcholine
liposomes and monitored the change in the epr spectrum.
As the proportion of cholesterol increased, the spectral line
widths increased with a consequent broadening of the spectrum due
to restriction of the spin label's movement in the phospholipid:
cholesterol mixture. Thus, by measuring this spectral change they
were able to calculate a value for the restriction of the spin
label motion in the presence of a defined percentage of cholesterol.
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This was termed the order parameter (S) and was an index of the
rigidity of the molecular environment surrounding a spin label.
This increased ordering could be attributed to an extension of the
fatty acyl chains and a decreased amplitude of motion of the
long axis of the fatty acyl chains (85).
The role of cholesterol in membrane structures has also
been investigated in liposomes prepared from saturated phospho¬
lipids such as dipalmitoyl phosphatidylcholine (DPPC). Using
the cholestane spin label (3NC) Hemminga (86) showed that the
incorporation of small amounts of cholesterol (10 mole per cent)
altered the orientation of the DPPC fatty acid side chains in
relation to the bilayer normal. Furthermore the interaction of
sterol with phospholipid has also been studied by monitoring its
effect on the sharp phase transition of DPPC. The spin label
Tempo (Fig. 2.5) can be used to indicate the phase transition
temperature due to its different solubilities in the gel and liquid
crystal phases of phospholipids and has been shown to give a
wider range of values for the phase transition than differential
scanning calorimetry (87). The transition temperature of a
pure phospholipid depends both on the chain length and on the head-
group of the phospholipid (88). The transition temperatures of
phospholipids containing cis unsaturated double bonds are much
lower than those of the corresponding saturated analogues.
Cholesterol acted as a fluidity regulator fluidising lipids below
their transition temperature and rigidifying those above this
transition temperature (32).
Thus far the observed properties of cholesterol have been
attributed mainly to the presence of the rigid steroid nucleus.
The monolayer studies of Demel et al. (89) have shown that in
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addition a 33 hydroxy group and an intact side chain were
required for optimal sterol phospholipid interaction, but
the exact length of the side chain for optimal sterol phospho¬
lipid interaction remained undefined. In order to define
the role of the side chain in cholesterol:phospholipid
interactions the cholesterol analogues described in Chapter 3
were incorporated into liposomes containing saturated or
unsaturated phospholipids and a series of spin labels.
The following sections describe
(a) experiments to determine the effect of cholesterol analogues
on the motion of two steroid spin labels intercalated in egg
yolk phosphatidylcholine liposomes and oriented films,
(b) experiments' that monitor the effect of cholesterol on the
phase transition of defined lipid species, and
(c) the effect of amphotericin B and ascorbate on spin label
spectra.
4.2 Cholesterol:phospholipid interaction monitored by 3NC spin label
The spin label 3NC was chosen because of its close similarity
to cholesterol. The monolayer studies of Cadenhead et al. (90)
j
and Tinoco et al. (91) showed that although 3NC was less polar
than cholesterol and did not condense phosphatidylcholine to the
same extent as cholesterol in a monolayer of 3NC and phosphatidyl¬
choline, it was a reasonably good analogue for cholesterol.
In liposomes3NC is thought to orient with its long axis
preferentially along the bilayer normal with the nitroxy group
near the aqueous interface and it is capable of rapid rotation
about its long axis . In addition the long axis performs an
angular motion of limited amplitude (92). For this spin label
the magnitude of the perpendicular splitting is greater than the
The results of the incorporation of a series of
cholesterol side chain analogues on the motion of
liposomal bound 25NC and JNC spin labels are
presented in figures 4«*1-4«12
pmole C24 3-NO fi mole 3. Y.PC . ( s )
0.5 50n mole 4-5 0.22
1.0 50n mole 4.0 0.24
1.5 50n mole 3-5 0.23
2.0 50n mole 3.0 0.29
2.5 50n mole 2.5 0.32
J
Table 4«1
Results in tables 4.1-4.12 are - 0.01 and are
the means of at least 4 determinations.
ximole C„ -
d j 3N0\ jumole S.Y.PG ( s )
0.5 50n mole 4.5 0.235
1.0 50n mole 4.0 O.295
1.5 50n mole 3.5 0.285
2.0 50n mole 3.0 0.297
2.5 50n mole 2.5 0.353
Table 4*2
^ mole Cgy 3 AG ja mole B.Y.P Ct ( a )
0.5 50n mole 4.5 O.24
1.0 50n mole 4.0 O.255
1.5 50n mole 5-5 0-295
2.0 50n mole 3-0 0.34
2.5 5O11 mole 2.5 0.396
Table 4-3
p mole C28 0
1
mole B.Y.PC, ( s )
0. 5On mole 5.0 0.22
0.5 50n mole 4-5 0.253
1.0 50n mole 4.0 0.25
1.5 50n mole 3.5 0.27
2.0 50n mole 3.0 0.305
2.5 50n mole 2.5 0.339
Table 4«4
« mole 5NC m mole E.Y.PC ( s )
0.5 50n mole 4.5 6.25
1.0 50n mole 4.0 0.27
1.5 50n mole 3.5 0.285
2.0 50n mole 3-0 0.31
2.5 50n mole 2.5 0.347
Table 4*5





1.0 5On mole 4.0 0.51
1.5 50n mole 3.5 0.52
2.0 50n mole 3-0 0.34
2.5 50n mole 2.5 0.37
Table 4*6
M mole C0.24 25 NC
mnole E.Y.PO ( S )
0.5 50n mole 4.5 0.21
1.0 50n mole 4.0 0.25
1.5 50n mole 3.5 0.26
2.0 50n mole 3.0 0.27
2.5 50n mole 2.5 0.27
Table i1.7
\
mole C 25NC umole E.Y.PC ( s )
0.5 50n mole 4.5 0.207
1.0 50n mole 4.0 0.217
1.5 50n mole 3-5 0.24
2.0 50n mole 3.0 0.25
2.5 50n mole 2.5 0.27
Table 4«8
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parallel and thus the order parameter (S) is expressed as
25G
(Section 2, Fig. 2.6).
The results of the incorporation of an increasing molar
percentage of cholesterol analogue on the ordering of the 3NC
spin label included in an unsonicated egg yolk phosphatidylcholine
liposome are shown in Tables 4.1 to 4.6. The order parameter (S)
is an indication of the rigidifying effect that the analogue is
exerting on the surrounding phosphatidylcholine molecules and its
value increases proportionally to the sterol present. Comparison
of the (S) values for egg yolk phosphatidylcholine alone with
cholesterol analogue-phosphatidylcholine mixture shows the following
(a) in the presence of 10 mole per cent analogue there is no
significant increase in ordering.
(b) with 20 mole per cent of all four sterols the order parameter
is increased ty 15 per cent compared to the value for egg yolk
phosphatidylcholine. Only when the molar proportion of sterol
is increased beyond 30 mole per cent does the different ordering
properties of each become apparent. At 40 and 50 mole per cent
sterol cholesterol and sitosterol cause an increase (56% at 40 mole
percent sterol and 69% at 50 mole per cent sterol) in ordering
greater than that due to ^25' ^28 an<* ^29 at m0^-e Per
cent, 55% at 50 mole per cent). Thus the results indicate that
with 40 mole per cent sterol, using a probe that is thought to
monitor the region of the bilayer adjacent to the aqueous phase,
optimal ordering of the surrounding phospholipid is obtained using
o
#
a sterol with a 9A long side chain, i.e. cholesterol or sitosterol.
A mole G2j 25NC Minole E.Y.P^ ( S )
0.5 50n mole 4.5 0.21
1.0 50n mole 4.0 0.23
1.5 50n mole 3.5 0.25
2.0 5On mole 3.0 | 0.268
2.5 5On mole 2.5 0.29
Table 4-9
A mole C28 25NC A mole E.Y.PG ( s )
0.5 50n mole 4.5 0.195
1.0 50n mole 4.0 0.21?
1.5 50n mole 5-5 0.235
2.0 5On mole 3.0 0.255
2.5 50n mole 2.5 0.27
Table 4.10
A mole C2g 25NC ximole E.Y.PC ( S )
0.5 50n mole 4.5 0.215
1.0 5On mole 4.0 0.24
1.5 5On mole 3.5 0.26
2.0 5On mole 3.0 0.275






mole S.Y.PG ( 3 )
0.5 50n mole 4.5 0.215
1.0 5On mole 4.0 0.240
1.5 50n mole 3.5 0.260
2.0 50n mole 3.0 0.275
2.5 50n mole 2.5 0.295
Table 4°12
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4.3 Ordering of 25NC spin label in liposomes containing the cholesterol
side chain analogues
A spin label containing the reporter group in the side chain
and thus reporting on a different part of the bilayer from 3NC
was incorporated in sterol:egg yolk phosphatidylcholine liposomes.
In contrast to the broad 3NC spectrum (Fig. 2.6a) which is
indicative of restricted nitroxyl motion consistent with its role
as a reporter of events at the bilayer surface, the 25NC spin
label (Fig. 2.6b) spectrum consists of three sharper lines.
The sharpness of the spectrum indicates that the nitroxyl group's
motion at position 25 is unrestricted by its surrounding environment.
In fact the nitroxyl behaviour is more akin to that of a fatty
acid spin label and this is reflected in the order parameter
calculation. This is consistent with a centre of the bilayer
location for the nitroxyl group at carbon 25.
The multilayer liposomal preparation described in the Methods
section was employed and the data are included in Tables 4.7-4.12.
The previously described increase in ordering with increasing
concentration of sterol is once more observed. However there are
some differences from the 3NC results.
(a) even with 10 mole per cent sterol there is an increase in
spin label ordering varying from 8.9% with C^^25' C28 an<* ^29
to 16% with cholesterol and sitosterol.
(b) with 40 mole per cent sterol C^ and sitosterol the order
parameter increases by 40% whereas ^25' C28 an(* ^29 only cause
a 32% increase.
C19 C21 C2l C25 c26 c28 c29
^27 sterol
^27 sterol
Comparison of the effect of alteration of the cholesterol side
chain on the motion of the 3NC and 25NC spin labels.
Fig. 4.1
(c) in the presence of 50 mole per cent sterol an^ sitosterol
the order parameter increases by 55% whereas C^C^g and
at the same concentration increase the ordering by 38%.
The 25NC results are slightly different from 3NC but confirm
the previously observed trend. If the 40 and 50 mole per cent
results for 3NC and 25NC for experiments using C19> C21 and C2g
are included in a graph of order parameter plotted against
analogue carbon number (Fig. 4.1) it is clearly seen that
cholesterol causes the maximum increase in order parameter at
both sterol concentrations.
4.4 Cholesterol-phospholipid interactions in oriented films
The interaction between cholesterol and phospholipids has
been studied in oriented films by Smith et al. (92) and Seelig (93),
among others. This system has advantages over a phospholipid
dispersion due to the greater resolution of the spectra obtained.
In addition the various contributions to the resulting spectra
could be more easily identified in this defined system allowing
a more detailed analysis of cholesterol interaction than was
possible using a liposomal system. Using this method Lapper et al.
(94) have defined the order parameter more precisely as the extent
to which the long axis of the lipids are oriented preferentially
in the direction perpendicular to the lamellar phase. In a
further study (95) using oriented films composed of brain lipids
and cholesterol-like molecules theyhave shown that the extent of
ordering caused by each sterol depended on the molar proportion
of sterol present and the actual structure of each sterol. At
20 mole per cent sterol, cholesterol and ergosterol were equally
effective whereas at 5-10 mole per cent ergosterol caused the
maximum amount of ordering but its effect decreased beyond 10 mole
per cent. Their conclusions were that for optimal ordering
of a brain lipid film, a sterol molecule required a 33
hydroxy group and a non-polar side chain of undefined length
(the presence of a hydroxyl group in the side chain prevented
the ordering of the surrounding lipid). As cholesterol and
cholestanol were equally effective at ordering the surrounding
phospholipid molecules, a double bond at C,. was not thought
to be of paramount importance.
In order to further define the sterol side chain requirements
for optimal sterol phospholipid interactions in this system,
oriented multi-bilayers of sterol and egg yolk phosphatidyl¬
choline (30:70 mole per cent) containing 1 mole per cent of the
3NC spin label were prepared by Dr. Keith Suckling from hydrated
films of the lipids as described by Seeling (93). The spin
label spectra were recorded with the film oriented parallel and
perpendicular to the applied magnetic field and the results
detailed in Table 4.13 were obtained.
This shows that cholesterol caused the maximum increase
in order parameter and increasing the side chain beyond 9$.
(C£g and ^29^ resulted in a significant decrease in its value.
This absolute value of and C^g were intermediate between
C19' ^21' C24' ^25 anc* ^27* This was slightly different from
the results obtained with the liposomes where the order
parameters were smaller due to averaging of the signals and
the values of (S) were similar for C^, C£g and C^g.
4.5 The effect of the cholesterol analogues on dipalmitoyl phosphatidyl¬
choline (DPPC) monitored by 2,2,6,6-tetramethylpiperidine-I-oxyl
(Tempo)
The experiments in Section 5 were designed to show that the
The epr spectrum of Tempo in an aqueous dispersion of the phospho¬
lipid, dipalmitoyl-phosphatidylcholine (a) above the phase
transition temperature (57°C) (b) nearly equal to the transition
temperature (37°C) (c) below the transition temp. (22°C).
Parameter (f) is an approximation to the fraction of Tempo
dissolved in the hydrocarbon phase and is measured from the
splitting of the high field line.
Fig. 4.2
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pattern of interaction observed with the egg yolk phosphatidyl¬
choline could be repeated when a dynamic event, namely the phase
transition of a saturated phospholipid, was studied by a
different spin label.
The basic design of these experiments concerned monitoring
the change in solubility of Tempo in the lipid phase when a
liposome containing the saturated phospholipid, dipalmitoyl
phosphatidylcholine, in the presence of a cholesterol side chain
analogue, was warmed from 22°C to 57°C. Fig. 4.2 shows the
-3
first derivative epr spectra of a 10 M concentration of Tempo
in an aqueous dispersion of dipalmitoyl phosphatidylcholine at
3 temperatures. The concentration of Tempo is kept low in order
to minimise interaction between spin labels which results in a
broadening of the spectra. Each spectrum is a superposition of
2 spectra - one due to Tempo dissolved in the fluid lipid
hydrophobic phase and the other due to Tempo in the aqueous phase.
Small differences in the nitroxide isotropic hyperfine
coupling and the 'g' factors in each environment result in a
partial resolution of the high field line (X band) whereas the
low and middle lines are not resolved. The spectral parameter
(f) was calculated according to the procedure of Shimshick &
McConnell (69). At room temperature dipalmitoyl phosphatidyl¬
choline is in a gel phase in which the hydrocarbon chains are
tightly packed in a hexagonal lattice (96). The tight packing
is reflected in the isotropic 22°C spectra&of Tempo (Fig. 4.2).
As the temperature is increased to 30-35°C, which is below
the phase transition temperature of DPPC (41°C) there is a slight
increase in the Tempo solubility. This is thought to be due to
the formation of a disordered liquid crystalline lipid region
10
30 40 50 60
Tempo partitioning into DPPC liposomes
containing 10, 20 or 30 mole % C .
Fig. 4.3
within the gel matrix. The partial disruption of the hexagonal
matrix is thought to be occurring in one of three ways
(1) as a result of changes on the configuration of the hydro¬
carbon chains from all trans to a trans-gauche mixture (33).
(2) due to a change in the orientation of the lipid fatty acid
chains from being tilted with respect to the bilayer plane to
being oriented perpendicular to the bilayer plane (97) thus
allowing rotation about their long axes.
(3) Levine et al. (98) suggest that the head group conformations
change at this temperature from being parallel to the bilayer
surface to being perpendicular to it. The pretransition spectrum
is shown in Fig. 4.2.
On further heating there is an increase in the cooperative
interaction between adjacent hydrocarbon chains resulting in
sharp transition from the gel phase to a completely fluid
crystal phase. At 57°C the solubility of Tempo is maximal
(Fig. 4.3$). Figures 4.3 and 4.10 show the effect of the
incorporation of an increasing molar proportion of cholesterol
analogue into DPPC liposomes, on Tempo partition. When the ratio
of DPPC to analogue was 10:1, of the sterols tested only C^
and
i caused any significant deviation from the melting profile
of the pure phospholipid (4.11). As the percentage of sterol was
increased to 20%, the value of (f) decreased due to increased
membrane rigidity and differences in the analogues relative
abilities to exclude the spin label became apparent (Fig. 4.12).
The analogues fell into two main groups with C2\> ^24 anc*
C25 causing a 47% reduction in Tempo solubility (relative to DPPC)
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30 40 50 60
Tempo partitioning into DPPC liposomes
containing 10, 20 or 30 mole % C„,.
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Fig, 4.7
30 AO 50 60
Tempo partitioning into DPPC liposome
containing 10, 20 or 30 mole % 0 .
Fig. 4.8
Tempo partitioning into DPPC liposomes
containing 10, 20, 30, 40 or 50












Tempo partitioning into DPPC liposomes
containing 10, 20, 30, 40 or 50
mole % C29.
Fig. 4.10
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Tempo partitioning into DPPC:
sterol liposomes containing 10 mole %
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Comparison of the ability of Tempo to
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Comparison of the ability of Tempo to
*
partition into DPPC liposomes containing
30 mole % cholesterol analogue.
Fig. 4.13
The effect of replacing DPPC by DMPC
on the partitioning of Tempo into




On the addition of a further 10 mole per cent sterol a
slightly different distribution was obtained - C^g and
reduced the (f) value by 50%: CC^ and C^ caused
a 70% reduction with C^ and C^-j giving a 77% decrease in
solubility (Fig. 4.13). At 30 mole per cent sterol the phase
transition disappeared. A similar value was calculated
from the differential scanning calorimetry experiments of
Hin & Sturtevant (99) with cholesterol and DPPC. This
disappearance of the phase transition of pure phospholipid in
the presence of cholesterol is well documented. Although the
mechanism involved is not fully understood, a possible explanation
could be that as the molar proportion of cholesterol is increased
the size of the cooperative unit of the phospholipid molecules
involved in the phase transition, which determines its sharpness
(101) , will decrease due to intercalation of the cholesterol
molecules between the hydrocarbon chains resulting in a
cholesterol-phospholipid mixture of intermediate fluidity (32) .
4.6 Solubility of Tempo in dimyristoyl phosphatidylcholine containing
20 mole per cent cholesterol side chain analogue
In order to ensure that the side chain pattern established
o
with dipalmityl phosphatidylcholine did not depend on a specificA
phospholipid with 16 carbons in the fatty acid chains, the same
range of analogues were incorporated at 20 mole per cent in
dimyristoyl phosphatidylcholine (DMPC, 14 carbons in the fatty
acyl chains) liposomes. Figure 4.14 shows the results obtained.
A similar pattern to that noted for DPPC was observed -
C25' C29 anC* C26' C27' C28 re<^uc^nS Tempo solubility by 33, 56
and 67 % respectively at 29°C compared to the results with

















The partitioning of 3N8 into DPPC liposomes containing
10 mole % cholesterol analogues.
Fig. 4.15
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solubility of Tempo was greater in DPPC than DMPC when both
phospholipids were in the fluid liquid crystalline phase.
The effect of cholesterol side chain analogues on the phase
transition of dipalmitoyl phosphatidylcholine as monitored by
a 3 nitroxide octane (3N8) spin label
The experiments described in Section 4.6 were repeated
using another spin label, 3-nitroxy octane, instead of Tempo.
The mechanisms by which each spin label indicates the nature of
its surroundings are slightly different. As stated previously
Tempo is capable of dissolving in both the hydrophobic and
hydrophilic regions of the membrane and analysis of the plot of
the (f) versus ( °C) (Fig. 4.l|) shows that it defines the lower
and upper end of the phase transitions. As the lipid layer
rigidifies, Tempo is extruded from the membrane phase, and the
lower end of the transition is defined. Using 5N10, an
analogous spin label to 3N8, Linden et al. (102) characterised
its ability to partition into a lipid bilayer.
They suggested that the aqueous solubility of this nitroxide
was limited and measured its lipid solubility by calculating
either (a) the peak height ratio of the midfield and high field
lines or (b) the apolar and polar high field line heights
(Fig. 2.7). In addition this hydrocarbon probe remained in the
membrane in the gel phase and appeared to separate laterally
in the hydrocarbon phase into the solid or liquid phase. They
state that the partitioning abilities prevented 5N10 from detecting
the upper limits of the phase transition and only a large reduction
in the concentration of liquid hydrocarbon chains resulted in the















The partitioning of 3N8 into DPPC liposomes containing
30 mole % cholesterol side chain
Fig. 4.16
b».
The results of the 3N8 experiments are illustrated in
Figures 4.15 and 4.16. The curves obtained do not resemble
those obtained with Tempo and unlike those of Linden et al. (102)
do not give a clear indication of the lower end of the phase
transition or the actual phase transition temperature.
The calculated values for the fluidity parameter are higher
than for Tempo in the liquid crystalline phase and the
analogues tested only seem to cause a small reduction in the
fluidity parameter above the transition temperature.
At temperatures less than 41°C the analogues are seen to
exert a greater effect on the solubility of the spin label.
Comparison of the (f) values at 38.5°C obtained for DPPC with
the analogues DPPC mixture showed that at 10 mole per cent
(Fig. 4.15) had no effect, C^ caused a 5% reduction
whereas ^25' ^26' ^27' ^28 and ^29 rec*uce<* t^ie partitioning
by 17%. Increasing the proportion of sterol present to 30
mole per cent (Fig. 4.16) still had no effect with C^ but a
17% reduction was noted with and C^q and a 45% reduction with
C25' C26 and C27*
4.8 Location of the available spin labels in egg yolk phosphatidyl¬
choline liposomes
In order to confirm the proposed locations for the spin
labels used in this study, Tempo, 3NC, 25NC, 1 nitroxy stearamide
(probe for the bilayer surface) and 3N8 (Fig. 2.5) were
incorporated into a liposomal structure and solutions of either
nickel chloride or ascefcbic acid were added. Both solutions
removed the spin label signal. Nickel reversibly removed the
spin label whereas ascorbate converted the nitroxyl group to
hydroxylamine destroying the free radical. Assuming that interaction
u: •
between the spin label and the nickel or ascorbate was very rapid,
the relative rates of removal of each spin label's signal should
give an indication of the location of the spin label's nitroxyl
grouping in the liposome membrane.
Nickel Chloride (NiCl^.bH^O)
In the presence of 100 nmoles of nickel chloride the
magnitude of the high field line of an aqueous nitroxide spectrum
of Tempo and 3N8 (10 nmoles) was reduced by an average of 44%
after five minutes at room temperature. The experiment was
repeated with the same spin labels (10 nmoles) incorporated
into dipalmitoyl phosphatidylcholine. Equimolar nickel chloride
did not reduce the signal obtained but-Table 4.14 shows the effect
of a 10 fold excess of nickel solution.. The high field line of
the epr spectrum for each sample was recorded on either side of
the phase transition prior to the addition of the nickel whem
the process was repeated. In the case of Tempo, the aqueous
signal seemed most susceptible to the addition of nickel with a
resultant increase in the value of (f). 3N8 underwent a 30 per
cent reduction in both the hydrophflic and hydrophobic signals in
the presence of nickel.
The phase of the lipid did not seem to determine nitroxyl access¬
ibility to the diamagnetic species, but the differences in
the spin label's aqueous signal reduction indicated that Tempo is
more accessible than the 3N8.
Ascorbate
Essentially the method followed was that described by
e,
Schreier & Mucillo et al. (103) with the differences that multi-
layered liposomes (4 mg egg PC/30 ml buffer) were used and the
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The effect of ascorbate (M) on the signals of
spin labels incorporated into egg yolk
phosphatidylcholine liposomes.
(For spin label structures see Fig. 2.5)
Fig. 4.17
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the midline was monitored on the addition of 2 ml of ascorbate
to 50 nmoles of the liposomal spin label over a ten minute
period. With this concentration of ascorbate each spin label's
signal was removed within 30 seconds in aqueous solution.
Figure 4.17 shows the results obtained with the surface probe 1
nitroxystearamide (INS), 3NC, and 25NC. The data seemed to
clearly support the view that the 3NC and 25NC nitroxyls are situ¬
ated at different depths in the bilayer. In addition it
appears that in all cases a portion of the spin label is
protected from the ascorbate.
4.9 The effect of amphotericin B on Tempo solubility in liposomes
prepared from dipalmitoyl phosphatidylcholine
Amphotericin B is one of the poylene antibiotics which
comprise a group of cyclic amphipathic lactones, which contain
a number (usually 4-7) of conjugated carbon:carbon bonds in
the ring structure and have molecular weights in the range
500 to 1300. With few exceptions the biologic effects of these
antibiotics have been attributed to the increased cellular
permeability to a variety of solutes which results from the
interaction of the polyene compounds with membrane bound
cholesterol. This interaction is believed to be non-covalent
and is dependent on the pH and relative concentrations of sterol
and amphotericin (104). When amphotericin B is incorporated into
a lipid film containing cholesterol, the steroltphosphatidyl-
choline interactions are reduced allowing the surrounding phospho¬
lipid chains to undergo a normal, sharp, gel to liquid crystal
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Tempo solubility in DPPC liposomes in the
presence of (a) 1 yl dimethyl-sulphoxide
(b) Amphotericin B (0.3 x 10 ^ mole) in 1 yl
dimethyl sulphoxide (c) Amphotericin B
(1.56 x 10 ^ mole) in 5 yl dimethyl sulphoxide.
Fig. 4.18 (a)
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Tempo solubility in DPPC liposomes
containing (a) 20 mole % cholesterol
(b) 20 mole % cholesterol + 1.56 x 10 ^ mole
Amphotericin B in 5 yl dimethyl sulphoxide.
Fig. 4.18 (b)
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Using Tempo solubility to monitor the phase transition of
dipalmitoyl phosphatidylcholine instead of DSC I attempted to
repeat the experiments designed to show that amphotericin B can
remove cholesterol from phospholipid. The effect of varying
concentrations of amphotericin on the phase transition of dipalmitoyl
phosphatidylcholine in the presence and absence of 20 mole
per cent cholesterol was measured (Fig. 4.18b).
As amphotericin B was extremely insoluble dimethyl sulphoxide,
which has no effect on Tempo solubility, was used to deliver the
antibiotic to the liposome. Figure 4.18a shows that the addition
of increasing amounts of amphotericin B to dipalmitoyl phospha¬
tidylcholine had no effect on the sharpness of the phase transition
but it did reduce the solubility of Tempo in the liquid crystal
phospholipid. In addition the spin label method did not reveal
any sequestration of cholesterol by amphotericin B as no fluidisation
of phospholipid mixture was apparent. In fact the addition of
amphotericin B seemed to reduce the solubility of Tempo and this
was maybe due to the addition of the large rigid amphotericin B
molecule.
4.10 Solution interactions of cholesterol analogues and amphotericin B
The UV spectrum of amphotericin B recorded between 350 and
450 nm (104) and the effect of the addition of a ten fold excess
of a cholesterol side chain analogue was noted. In each instance
there was evidence of some kind of interaction between the respective
cholesterol analogue and the antibiotic, which alters the ultra
violet spectrum. This can be monitored by the change in the ratio
of the peaks at 360 nm and 410 nm that occurs after a 30 minute







35 4.4 1.2 0.214 0.719 O.4O6
38.5 3-9 1.7 0.304 0.7H 0.404
43 2.55 3-8 0.593 0.710 0.409
The effect of 8.4*10~^ mole NiCl^HgO on the aqueous






( f ) s; „2+
35 4.4 4.2 0.516 0.88 0.7
38.5 4.5 3.3 0.576 0.714 0.66
43 8.2 6.3 O.565 0.766 0.78
The effect of 8.4 10 ^ mole NiOl 6Hg0 on the aqueous
and the hydrophobic components of the 3N8 spin label
signal.
Table 4.14
Hot a- H represents the signal obtained in the absence
of Bi2+
Cholesterol ratio











pH 7 solution interactions of 1.,55*10 mole
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summarised in Table 4.15 which shows that although the interaction
of amphotericin B with C^g and was less than that with the
cVwi\
longer side^analogues, no absolute requirement for a specific
side chain length was observed. This result was similar to the
finding (105) that spectral changes of amphotericin B were not
sensitive to the structure of a series of liposomallybound naturally
occurring cholesterol analogues.
4.11 Interactions of amphotericin B with liposomally bound cholesterol
side chain analogues
Essentially the interaction was monitored in an identical
manner to the solution interactions of amphotericin B and sterol
described in the previous section. The liposomes were
prepared from a dried lipid film containing 12 mole per cent
_8 __g
(2 x 10 mole), 25 mole per cent (5 x 10 mole) and 33 mole
per cent (1 x 10 ' mole) cholesterol analogue by vortexing in
10 mM Tris-acetate at either pH 7 or pH 2. A dimethylsulphoxide
_8
solution of amphotericin B (1.5 x 10 moles) was added to the
liposomes and the mixture was incubated for 30 minutes prior to
the recording of the U.V. spectra. Tables 4.16a,b do not give
any indication of a sterol's side chain requirement for optimal
interaction with amphotericin B molecules. Alteration of the
proportions of antibiotic, sterol and egg yolk phosphatidylcholine
had no effect on this interaction, but comparison with Table 4.14
showed that incorporation of the sterol in a liposome resulted in
a reduction of the 360/410 ratio.
Unlike Norman et al. (104) the presence of 33 mole per cent
cholesterol analogue did not seem to alter cholesterol:amphotericin
B interaction at pH 2 and Z Z ~i the absolute










C19 1-33 1.38 1.48
C21 1.41 1.59 1.28
°24 1.52 1.74 1.79
C25 1.38 1.58 1.57
°26 1.42 1.69 1.4a
C27 1.34 1.66 1.44
C28 1.34 I.84 1.44
c29 1.21 1.36 1.33











Cl9: ' 1.55 1.44 1.28
C21 1.53 1.71 1.35
C24 1.59 1.72 1.37
c25 1 ° 5 3 lo57 1.49
°26 1.65 1.52 1.35
°27 1.63 1.61 1.48
628 1.48 1.53 1.30
C29 1.42 1.49 1.43
(*)
/ ®8
Interaction of amphotericin B ( 1.5*10 mole)
with cholesterol analogues contained, in egg yolk
phosphatidylcholine liposomes at (a) pH 7 an<l (*>) pH 2
Table 4.16
560/410 ratio










The effect of a $0 second sonication on the interaction
—8
at pH 7 of amphotericin B (1.5*10 mole) -with egg yolk
phosphatidylcholine liposomes containing cholesterol
—8
analogues ( 2*10~ mole : 16 molejj sterol )
Table 4*17
73.
The effect of sonication of amphotericin B and sterol
containing liposomes is shown in Table 4.17. Column (a)
shows the ratio 360/410 peaks after a 30 minute incubation of
liposomes and amphotericin B. The mixture was then sonicated
for 30 seconds and the ratio was remeasured, column (b).
Although the sterol:amphotericin B interactions seems to
withstand this sonication by comparisonvith the egg yolk
phosphatidylcholine controls, the absolute values of the
360/410 ratio are reduced by approximately 20 per cent in all
cases.
Taken together all the spin labelling experiments which
were concerned with different aspects of the role of cholesterol
in membranes show that cholesterol elicits the maximal response
in each case. As a natural extension to the spin labelling
experiments, the role of cholesterol was examined by a further
set of physical techniques namely stopped-flow spectrophoto¬
metry and monolayer studies.
m.
Summary to Chapter 4
(1) AT 40 and 50 mole per cent cholesterol side chain analogue,
cholesterol norcholesterol and sitosterol cause optimal ordering
of the surrounding phospholipid chains as judged by the epr
spectrum of 3NC incorporated into egg yolk phosphatidylcholine:
analogue liposomes. With the rest of the available analogues
the ordering is similar in all cases hut the absolute value is
less than that for cholesterol. A similar pattern is obtained
with the 25NC spin label.
(2) Oriented films of cholesterol analogue:egg yolk phosphatidyl¬
choline (30:70) containing 1 mole per cent 3NC have slightly
higher values for the order parameter as compared to liposomes of
the same composition. The pattern observed is similar to the
liposomes studies but the values for and are intermediate
between C^ and the other analogues.
(3) Dipalmitoyl and dimyristoyl phosphatidylcholine liposomal
studies with Tempo as an indicator group confirm the steroid
spin label results obtained in egg yolk phosphatidylcholine
although this spin label is reporting on a different physical
effect. In addition use of the two phospholipids confirms
that the sterol side chain and not the fatty acid side chain
determines the cholesterol analogue phospholipid interaction.
(4) The results of the 3 nitroxyl octane spin label studies are
similar to those for Tempo although each spin label reports in a
slightly different manner.
(5) Interaction of the various spin labels with either ascavrbate
or nickel confirms that the 25NC spin label is buried deeper
in the bilayer than the 3NC.
/ D .
(6) Addition of amphotericin B in dimethylsulphoxide to an aqueous
solution or a liposomal preparation of a sterol side chain
analogue results in a sterol-amphotericin B interaction which is
independent of the side chain present.
(7) Spin labelling using Tempo does not seem to be a useful
technique for determining if amphotericin B can sequester
cholesterol restoring the lipid phase transition in the
process. Amphotericin B itself is a large, rigid, molecule
and perhaps its presence interferes with the Tempo partitioning
into the postulated cholesterol free regions in the dipalmitoyl
phosphatidyl choline.
The implications of the results in Chapter 4 are
discussed with the results of other physical studies, at
the end of the following chapter.
CHAPTER 5
THE USE OF STOPPED FLOW SPECTROPHOTOMETRY AND




The results described in the previous chapter were obtained
with an external reporter group which partitions into a
phospholipid:cholesterol dispersion. The possibility exists
that the incorporation of the spin label into a membrane
alters the structure of the membrane in such a way that the
spin label's environment is unrepresentative of the bulk of
the membrane. An alternative model system would be one in
which the characteristics of the membrane could be determined
in the absence of a reporter molecule. In this chapter two
further physical techniques are described (a) stopped flow
spectrophotometry of liposomes, and (b) monolayer studies,
(a) Stopped flow spectrophotometry of liposomes
Liposomes formed by swelling a dried lipid film in an
aqueous salt solution consist of concentric spheres of lipid
bilayers whose precise geometry depended on the water
content, temperature, ionic strength and the method of dispersion
(25) . At equilibrium each and every lipid bilayer was
visualised (106) as forming an unbroken membrane implying that
every aqueous compartment was discrete and isolated from its
neighbour. In addition the liposomally bound aqueous compartment
was separated from the bulk aqueous phase in which it was
suspended. Electron microscopy of liposomes (10*5) showed
this closed structure was present and revealed that each bi-
molecular lamella was separated by 45$ by an aqueous compartment,
which contained water and trapped ions from the swelling buffer.
This intraparticulate water can be lost by the addition of an
osmotically active species such as hypertonic salt solution.
11%
The permeability of liposomes has been monitored spectro-
photometrically in a stopped flow device by Bittman and Blau
(108) and Jain et al. (26). They assumed that the amount of
light scattered by liposomes was a function of their volume at
those wavelengths where absorbance was due entirely to scattered
light (109) . In addition the liposomes were shown to be ideal
osmometers and thus were permeable to water but not to solute
molecules. The net flow of water through a membrane per unit
time is proportional to the surface area of the membrane and
the osmotic gradient across it and the large surface area of
liposomes permits the initial rate of volume change upon sudden
change in the osmotic pressure of the suspending medium to be
measured. With potassium chloride in the osmotically active
spaces the initial rate of the volume change provided an indication
of the velocity of water diffusion through the outer lipid layer.
Dicetyl phosphate was included in some preparations (108) in order
to confer a net negative charge on the bilayer which increased
the liposomal radius facilitating the trapping of potassium
chloride in the aqueous interstices.
In recent years two main molecular mechanisms have been
proposed for water transport across lipid bilayers. In the
first mechanism, non-specific water permeation is explained in
terms of channels or pores within the membrane which are transiently
formed by thermal fluctuations of the molecules comprising the
membrane structure (110). Electron microscopy of liposomes
does not reveal the existence of such tiny pores and thus this
explanation of the phenomenon has become less popular.
The second and more important theory of transmembrane movement
is that proposed by TrHuble (111). Transmembrane movement of
78.
water depends on the partition coefficient of the permeating
molecules between the aqueous phase and the hydrocarbon region
of the membrane. The relationship of both phases can be altered
by thermal fluctuations in the hydrocarbon chains of membrane
lipids. The thermal fluctuations result in the formation of
conformational isomers which are the so-called "kink" isomers
of the hydrocarbon chains. The kinks so formed may be described
as mobile structural defects which represent small mobile free
volumes of different size depending on the type and arrangement
of kinks in the hydrocarbon membrane phase. A molecule present
in the aqueous phase adjacent to the membrane may jump into the free
volume of a kink at the membrane surface and may then diffuse
across the membrane together with the mobile kink in a rapid
-5 2
hitch-hiking process (10 cm /sec). By an appropriate
combination of kinks volumes large enough to accommodate molecules
of water can be formed. Most of these holes will only extend for
a few chain segments and not completely across the membrane so
that in general no pores would be formed.
The effect of cholesterol on the liposomal structure has
been well documented (100). Johnson (112) has shown that the
addition of 10 mole per cent cholesterol resulted in a 30%
increase., in the phospholipid molecule surface area with a consequent
decrease in bilayer thickness. As the molar proportion of cholesterol
rose further the surface area of the bilayer per phospholipid
molecule remained constant at 89R*and the bilayer thickness increased.
In addition the X-ray data (22) obtained for dipalmitoyl phosphatidyl¬
choline liposomes revealed that there was a large increase in the
long spacing of the X-ray diffraction bands from 70& to 8lX in
the presence of 7.5 mole % cholesterol and a decrease to 64& at 50
8 10 12 14 16 18 20
1 (M_1)KC1




Both of these observations correlate with the effect that
varying proportions of cholesterol have on water permeability
across lipid bilayers. Jain et al. (26) have shown that
water permeability increased up to 10 mole % cholesterol and
decreased beyond this level of sterol. Their results can be
explained by the relative abundance of kinks present in each
mixture due to the different packing characteristics of
phospholipids in the presence of different amounts of
cholesterol.
In order to clarify the cholesterol mediated reduction
in permeability, it was decided to determine what effect
altering the side chain structure of cholesterol had on water
permeability across a bilayer.
Osmotic shrinking of liposomes prepared in 0.05 M KC1
The liposomes were prepared as described in the Materials
and Methods section. Figure 5.1 shows that liposomes prepared
with potassium chloride as the osmotically active species give
linear Boyle-van't Hoff characterisics for osmotic shrinking
when exposed to an osmotic pressure gradient. The linear
dependence observed for liposomal osmotic shrinking indicates
that they are ideal osmometers under these conditions and are
completely impermeable to solute, and thus they are ideal for
the study of the effect of the incorporation of cholesterol
analogues with altered side chains.
As mentioned in the previous section, liposomes prepared
for permeability studies either contain phosphatidic acid (109),
dicetyl phosphate (26,108). The absolute amount of dicetyl
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The effect of increasing mole % dicetyl phosphate on
and AT«,
to 4 mole per cent (26). At either of these concentrations
the presence of dicetyl phosphate increases both the total
extent of shrinking (AT) and the initial rate of shrinking
(9t), Fig. 5.2b. In order to ensure that any effect observed
was due to the presence of sterol and not to the presence of
dicetyl phosphate, Jain et al. (26) calculated the ratio of
the initial rate of shrinking to the total extent of
shrinking, 9T/AT, and it is their approach that is employed
in this chapter. Figure 5.2a shows that even up to 40 mole
per cent dicetyl phosphate, 9t/AT remains constant in dicetyl
phosphate:phospholipids liposomes. Thus any alteration in
this value (9T/AT) cannot be attributed to variation in dicetyl
phosphate present when the data a<at treated in this manner.
5.3 The effect of cholesterol analogues on water permeability
across egg yolk phosphatidylcholine liposome membranes
The effect of cholesterol on water permeability of
phospholipid bilayers has been documented by Bittman and Blau
(108) and Jain et al. (26). Both groups of workers studied
the osmotic shrinking in a stopped flow spectrophotometer
which allows measurement to be made almost instantaneously as
opposed to the 2-5 second delay experienced with mechanical
mixing (109). Bittman and Blau found that cholesterol decreased
the initial rate of volume change by 42% at 33 mole per cent
cholesterol and by 30% at 20 mole per cent cholesterol. In
addition they found that introduction of unsaturations into
the hydrocarbon fatty acid chain increased water permeability
across the liposomal membrane. Taken together these results
appear to be consistent with the solubility diffusion mechanism









0. 6.9 0.839 0
0.1 5.6 0.748 -0.091
0.2 4.8 0.681 -0.158
0.3 4.5 0.653 -0.186
0.4 4.a 0.O23 -O.2I6
0.5 3.85 0.585 -0.254
0.6 3.8 0.580 -0.259
0.7 3.5 0.544 -0.295
0.8 3.4 0.531 -O.3O8
6-9 3.2 0.505 -0.334
1.0 3.0 0.477 -e.362
From figure 5.3 the slope of log^x^xj)versus t is
log x~iogX per second = -0.245
b O
Converting to a positive mantissa
log X, -log X per 1 second = 1.755
w O
Since log xq is 0.839
log x^ = 0.839 +T.755 = 0.594
Antilog: x^ = 3'. 93
Therefore, in 1 secimd-there has been a transmittance
change of fa. 9-3.93/20*0.5 V 0.0745V * o-ozSV
S4- = 0.0745 V
kf = O.I73 V change in 50 seconds
0.430 sec"1
Fig- 5.3
An example of the method of calculation of the kinetic




diffusion coefficient of water permeation by rigidifying the
crystalline hydrocarbon chains and limiting the formation
of mobile structural defects. The reduction in permeability
was not so marked when the OH group at position 3 was changed
from B to a (epicholesterol) or replaced by an SH group (thio-
cholesterol). Thus there appeared to be a precise structural
requirement of the polar groups for optimal cholesterol-
phospholipid interaction.
In order to determine if alterations of the side chain
structure of cholesterol affected its ability to reduce water
permeability, the available cholesterol analogues were incor¬
porated into egg yolk phosphatidylcholine liposomes. At the
concentration used, all the analogues including cholesterol can
be'equally incorporated into a liposomal structure. Essentially
the experimental method employed was that described by Jain et al.
(26). As described by Bittman and Blau (108), use of a 1:1
ratio of liposomes and 0.18 M KC1 occasionally resulted in a
disturbance of the trace within the first 150 m sees after mixing.
For each liposomal mixture the initial rate of osmotic shrinking
over the first second was calculated from the exponential curve
by treating the transmittance data in the manner (113) described
in Figure 5.3 and expressing it as a fraction of the total
transmittance change.
The results of the osmotic shrinking experiments are given
in Table 5.1 and 5.2 which show that the values for different
t
batches of phosphatidylcholine and different liposomal
preparations can vary by up to 25 per cent, although the normal
variation is approximately 10 per cent. This divergence is
similar to figures quoted by Jain et al. and may be due to
molejt °21 c27
sterol fy[\T S%T &%T
0 0.463 0.602 0.629
10 0.463 0.602 0.492
20 0.463 0.602 0.478
30 0.463 0.580 0.410
40 0.500 0.570 O.383
50 0.353 0.342
Sable 5•1
Comparison of° AT (22 C) for liposomes containing
r 0-50 mole% C^fCjj-^and 0^. Results are the mean





ci9 °21 C24 C25 Rf.6 Q27 O ro CD C2S
0 0.463 0.602 0.578 0.620 O.58O 0.629 0.472 0.540
10 0.463 0.602 0.578 0.530 0.548 0.492 0.451 0.532
33 0.463 0.580 0.472 0.510 0.408 0.410 0.454 0.525
Table 5.2
The effect of cholesterol analogue incorporation on water
e
permeability across the liposomal membrane at 22 C
The results are the mean of at least 4-5 experiments.
•j Temp.
(V)
°19 '°21 C24 o25 C27 00C\J
j
0 C29
25 0.96 1.07 0.91 0.89 0.69 1.05 1.07
30 0.96 0.92 0.94 0.88 0.72 1.05 0. 98
35 0.91 0.93 0.89 0.89 0.88 1.02 0.91
40 0.98 0.96 1.00 0.97 1.01 0.98
45 0.97 0.97 0.931 0.99 0.88 1.05 0.90
The effect of temperature on water permeability across
liposomal membranes containing 25 mole/0 cholesterol




differences in the numbers of sealed vesicles present from batch
to batch. As shown in Table 5.1 even at 40 mole per cent
sterol, and C^ sterols do not result in a reduction of the
water permeability, whereas cholesterol causes a 39% decrease.
Table 5.2 gives the values for 3T/AT at 0, 10 and 33 mole %
sterol, and reveals that the incorporation of 33 mole per cent
sterol results in a 17% reduction in permeability in the case
of and and a 29 and 35% reduction in liposomes containing
and C2y respectively. When C^g, C,^, C2g and C^g are present,
no reduction in permeability is observed.
Temperature effects on water permeability across liposomal membranes
containing cholesterol analogues
The effect of increasing temperature on water permeability is
detailed in Table 5.3. At 25°C a similar trend to that described
in the previous section is observed.
At 35°C the differences between the analogues are eliminated
and this trend is continued at 40°C and 50°C. The 3T/AT results
in the table at each temperature are expressed as the ratio of
the value for egg yolk phosphatidyl choline due to the previously
mentioned variability in the phosphatidylcholine preparations and




The main conclusion of Sections 5.3 and 5.4 is that "altering
the side chain of cholesterol by the removal or addition of methyl
groupings results in the diminution of the regulatory role that
cholesterol plays in water permeation.
Increasing the temperature to 35°C removes the cholesterol
mediated reduction of water permeability noted at 25 mole per cent
sterol. This observation can be easily explained by Tr&uble's
theory of water permeation (111) in terms of the increased likeli¬
hood of kink formation at elevated temperature. The increased
number of kinks present could alter the liposomal structure.
Thus the water permeability characteristics of sterol:phospholipid
liposomes are comparable with sterol free liposomes on increasing
the temperature.
5.5 Monolayer studies of cholesteroltphospholipid interactions
When a chloroform solution of lipid is placed on the surface
of a water layer in a Langmuir trough by means of microsyringe,
the solvent evaporates leaving insoluble lipid monolayers at the
air water interface. The film so formed can then be made to
compress by means of a moveable barrier in contact with the film,
until it collapses. The area per molecule for a monolayer can
be calculated at any surface pressure. Hence the monolayer
studies permit a direct determination of the cross-sectional area
of an insoluble surface-active molecule. Usually the results
are shown by a surface pressure-area (tt-A) plot. Surface pressure
can be regarded as the osmotic pressure of a two dimensional
solution.
When cholesterol was added to phospholipid preparations the
mixed monolayers were considerably condensed, and the area per
molecule was less than the sum of each individual molecular area
(114). An indication of the precise role played by the phospho¬
lipid in the cholesterol:phospholipid mixture was provided by
Demel et al. (115), by preparing, among others, mixed monolayers
of 1,2 dimyristoyl phosphatidylcholine and cholesterol, and 1,2
diste<?royl phosphatidylcholine and cholesterol. The mixed mono¬
layers of cholesterol and 1,2 disteqroyl phosphatidylcholine
c
essentially follwed the additivity rule of molecular areas, whereas
cholesterol caused condensation of 1,2 dimyristoyl phosphatidyl¬
choline. Thus a slight alteration of the fatty acyl chain was
seen to have an important effect on the monolayer cholesterol
phospholipid interaction.
The same group have also studied the structural requirements
for sterols for sterol:phosphatidylcholine interaction at the air
water interface (89). Using a selection of 3a and 38 hydroxy
sterols, and 3 keto-steroids, the interaction of sterol with
18:1/18:0 phosphatidylcholine in a 1:1 monolayer was determined
by calculation of the area per molecule at 22°C. On the basis
of their monolayer data it could be demonstrated that cholestanol,
lathosterol, 7-dehydrocholesterol and 8~norcholesterol were as
effective as cholesterol in achieving a minimal mean molecular
area (Fig. 1.1). The mixture of 18:1/18:0 phosphatidylcholine
with the plant sterols ergosterol and stigmasterol, and with
androstanol showed a slightly higher mean molecular area. The
less effective interaction of these three compounds must be due
in the cases of ergosterol and stigmasterol to double bond at
^22' ^23 anc^ t*ie extra methyl and ethyl group respectively at
C„, and to the lack of an intact side chain in the case of24
androstanol.
The apparently complex behaviour of various phosphatidyl¬
choline: sterol monolayers has been interpreted in two different
ways
(a) One interpretation attributes the observed effects to
alteration in Van der Waals interactions, configuration entropy
effects and alterations in the water structure adjacent to the
monolayer.
c.
(b) The second interpretation proposed by Shah and Shulman (23)
u_/ .
stated that the deviation in molecular area was not due to an
interaction, but rather to steric factors such as unsaturation
and length of phosphatidylcholine hydrocarbon chains. They showed
that the average area per molecule in dipalmitoyl-phosphatidyl-
choline:cholesterol monolayers exhibited deviation at low surface
pressure but at 30 dynes/cm the monolayers followed the additivity
rule.
The apparent condensation of the mixed monolayers was
explained as follows.
The fatty acyl chains of phosphatidylcholine in an expanded
monolayer because of their thermal motion effectively occupy a
volume represented by a cone with its apex at the air water
interface and base at the methyl terminal of the fatty acyl
chains. This movement of fatty acid chains would result in the
formation of a vacancy or cavity between molecules. If other
molecules that have dimensions smaller than or equal to those of
the cacity are added to the phosphatidylcholine monolayer they
may partially occupy these cavities without causing a proportional
increase in the area of the monolayer. This would explain the
observed deviation from the average area per molecule (the additivity
rule). At high surface pressures the fatty acyl chains are
vertically packed and the addition of cholesterol therefore causes
a proportional increase in the area of the mixed monolayer.
Shah and Shulman (23) have also shown that egg yolk phospha-
tidylcholine:cholesterol monolayers are optimally condensed at
molar ratios of 1:3 and 3:1 which allow optimal geometrical
arrangements of those molecules for packing in the mixed monolayer.
This ratio is thought to be related to the fraction of oleoyl
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A comparison of the effect of the incorporation of a series of




The monolayer packing characteristics of the available
cholesterol side chain analogues were assayed and the results
of these experiments were related to the spin label and the
osmotic shrinking results.
5.6 Measurement of the force area curve for mixed films of cholesterol
analogues and egg yolk phosphatidylcholine
These experiments were performed by Dr. B.R. Malcolm,
Department of Molecular Biology, University of Edinburgh.
A quantitative measurement of the cholesterol analogue's
interaction with its surrounding lipid molecules was obtained
by plotting the variation of the mean molecular areq at a constant
surface pressure (12 dynes/cm) as a function of the egg yolk
phosphatidylcholine mole fraction present. This is the
treatment employed by Goodrich (see 116) and the results are
plotted in Figure 5.4a-f. Analysis of the data at 50 mole per
cent sterol shows that and C^ exhibit a 12% deviation from
ideality, whereas all the other analogues tested exhibited
approximately a 20% deviation from ideality.
The results show that monolayer interaction between cholesterol
and side chain analogues and egg yolk phosphatidylcholine does not
have the absolute requirement for an isoctane side chain for
optimal interaction previously observed in the liposomal studies.
Perhaps the lack of specificity in monolayers can be explained
by the absence of the constraints imposed on liposomal cholesterol
phospholipid interactions as a result of incorporation into a
bilayer structure of fixed dimensions. Thus the variation in
the cholesterol side chain seems to assume a greater importance
with regard to cholesterol's molecular packing properties when the
phospholipid-cholesterol interaction is subjected to certain
u / .
structural limitations. These structural limitations also
enable cholesterol to exert a molecular control of membrane
morphology in areas with high radius curvature (117). Such
changes in lateral distribution of cholesterol (69) - ~ could
result in alteration of the biological activity of the
cholesterol containing membrane.
A discussion of the role of the cholesterol side chain in
the interaction between cholesterol and phospholipids
The foregoing two chapters have been concerned with trying
to define the role played by the cholesterol side chain in the
interaction between cholesterol and phospholipids when . both
are incorporated into a model membrane.
Chapter 4 dealt with the epr studies of the interaction using
a variety of spin labels. Although the four spin labels were
reporting on slightly different aspects of the interaction they
all showed the same basic trend. The results obtained showed
slight differences from label to label. The 3NC spin label
reported on the effect that the incoporation of cholesterol side
chain analogues had near the liposome surface whereas the 25NC spin
label reporter group was situated deeper in the membrane structure.
Both spin labels showed that cholesterol has the optimal structure
for sterol-phospholipid interaction but the absolute values differ
in such a way as to suggest that cholesterol exerts its maximal
ordering effect at the bilayer surface. At 50 mole per cent
cholesterol, the 3NC order parameter showed a 69% increase over
that observed with egg yolk phosphatidylcholine alone, whereas the
25NC order parameter indicated that 50 mole per cent cholesterol
showed a 55% increase in ordering. As the 3NC spin label signal
is more rapidly removed by ascorbate than 25NC signal the results
O
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are consistent with the hypothesis that cholesterol is exerting
its maximal ordering effect nearer the phospholipid head group
region than the bilayer centre. In addition the 25NC results
showed that incorporation of 10 per cent sterol caused an ordering
of the bilayer centre whereas the 3NC did not detect any change
in fluidity of phospholipid at this sterol concentration. Thus
both spin labels gave the same overall picture hut there were
differences in the actual values obtained.
The preparation of the oriented sterol:egg yolk phosphatidyl¬
choline films containing 3NC which allowed a greater resolution
of the spectra also showed that cholesterol caused the maximum
increase in order parameter. The values of the order parameter
calculated for oriented films are higher due to the separation
of the various spectral contributions that are averaged in the
3NC liposomal spectra.
When Tempo and 3N8 were used to report on the cholesterol
interaction with defined, saturated phosphatidylcholine, the same
basic pattern was noted with cholesterol causing the maximum
broadening of the phase transition at all the concentrations studied.
The results for the C^g analogue monitored by 3N8 were slightly
unusual in that there was no deviation from ideality up to 30 mole
per cent sterol. In the other experiments at all concentration
the analogue caused a moderate increase in rigidity with the C^
and somewhere between C^g and cholesterol. The simple act of
removing the iso-octane side chain completely or adding to its
length obviously has an important effect on sterol phospholipid
interactions studied by spin labels.
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These last observations can be explained in one of two
ways
(a) In terms of a cleft formed between the phospholipid molecules
in a bilayer which is optimally adapted to fit the cholesterol
molecule.
(b) By considering that the phospholipid fatty acyl chains exist
in an equilibrium between an ordered state and a state of random
motion. Their precise equilibrium position is determined by the
structure of the cholesterol analogue that is incorporated into the
phospholipid bilayers.
(a) The existence of a cleft of precise dimensions, specific
for the cholesterol side chain, between the phospholipid molecules
is an attractive proposition which would explain the results obtained
with cholesterol molecules with altered side chains. The cleft
would only be formed when the concentration of cholesterol analogues
was increased to levels where it started to rigidify the fatty
acyl chains. At approximately 30 mole % sterol the cleft would
be visualised as exerting a fine adjustment on cholesterol-phospho-
lipid interaction by its differing interaction with the cholesterol
side chain of various lengths. The cholesterol analogues with
shorter side chain than cholesterol have a higher motional freedom
as cleft is only partially occupied. This increase in the motion
of the analogue would be observed through the bilayer with a
consequent decrease in the order parameter as compared to the
molecule with the optimal fit in the cleft (cholesterol). The
decrease in ordering of the spin labels observed with the sterols
with longer side chains Cot3 and Con could also be explained in termsZo Zy
of the existence of a precise cleft that is adapted for optimal
fitting by an iso-octane side chain. If the sterol nucleus of
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or C^g was positioned in a phospholipid bilayer in an identical
manner to cholesterol (49) then especially in the case of C^
the larger side chain would protrude through the other half of
the bilayer. However if the existence of a cleft with specific
limitation regarding the size of a side chain that it can
accommodate is postulated, incorporation of longer side chain
analogues would result in altered packing characteristics of
their ring system. This alteration of the molecular packing
would also reduce the interaction by the cholesterol hydroxyl group
with the phospholipid head group (51) by increasing their spatial
separation. The increase in disorder of the bilayer caused by
the disruption of the specific interaction normally operative
in the case of cholesterol is consistent with the calculated
order parameters.
(b) In the absence of sterol the fatty acyl chains of egg yolk
phosphatidylcholine are in rapid motion and loosely packed.
This loose association allows molecules of cholesterol to be
intercalated between the fatty acyl chains which disrupts the
intermolecular associations operative in the phospholipid. As
the molar proportions of cholesterol present are increased the
available sites that cholesterol can occupy decrease in direct
proportion. This has the dual effect of increasingly immobilising
the fatty acid chains and altering the equilibrium that existed
between the rigid and fluid fatty acyl chains. The equilibrium
position of that membrane can be slightly altered by the selective
addition or subtraction of carbon atoms from the side chain of the
cholesterol molecule. The short side chain analogues may allow
more freedom of movement of the surrounding phospholipid molecules
and thus the order of the bilayer is decreased as compared with the
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ordering of phospholipid by an equivalent amount of cholesterol.
In the case of C„0 and C _ where the side chain is extended,
zo zy
the order of the sterol:phospholipid bilayer is decreased
which is similar to the results obtained with the short side
chain analogues. A possible explanation for this disordering
effect could be that in the case of C and C„_ the side chain
Zo zy
will penetrate into the other half of the bilayer and increase
the disorder. Alternatively, the side chain could fold back
on itself, thus occupying a greater volume than the cholesterol
side chain, leading to the increase in the movement of the fatty
acyl chains.
Explanations (a) and (b) partly account for the observed
specificities for cholesterol analogue phospholipid interaction.
Perhaps each new equilibrium position established by the addition
of varying amounts of cholesterol analogue result in the formation
of transitory clefts between the fatty acyl chains which are
optimally adapted to fit the cholesterol molecule. The work of
Opella et al. (45) has shown that the motion of the isopropyl
tail of the cholesterol side chain is subject to steric restraints
and thus this would tend to suggest that some interaction is
occurring between the sterol side chains and its surroundings.
The overall results of Chapter 4 suggests that alteration of the
side chain interferes with this interaction.
Chapter 5 described the cholesterol-phospholipid interactions
using two physical techniques which did not require the addition
of an external reporter group. The results of the osmotic
shrinking experiments at 25°C showed that at 10 mole % sterol none
of the cholesterol side chain analogues (including cholesterol
itself) cause a reduction in water permeability. At 33 mole %
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the effect of sterols with altered side chains became apparent,
with C^g, ^2^, C2g and C2g causing no reduction in permeability
and C28 and C^ reducing the permeability by 29 and 35%. The
observed value for lay exactly in the middle of these two
groups (17% reduction). These results can be simply explained
by Trauble's theory (111) on the grounds that alteration of
side chain will interfere with the optimal packing described
in Chapter 4, resulting in the formation of free volumes in the
bilayer capable of holding water. The fact that increasing
the temperature to 35°C abolished these side chain differences
and the cholesterol mediated reduction in water permeability,
indicated that an increase in the thermal energy of the fatty
acids could overcome the rigidifying effects of cholesterol at
this concentration allowing the water to permeate freely.
A similar set of experiments using Acholeplasma laidlawii
membranes showed that while cholesterol increased the molecular
packing, decreased the fluidity of phospholipid hydrocarbon chains
and decreased non-electrolyte permeability, epicholesterol had
none of these effects and choleste*one had opposite effects to
cholesterol (29,118). It has been concluded that a planar
steroid nucleus, an intact side chain bearing no polar groups and
a 38 hydroxy group are needed for the permeability reducing effect,
and these are the same factors that were required to induce optimal
order of spin probes in hydrated films of beef brain phospholipid
(95). In contrast Singer and Wan (119) reported that there was
no apparent correlation between the effects of various steroids on
the permeability of egg yolk phosphatidylcholine-dicetyl phosphate
liposomes to Na+ and the fluidity as measured from the epr spectra
of spin labels intercalated in a lipid dispersion. This report
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seems to contradict the more recent results of Butler and Smith
(120) which were consistent with their earlier conclusions (95)
that sterols which disorder lipid bilayers (epicoprostanol) lead
to increased permeability whereas those which order lipid bilayers
lead to decreased permeability (cholesterol and cholestanol).
Thus the results of the spin labelling experiments and the
osmotic shrinking studies using liposomes containing cholesterol
analogues with altered side chains confirmed the correlation between
spin labelling and osmotic shrinking results observed by other
workers. Furthermore they showed that the effect of cholesterol
on both processes was closely linked with the iso-octane side
chain structure.
The other half of Chapter 5 dealt with cholesterol phospholipid
interactions in a monolayer. The results did not show the same
pattern that had been previously observed in the other physical
methods. and showed a 12% deviation from ideality whereas
the rest caused a 20% deviation.
An increase in the side chain beyond eight carbons does not
decrease the interaction of cholesterol analogue with the phospholipid.
The monolayer results can be explained in terms of the removal of
a constraint on the interaction between cholesterol and phospholipid
that operates in the liposomal system. Evidence for this constraint
comes from the reported alterations in the packing characteristics
of cholesterol in liposomes as the proportion of cholesterol is
increased (19). The incorporation of cholesterol in a bilayer
r*\»ec,ls.
_ certain structural modifying properties otr cholesterol
which are not observed when it is present in a monolayer of identical
composition.
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In conclusion, the results of the liposome studies show
that when the cholesterol phospholipid interaction is monitored
by a series of techniques the important role played by the
side chain in regulating this interaction becomes apparent.
In the intact cell the cholesterol side chain may be
performing a similar function to that observed in models,
but this system is more difficult to evaluate due to the
presence of heterogeneous phospholipids and different classes
of proteins which complicate the interpretation of the data.
Preliminary experiments which extend this study to natural
membranes are described in Chapter 7.
CHAPTER 6
OXIDATIVE METABOLISM OF THE CHOLESTEROL ANALOGUES BY
THE CHOLESTEROL OXIDATION ENZYME SYSTEMS IN
RAT LIVER MICROSOMES AND RAT ADRENAL MITOCHONDRIA
y}.
Introduction
Two of the main sites of cholesterol metabolism are located
4r\<\
in liver endoplasmic reticulum in adrenal cortical mitochondria.
These are the respective locations of cholesterol 7a-hydroxylase
which is thought to be the rate limiting step in the production
of bile acids from cholesterol, and the cholesterol side chain
cleavage enzyme which converts cholesterol to pregnenolone.
The cholesterol 7a-hydroxylase enzyme is a cytochrome P450
dependent enzyme as is the drug metabolising enzyme system also
found in the liver. In this chapter several experiments have
been performed to find out the substrate specificity of both
enzymes and the effect of various treatments on cholesterol 7a-
hydroxylase activity in order to determine if cholesterol 7a-
hydroxylation was achieved by the drug metabolising enzymes.
The drug hydroxylation system of rat liver microsomes
accepts a remarkable range of substrates, enabling compounds
as diverse as ethylmorphine, aminopyrine, cyclohexane, and
aniline to be hydroxylated. Conversely the cholesterol 7a-
hydroxylase enzyme seems to have definite structural requirements
for substrate molecules. These structural features have been
investigated by presenting a series of cholesterol analogues
in acetone to the enzyme and noting their metabolic fate.
Brown and Boyd (2) showed that androst-5-en-33~ol-17-one,
androst-5-en-33~ol, and pregn-5-en-33-ol were metabolised to one
or more products when they were incubated with rat liver microsomes,
a source of NADPH, and a molecular oxygen. This pattern of
metabolism was unaffected by cholestyramine. This study was
repeated in part (10) but in addition a more comprehensive
collection of cholesterol side chain analogues was available for
valuating if the complicated pattern of metabolism noted by Brown
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and Boyd (2) was due to the absence of an intact side chain.
In fact the results of the study showed that cholesterol
side chain analogues were hydroxylated by the liver in a manner
which is determined by their side chain structure, 26-nor-
cholesterol (^g) > (Fig. 2.23) was hydroxylated to a 7a-hydroxy
derivative t© an extent which is 65% that of cholesterol, 26-
dimethyl-27-norcholesterol (C^g) formed a single product,
under the same assay conditions, at 10% the extent of cholesterol
hydroxylation and cholenol (C^) was metabolised to a single
unidentified product consistent with 7a-hydroxylation of cholenol.
Shortening the sterol side chain still further appeared to
introduce the possibility of a completely different mechanism
for the oxidative metabolism of sterols. C^ and were
oxidised to a range of products which was not consistent with
a specific 7a-hydroxylation of these shorter side chain analogues.
This led to the proposal that a different enzyme system was
responsible for the oxidation of short side chain analogues
in the endoplasmic reticulum. Boyd et al. (10) postulated
that the C^ and C22 were oxidised by the drug metabolising
system. The activity of the cholesterol 7a-hydroxylase enzyme
.
was unaffected by pretreatment with phenobarbitone at least in
the case of Wistar strain rats (121). The effects of drug
mediated induction on enzymes of the endoplasmic reticulum have
been well documented (122).
The pretreatments used in this study to try to elucidate
the metabolic fate of and C22 involved the use of a selection
of recognised drug inducing agents, (a) phenobarbitone (Pb),
(b) the polycyclic hydrocarbon 3-methyl-cholanthrene (3MC), and
(c) pregnenolone-16a-carbonitrile (PCN). Many compounds
Fig. 6.1(a)
(mins)











The effect of Pb, PCN, and cholestyramine on ethylmorphine-N-
demethylase from rat liver microsomes.
\
Fig. 6.1 (b)
Comparison of the effect of Pb, PCN, and cholestyramine on the
levels of two components of the ethylmorphi$ne-N-demethylase
found in rat liver microsomes.
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behave like phenobarbitone in stimulating varied pathways of
xenobiotic metabolism by liver microsomes including oxidation
and reduction reactions, glucuronide formation and de-esterifi-
cation. In contrast polycyclic aromatic hydrocarbons stimulate
a more limited group of reactions. The differences between
Pb and 3MC inductions have helped in the identification of
several different hydroxylating enzyme systems in rat liver.
N-demethylation of ethylmorphine by liver microsomes from
normal or Pb treated rats was inhibited by SKF 525A whereas
that from rats treated with 3MC was not (123). In addition Pb
administration increased the maximal velocity of ethylmorphine-N-de-
methylation without influencing the Michaelis constants (124).
The three types of inducers differ in course and intensity
of induction
(a) on daily administration of phenobarbitone to rats by
intraperitoneal injection or by inclusion in drinking water,
the maximal increase in enzyme activity (3-10 fold) is not
reached for at least 3 days.
(b) the induction with 3MC reached its maximum stimulation
(5-10 fold) 24 hours after i.p. injection.
(c) the stimulation induced by PCN required delivery by
gastric incubation in Tween:water and 3 doses given at 24 hour
intervals (122) . The enzyme activity is stimulated 2-5 fold
within 3 days.
In addition the mechanism by which the stimulation is achieved
is slightly different in each case. Although both Pb and 3MC
increase P450 (P448 in the case of 3MC) , NADPH cyt c reductase
and perhaps cytochrome b,. levels (125) Pb administration causes
a marked proliferation of smooth surfaced membranes of the
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endoplasmic reticulum while 3MC has no effect.
Using inbred strains of mice Haugen et al. (126) showed
that the Pb mediated stimulation was as a result of de novo
synthesis of cytochromes. Four polypeptides were detected
which corresponded to species formed by drug inducements;
Pb, PCN and 3MC induced polypeptides with MW 51000, 54,000 and
55,000 respectively. In addition, Pb induced a, 49,000 MW
polypeptide but to a lesser extent than the 51,000 MW species.
Thus using these proven inducing agents of the drug
metabolising systems it should be possible to further investigate
the differences that alteration of the cholesterol side chain
confers on hepatic sterol metabolism.
6.2 The effect of drug administration on endoplasmic reticulum
As a means of determining if the administered compounds
were causing an alteration in the activity of the drug metabolising
enzymes, the levels of cytochromes P450 and b,. and the activity
of N-ethyl-morphine demethylase were determined in livers of
male rats after treatment with Pb, cholestyramine and PCN.
Figure 6.1 (a and b) shows that drug administration increased
the specific content of cytochrome P450 without increasing
cytochrome b,. and stimulated ethylmorphine-N-demethylase activity.
i
In contrast the bile acid sequestrant cholestyramine had no effect
in the amount of cytochrome P450 or b,. present and the ethylmorphine
demethylase activity remained unaltered. These results show that
a fully induced drug metabolising system was obtained.
The metabolism of [^- ^cj -cholesterol and
was checked by adding acetone solutions of each sterol to a 7a-
hydroxylase incubation medium containing NADPH generator and 10 mg
of microsomal protein from control or treated rats. After an hour
/
'iage of.radioactivity Total %age of
in numbered fraction -'sage of radioactivity
product remaining ir
Treatment Sterol 1-4 7-8 substrate.
control °21 32 12 44 16.7
Pb. °21 53j 7 60 15
cholesty¬ °21 27 11 38 17
ramine
P.C.N. C21 71 / 71 22
control C22 14 12.2 26 60
Ph.
C\JC\J
o 31 15 46 30
cholesty¬ C22 15 5 20 57
ramine
P.C.N. C22 44 / 44 50
con trol °27 / 6.25 6.25 44
Pb. °27 / 5.3 5-3 83
cholesty¬ °27 / 12 12 74
ramine
P.C.N. °27 / 7 7 85
Comparison of the effect of Pb.,P.C.N. and
cholestyramine in the metabolism of ^21'^22 an<^ ^2'/"
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20 25 14 39 35
40 40 8 48 31
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at 37°C the reactions were stopped and the lipids extracted.
Figure 6.2, 6.3 and 6.4 show the TLC scans of extracted hourjncub&V-iovvs,
Table 6.2 shows that after a 2 minute incubation of [3-Ki
with 10 mg of Pb induced microsomal protein in the presence of
NADPH generator, the polar fraction (1—4) only contained 8%
of the recovered radioactivity. The proportion of the total
radioactivity present in fraction (1-4) increased with
increasing incubation time, whereas the radioactivity in other
product fractions remained relatively constant throughout the
incubation. Although the nature of the main polar product has
not been determined it is perhaps a polyhydroxylated product
which is only slowly formed due to its inability to gain immediate
access to the drug metabolising enzymes. Figure 6.5 gives a good
comparison between the time courses of cholesterol 7a-hydroxylation
and C2^ metabolism. The differences observed in the rate and
extent of cholesterol and C^ metabolism under identical assay
conditions suggest that C^ and cholesterol are metabolised by
different enzymes.
6.4 The effect of the addition of a large excess of unlabelled sterol
on cholesterol 7a-hydroxylase activity
From the foregoing studies it is clear that alteration of the
side chain of cholesterol resulted in observed differences in the
metabolic fate of these cholesterol analogues. As the ^24~^28
analogues appeared to be metabolised in a similar manner to cholesterol
(10) it was decided to investigate the effect of the addition of these
previously studied steroids on the rate of 7a-hydroxylation of
cholesterol. In order to ensure that any effect noted was due to
the presence of the exogenous analogue alone the experiments were
carried out in intact microsomes and in a butanol extracted, Nonidet
Comparison between the time courses for (a) total metabolism of
13h]c2i by Pb induced microsomes and (b) metabolism of



















The effect of the addition of varying amounts of cholesterol
analogues on the production of 7a hydroxycholesterol by rat
liver microsomes.
Table 6.3
The effect of the addition of 100 pM unlabelled cholesterol
analogues on the production of 7a hydroxycholesterol by a
Nonidet solubilised, butanol powder of rat liver microsomes.
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P42 solubilised, microsomal preparation. The butanol removes
endogenous cholesterol which could interfere with the transport
of the analogue to the enzyme active site. The experimental
design in both cases was identical and involved the addition0"f
up to 100 yM exogenous analogue to a standard 7 ml incubation
mixture containing 10 mg protein and radioactive cholesterol.
The effect of the unlabell ed exogenous cholesterol analogue
was quantified by expressing the amount of 7a-hydroxycholesterol
formed in the presence of the cholesterol analogue as a percentage
of the control value. Figure 6.6 shows the effect of 3 added
analogues on cholesterol 7a-hydroxylase of rat liver microsomes.
The results show that even in the presence of 200 yg of endogenous
cholesterol, C^ and C^ cause a much greater reduction of 7a-
hydroxycholesterol formation than does When part of the
experiments were repeated with a Nonidet solubilised butanol
extracted preparation and a fuller range of non-radioactive
analogues at 100 yM (Table 6.3) a similar result was obtained.
This result confirmed the previous findings that cholesterol
7a-hydroxylase has a specific substrate requirement for a sterol
molecule with an iso-octane side chain.
6.5 An absolute assay for cholesterol 7a-hydroxylase
The use of a more precise assay could improve experiments
outlined in the previous sections that were designed to further
illustrate the side chain dependence of cholesterol 7a-hydroxylase.
The cholesterol analogue that was added to the incubation mixture
with radioactive cholesterol was present in a vast excess over
the radioactive cholesterol. The results obtained were accordingly
limited in their application and difficult to interpret in mechanistic
terms, because the radioactive cholesterol used to monitor the enzyme
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activity constituted such a small part of the total sterol pool.
In addition the radioactive cholesterol assay involved the
assumption that the tracer amounts of cholesterol added achieved
complete equilibration with all the cholesterol of the endoplasmic
reticulum and that the 7a-hydroxycholesterol formed had the same
specific radioactivity as total cholesterol. The extent of the
equilibrium with all the methods is also thought to he determined
by the form that the exogenous cholesterol is presented to the
enzyme. When cholesterol is presented to the enzyme in an
emulsion the rate at which the added cholesterol is 7a-hydroxylated
may be influenced by the particle size (127). Hence apparent
differences in enzyme activity may be due to the physical state of
the exogenous substrate rather than to differences in the
capacity or degree of activation of the enzyme. The most common
methods of addition of cholesterol are in an organic solvent (10) ,
or in a solution of a non-ionic detergent (11) . However in intact
microsomes the presence of a large excess of endogenous cholesterol
complicates the interpretation of results and one cannot be sure
o
that the behaviour of an enzyme twards exogenous cholesterol is
identical with its behaviour towards endogenous cholesterol.
A cholesterol 7a-hydroxylase assay system involving the addition
of a cholesterol molecule tritiated at the 7a position to the
microsomal enzyme system has been developed by Van Cantfort et .
(128). The assay was based on the assumption that 7a hydroxylation
of this specifically labelled substrate will result in the release
3
of ^0 which can be detected by liquid scintillation. Although
this method is quicker and does not involve lipid extraction or thin
prodocV
layer chromatography of mixtures to isolate the desired it does
n
suffer from two major disadvantages (a) the -cholesterol is
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difficult to synthesise (b) the equilibration problems described
for radiotracer assay also apply in this case.
In order to overcome these disadvantages a number of workers
have developed cholesterol 7a-hydroxylase assays which determine
the actual mass of 7a-hydroxycholesterol formed during the assay.
14
Mitropoulos and Balasubramaniam (129) added a trace of 4- C -
cholesterol to the microsomal incubation mixture as an exogenous
substrate. The radioactive 7a-hydroxycholesterol present at the
end of the incubation was then isolated from the total sterol
fraction by TLC and acetylated with tritiated acetic anhydride
of known specific radioactivity. The doubly labelled diacetate
.3 14
of 7a-hydroxycholesterol was purified and its H and C radio¬
activities determined. The mass of 7a-hydroxycholesterol
recovered as the diacetate could then be calculated from the
known specific radioactivity of the tritiated acetyl group,
3 14
measurement of the H/ C ratio also making it possible to
correct for losses of sample. The mass of 7a-hydroxycholesterol
formed during the incubation was estimated from the difference
between the amount present at the beginning and end of the incubation.
This is a rather complex procedure.
Another means of measurement of the mass of 7a-hydroxycholesterol
has been developed using gas liquid chromatography alone or gas
liquid chromatography combined with mass spectrometry. Malinow
et al. (80) determined the mass of 7a-hydroxycholesterol present
after an incubation, thin layer chromatography and extraction of
the silica gel with methanol. Trimethyl silyl (TMS) ethers of




Sample traces obtained when 7a hydroxycholesterol is injected
onto a 1% SE30 GLC column.
(a) Analysis of the TMS derivative.
(b) Analysis of the diacetate derivative.
(c) Analysis of the di-trifluoroacetate derivative.
(d) Analysis of the underivatised material with a
column temperature of 205°C.
(e) As (d) but with a column temperature of 240°C.
\
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on 100/120 mesh gas chrom Q column maintained at 240°C with the
detector temperature at 240°C, the injection port temperature
250°C and a nitrogen flow of 35 cm per minute. The mass of
7a-hydroxycholesterol formed was determined after taking into
account losses in the radioactivities of internal standards.
This method has been refined by the use of a mass spectro¬
meter attached to the outlet of a GLC column. After the
termination of incubation, Bjorkhem and Danielsson (11)
added a known amount of trideuterated 7a-hydroxycholesterol.
A chloroform methanol extract of the incubation mixture was
subjected to TLC and the fraction containing 7a-hydroxycholesterol
was converted into the TMS ether and subjected to combined GLC-mass
spectrometry. The ratio between the relative intensities of
the nature peaks at m/e 456 corresponding to the native and m/e
e
459 corresponding to the deutrated allowed determination of the
A
7a-hydroxycholesterol formed from endogenous cholesterol after
taking into consideration the extent of dilution of the deuterated
molecules with undeuterated. This method entails the preparation
of deuterated 7a-hydroxycholesterol and TLC purification of the
extract.
A new mass spectrometric procedure has recently been published
which avoided the use of a specifically labelled substrate or
recovery marker, or TLC (12). This method involves the injection
of TMS ethers present in a chloroform-methanol extract of an
incubation directly onto a 2 m by 3 mm glass column packed with 1%
SE30 on 100-120 mesh gas chrom Q. The TMS sterol ethers present
are detected by multiple selected ion monitoring and the endogenous
cholesterol present serves as an internal standard. Although this
method is by far the easiest and quickest assay described in the
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literature it requires the use of a highly sophisticated,
expensive piece of apparatus. In the following six sections
the development of a GLC assay for 7a-hydroxycholesterol and
its subsequent use for preliminary investigation of methods
of supplying substrate to the cholesterol 7a-hydroxylase enzyme
will be described.
Development of a gas liquid chromatographic assay for cholesterol
7q-hyd roxy1as e
Liver microsomes contain approximately 500 nmoles of
cholesterol per gram wet weight. This cholesterol pool is not
necessarily homogeneous as the cholesterol is continually
being synthesised and degraded and augmented by intestinal
absorption. The disadvantages associated with the radio¬
active cholesterol assays have already been mentioned and thus
it was decided to try to improve the existing mass assays involving
the use of gas liquid chromatography.
The initial attempts at the development of a GLC assay for
cholesterol 7a-hydroxylase followed the Malinow procedure (80).
This method involved the preparation of a trimethylsilane
derivative of 7a-hydroxycholesterol using 10 parts pyridine, 3
parts hexamethyldisilazone, and 1 part trimethyl chlorosilane
as sily|ating reagent. The derivative so formed was applied to
the 1% SE30 column with the column temperature set at 240°C.
Analysis of the trace showed that three products were present
(Fig. 6.7a) none of which could be attributed to the presence of
unreacted TMS reagent. As the formation of the multiple products
irrespective of the cause was undesirable another method of sample
preparation detailed in (130) was investigated. This procedure
involved exposing the 7a-hydroxycholesterol to the vapour of a
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mixture (2:1) of dry pyridine and acetic anhydride for 16 hours
at room temperature. The sample was dried, the diacetate was
extracted by chloroform which was subsequently removed by
nitrogen and an acetone was injected on to the same 1% SE30
column which was maintained at the same conditions as described
above. Figure 6.7(b) indicates that many components were present
in the acetone solution and that the acetylation procedure was not
ensuring that only one form of product was detected. None of
the peaks were due to pyridine contamination. This result is in
contrast to previous published studies by Van Lier and Smith (13)
who showed that the diacetate of 7a-hydroxycholesterol does not
decompose under the condition described.
In order to check that the previous result was due to incomplete
acetylation the experiments were repeated exactly apart from the method
of preparation of the diacetate derivative. The acetylating
reagent was prepared from dry distilled tetrahydrofuran and tri-
fluoroacetic anhydride (2:1) and added to the standard 7a-hydroxy-
cholesterol contained in a stoppered bottle. After 15 minutes
at room temperature the solvent was removed under nitrogen followed
by an hour in a vacuum desiccator and then the extract was dissolved
in acetone and applied to the GLC column maintained at 240°C. This
procedure gave a much improved conversion to the di-trifluoroacetate
and only two products were detected (a) a minor peak with a
retention time of 7 minutes and (b) a major peak with a retention
time of 4.5 minutes (Fig. 6.7c). Under these column conditions
injection of underivatised cholesterol gave a single sharp peak and
its inclusion with derivatised samples of 7a-hydroxycholesterol allowed
the construction of a calibration curve for the determination of 7a-
hydroxylation. Unfortunately the GLC traces still contained an extra
peak with a retention time which was midway between that of cholesterol
Fig. 6.8












and 7a-hydroxycholesterol diacetate, whose precise nature could not
be identified.
The method finally arrived at measured underivatised 7a-
hydroxycholesterol at a slightly lower column temperature (205°C).
The full details of the assay procedure are described in the
Materials and Methods section. Using this method a single peak
was obtained (Fig. 6.7d). It should be mentioned that it is
also possible to obtain a single product from 7a-hydroxycholesterol
at 240°C (Fig. 6.7e) which is in contradiction to the results of
Van Lier and Smith (131) but the results of the experiments
described in the following sections were determined at 205°C.
This method is an improvement on the published procedure of
Malinow (80) in that it does not require the preparation of a
derivative. Thus the results obtained do not contain an error
due to the inability to obtain a hundred % yield of derivative and
the procedure employed contains fewer steps where recovery losses
could occur.
The behaviour of 7a-hydroxycholesterol on gas liquid chromatography
Using the GLC conditions described in the Materials and Methods,
underivatised 7a-hydroxycholesterol gave a single symmetrical peak
with a relative retention time as compared to cholesterol of
I
0.55 ± 0.4. This value is similar to that proposed by Brown (130)
for the diacetate derivative (0.64) to the given value for the
TMS derivative relative to cholesterol isobutyrate (0.57) (80).
However these results are in contradiction to the results of Van
Lier and Smith (131) who stated that a diacetate derivative of
7a-hydroxycholesterol has a relative retention time compared to
cholesterol of 1.69 on SE30 columns. The fact that the retention
time of 7a-hydroxycholesterol was less than cholesterol indicated
that under the conditions used, injection of underivatised material
Fig. 6.9
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resulted in a breakdown of the molecule into one product.
Assuming total decomposition of the 7a-hydroxycholesterol on
injection it should be possible to obtain a quantitative measure¬
ment of the mass of 7a-hydroxycholesterol present in an incubation
by constructing an assay based on the fact that a single
symmetrical peak was obtained. However it is essential that a
calibration curve with varying amounts of cholesterol and 7a
hydroxycholesterol be run with each set of assays. This was
seen to be necessary as the gradient of the graph of peak height
ratios versus concentration ratios added (calibration curve)
varied between 1 and 2, although symmetrical peaks were obtained
and similar column conditions were employed. A typical calibration
curve is shown in Fig. 6.8.
This method is not sufficiently sensitive to discriminate
between the 7a and 78 isomers, but the preliminary TLC step will
remove interfering 78 isomers.
The effect of the incubation period and the total amount of
protein present on the production of 7a-hydroxycholesterol
As an initial test of the assay procedure the relationship
between product formation and the incubation time and the
protein concentration wi&S- determined. Figure 6.9 shows the time
course obtained when fresh microsomes containing 10 mg of protein
and 150 yg cholesterol were incubated for varying periods of time.
The pattern of 7a-hydroxycholesterol production is similar to that
obtained for the tracer assay and the decrease in the rate of
product formation with increasing time conforms to the published
data for this process (80). In addition the value for the amount
of material produced per hour is on average 10-15 ng/min/mg protein
which is comparable with published results for cholestyramine treated
protein i endogenous exogenous /•t hydroxy- 1
(rag) chole sterol cholesterol cholesterol
fag) ■ fas) cUg)
20 300 0 9
20 300 50 9
20 300 100 8.6
20 300 150 9
20 300 200 10.1
20 300 250 8
Values for hyd.roxycholesterol±0. 5 S
and. are the means of 4 determinations.
The' effect of the addition of exogenous cholesterol
in acetone on 7* hydroxycholesterol production by rat liver
microsomes.
Table b.4
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rats. Malinow data expressed in the same units gave the value
as 9.2 (80) which agreed with the previously published figure of
Mitropoulos (132). Figure 6.10 shows that the production of
7a-hydroxycholesterol is proportional to the amount of
microsomal protein present.
Investigation of the supply of cholesterol to the enzyme
In order to investigate if the rate of production of 7a-
hydroxycholesterol observed in the intact microsomes was limited
by substrate supply, increasing amounts of cholesterol in acetone
were added to fresh microsomes containing 150 yg endogenous
cholesterol and 10 mg of protein and the amount of 7a-hydroxy-
cholesterol produced by this system was measured by GLC. Table
6.4 shows that the addition in 50-400 yg exogenous cholesterol in
acetone (50 yl) has no effect on the production of 7a-hydroxy-
cholesterol. When the exogenous cholesterol was added in Tween
80 a similar pattern to that obtained with acetone was observed.
These results indicate that the addition of exogenous
cholesterol to intact microsomes has no effect on the mass of 7a-
hydroxycholesterol produced by endogenous cholesterol. The question
of the substrate saturability of the enzyme has been discussed in
the literature. Initially Bjorkhem and Danielsson (133) reported
that the addition of cholesterol in acetone to the incubation medium
did not increase the yield of 7a-hydroxycholesterol and thus they
suggested that the endogenous substrate was saturating the enzyme
under assay conditions. In a more recent paper (11) they compared
the addition of exogenous cholesterol in acetone and in Tween 80
and noted that the degree of equilibration of exogenous cholesterol
with endogenous cholesterol depended on the amount of cholesterol
added and the physical state in which it was presented. Using
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Tween 80 to introduce increasing amounts of exogenous cholesterol
they could influence the production of 7a hydroxycholesterol,
indicating that the 7a-hydroxycholesterol hydroxylase is not
saturated with substrate under these conditions. They calculated
that the substrate pool of cholesterol 7a-hydroxylase maximally
corresponded to about one third of the total amount of cholesterol
normally present in the microsomal fraction. This figure differs
from the 70% quoted as available to the enzyme by Van Cantfort
et al. (128). All the experiments that report an increase in
formation of 7a-hydroxycholesterol on the addition of exogenous
cholesterol utilised detergent solutions to deliver the substrate.
In addition to providing an extra source of cholesterol the detergent
disrupts the membrane structure, destroying the intermolecular
organisation normally operative in the membrane. The question
of enzyme saturation therefore remains a matter which cannot be
definitely answered using either of these two techniques to supply
substrate to enzyme.
6.10 The influence of exogenous cholesterol on the 7a-hydroxylase
activity of a cholesterol depleted microsomal preparation
In an attempt to clarify the position regarding the supply of
substrate cholesterol to the enzyme, a butanol extract of microsomes
which retained the activity of the enzyme as judged by the oxidation
of radioactive cholesterol, but did not contain any endogenous
cholesterol, was prepared and treated with cholesterol in various
physical forms. In all the experiments to be described the cholesterol
was preincubated with the butanol powder for 1 hour at 37°C prior to
the addition of the NADPH generating system. The microsomal extract
was then incubated for a further hour and the mass of 7a-hydroxy-
cholesterol formed was determined as previously described. The







10 80 70± 2





Binding- of cholesterol added in acetone to a
butanol powder of rat liver microsomes. Results are mean
i standard error of the mean.
Table 6.b
Butanol Powder exogen ous \ E.Y.PC . ']< hydroxy-
protein ^mg) chole st<~ -"ol (u g) (mg) chole sterol (-4 g)







9 100 1 3-4
9 100 0.1 3.3
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Comparison of the ability of liposomal cholesterol
to act as substrate for cholesterol ^hydroxylase.
Table 6.7
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effect of the addition of an increasing amount of cholesterol in
acetone is shown in Table 6.5. The results indicate that
exogenous cholesterol added in acetone can act as a source of
substrate for a cholesterol depleted preparation of microsomes.
The results also show that (a) the rate of production of 7a-
hydroxycholesterol does not increase in direct proportion to
the increasing amounts of exogenous cholesterol presented to
the membranes and (b) although the microsomes have been treated
with organic solvents the enzyme activity of a butanol powder
containing an equivalent amount of protein and exogenous
cholesterol is comparable with the enzyme activity of intact
microsomes of the same composition. This also implies that the
cholesterol removed by the butanol contains cholesterol which acts
as substrate for the enzyme.
6.11 Investigation of the ability of a cholesterol depleted powder
to sequester cholesterol added in acetone
The possibility that the failure of large amounts of
cholesterol to stimulate . 7a-hydroxycholesterol production wtis.
Supply due to the fact that the butanol powder could not bind elevated
amounts of cholesterol, was investigated. To a butanol powder
reconstituted in 0.1 M phosphate buffer pH 7.4, containing 10.0 mg
of protein and essentially no cholesterol (<2 yg chol) varying
amounts of cholesterol in acetone were added. The mixtures of
protein and cholesterol were incubated at 37°C for 1 hour, then
the protein was sedimented by centrifugation of the mixture at
100,000 g for 1 hour. The pellet thus obtained was resuspended
in 0.1 M phosphate buffer pH 7.4 and the process was repeated.
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The supernatant was once more poured off and 10 yl of 4 C
cholesterol (0.1 yc) was added to the pellet as a recovery marker
111 •
and the lipids were then extracted with chloroform:methanol (2:1).
The tracer was added after the centrifugations as preliminary
experiments had shown that a portion of the radioactivity was
located in the supernatant which is discarded. The cholesterol
present in each lipid extract was then determined either by GLC
which required a further TLC step to separate cholesterol from
phospholipids or by an enzymatic assay using cholesterol oxidase.
The results obtained with both methods were identical and
Table 6.6 shows that in every case approximately 85% of the
cholesterol was bound to the butanol powder up to a maximum
cholesterol:protein ratio of 0.013 mg/mg which is the approximate
ratio found in the intact microsomes. Comparison of the
binding of exogenous cholesterol to the butanol powder with
the enzymatic conversion of cholesterol to 7a-hydroxycholesterol
by a similar preparation does not show any correspondence between
the amount bound and the amount converted to product. Thus
these cholesterol depletion experiments show that the removed
cholesterol can be replaced by addition of exogenous cholesterol
but they do not give any indication of the extent of substrate
saturation of the enzyme.
j'
6.12 The effect of the addition of exogenous cholesterol to a butanol
/'
powder in the form of a liposome /
As the form in which the exogenous cholesterol is added has
been to play an important role in determining the extent of its
metabolism (11) , the effect of the inclusion of cholesterol in a
liposome was compared with the results obtained from an acetone
solution of cholesterol. Table 6.7 shows that the incorporation
of the cholesterol in a multibilayered liposome does not improve
the metabolism of the cholesterol to 7a-hydroxycholesterol. This
■LIZ.
could be due to the fact that unsonicated liposomes which
consist of many layers of lipid were used which prevented
the cholesterol gaining access to the enzyme active site in
the hour preincubation time used in the study. The table
also shows that the results of the mass assay and the tracer assay
are directly comparable in the system. The assay described in
Section 6.7 was developed to try to better define the possible
mechanisms involved in the supply of substrate cholesterol to
the cholesterol 7a-hydroxylase enzyme. The use of a butanol
powder of microsomes is open to the same criticisms that are
levelled at the detergent mediated cholesterol transfer to
microsomes in that the treatment of microsomes with organic
solvents removes protein and phospholipid in addition to 99%
of the cholesterol.
6.13 The effect of alteration of the cholesterol side chain on the
production of pregnenolone by the cholesterol side chain cleavage
enzyme from rat adrenal
The cholesterol side chain cleavage enzyme occurs in the
mitochondria prepared from the cortex of adrenal glands and in
common with other mixed function oxidases requires molecular
oxygen and NADPH as cofactors. The early studies of Saba et al.
(134) established that the enzyme converted cholesterol to
pregnenolone, with the simultaneous formation of isocaproic
aldehyde which could be subsequently oxidised to isocaproic acid.
This enzymic conversion of cholesterol to pregnenolone is thought
to be the rate limiting step in steroidogenesis and involves two
hydroxylations followed by an oxidative cleavage of a C-C bond.
s
A selection of the proposed molecular mechanism for the hydroxylation
A
reactions are catalogued in the review of Simpson and Mason (135),
however Dr. R. Hume has recently provided convincing evidence
(136) that the side chain cleavage enzyme firstly converts
cholesterol to 22-hydroxycholesterol which is immediately
transformed to 20, 22-dihydroxycholesterol. This dihydroxy-
compound is cleaved between carbon 20 and 22 with the formation
of pregnenolone.
The side chain cleavage enzyme system consisting of an
electron transport chain formed from the iron sulphur protein,
adrenodoxin, and adrenodoxin reductase, with a unique cytochrome
P450 (P450scc) as the terminal electron acceptor, is situated on
the mitochondrial cristae (Fig. 1.3). Simpson et al. (137)
have postulated the existence of a cholesterol pool within
mitochondria that is specifically associated with cytochrome
P450scc and suggest that a rate limiting process for cholesterol
side chain cleavage is the ease with which the remaining
cholesterol within the mitochondrion can form an active substrate
cleavage product with cytochrome P450scc.
The activity of the side chain cleavage enzyme can be
enhanced by treatment with adrenal cortex trophic hormone
(ACTH). The mechanism of ACTH stimulation is not precisely
understood. Koritz and Kumar (138) observed that adrenal
mitochondria prepared from rats injected with ACTH showed an
increased capacity for pregnenolone formation compared with
adrenal mitochondria from control rats on incubating both sets
of mitochondria in vitro with succinate. These results were
interpreted in terms of the relative permeabilities of each
mitochondrial preparation to pregnenolone. Thus ACTH pretreatment
was thought to render the mitochondrial membrane very permeable to
lilt
pregnenolone, releasing pregnenolone mediated feedback inhibition
of side chain cleavage. Based on their inability to observed
any change in permeability of mitochondria to pregnenolone on
ACTH treatment, Johnson et al. (139) suggested that pregnenolone
feedback was not the most important regulating factor and
surmised that the availability of substrate was most important.
ACTH treatment of rats also reduced the mitochondrial stores of
cholesterol in addition to its effect on cholesterol side chain
cleavage (140). The ability of ACTH stimulated mitochondria
to metabolise the cholesterol side chain analogues was studied
in order to check if a similar specificity to that observed in
the liver system was operative in the adrenal.
A previous report from this laboratory (141) has investigated
the metabolism of these sterols by unstimulated adrenal mitochondria.
The incubation medium used contained 250 mM sucrose, 20 mM KC1,
15 mM NADP+ and 0.b% BSA and cyanoketone. The reaction was
initiated by the addition of D-L isocitrate (2.0 mM final cone)
and the metabolism of each non-polar side chain analogue studied
(10 pi of a 4 mg/ml solution in ethanol) was similar to that
obtained with cholesterol.
In the present work, adrenal mitochondria (0.5 mg protein)
from ether stressed or ACTH pretreated rats were incubated with
10 pi of 4 mg/ml cholesterol side chain analogue in an incubation
medium containing sucrose (0.25 M), KC1 (20 mM) , triethanolamine
(15 mM), potassium phosphate pH 7.4 (10 mM) , MgC^ (5 mM) , 0.1% BSA
and EDTA (0.1 mM) . In addition each incubation contained 1 pmole
of calcium and 5 ml of cyanoketone (1 mg/ml) which prevents the
pregnenolone from being further metabolised to progesterone.
The side chain cleavage activity present was determined by assaying
Fig.6.11
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pregnenolone formation by means of a radioimmunoassay using anti¬
serum raised in New Zealand white rabbits against a pregnenolone-
20-albumin conjugate.
Figure 6.11 shows the standard curve for the pregnenolone
radioimmunoassay, losing the standard curve the amounts of
pregnenolone formed from each cholesterol side chain analogue
could be determined with mitochondria from ether stressed and
ACTH treated rats. The results in Figures 6.12a and b are
expressed relative to the pregnenolone produced by the
mitochondria in the absence of exogenous sterol. The endogenous
rate differs between ether stressed and ACTH pretreated mitochondria,
being almost zero in ACTH treated animals which is consistent with
the noted reduction in the cholesterol levels of ACTH treated
adrenal mitochondria (140). The results show that the side chain
cleavage enzyme when studied after a 3 minute preincubation of
2+
exogenous sterol in the presence of Ca metabolises cholesterol
optimally. It should be noted that C^> ^8 an<* ^29 are n0t
metabolised to any extent and that C^ and C^-^ were not tested
due to their structural similarities to pregnenolone and hence
their ability to cross-react with the antibody. The results
obtained are in contrast to the earlier study in our laboratory
I
(141) which did not show side chain dependence.
It is interesting to speculate why this side chain
dependence was not detected in the untreated rats. In the
previous study the metabolism of the exogenous sterols exhibited
a biphasic pattern over 10 min incubation. However in the
2+
presence of Ca (142) the initial rate of pregnenolone production
is maintained over the assay period. The previously observed bi¬
phasic response was possibly due to the exhaustion of the available
(mins)
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steroidogenic pool of cholesterol in mitochondria. Perhaps Ca
acts to promote intramitochondrial cholesterol translocation to
the side chain cleavage binding sites (143) by altering the lipid
phase separation in the mitochondrial membrane.
The results in Figures 6.12a and b could be explained in terms
of the relative affinity of each cholesterol side chain analogue
for an ACTH stimulated enzyme, or their relative translational
mobilities, through the mitochondrial membrane to the active site
of the enzyme. Further study would be required to ascertain which
mechanism was the more important or if a combination of both
factors was determining pregnenolone production from each analoaye.
Conclusion
The results of both the cholesterol 7a-hydroxylase and the
cholesterol 'Jide chain cleavage assays indicate that although the
absolute values are seen to differ for different preparations
(comparison of the ether stressed and ACTH treated rats (Fig. 6.12a
and b)) the side chain of cholesterol precisely defines both the
metabolic fate of the cholesterol molecule and the efficiency of
its metabolism. This specificity noted for product formation
may have contributions from the relative translation rates of
the side chain analogue through the membrane. This may be related
to the ability of cholesterol to interact with a phospholipid
which enables it to gain rapid access to the enzyme. This would be
consistent with the results of Chapters 4 and 5.
Another contribution to the observed metabolic fate of the
various side chain analogues could be made by the relative interaction
of the cholesterol analogues with the enzymes. This interpretation
of the data would be consistent with some recent reports of
cholesterol:protein interactions. Using a purified preparation
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of band 3 protein from erythrocytes Klappauf et al. (14) demonstrated
by monolayer studies that the protein would not bind phospholipid
but gave a large interaction with cholesterol. On further
investigation using a preparation of monolayers from and
they found that altering the side chain structure reduced this
interaction „ implying that the cholesterol side chain was
determining the nature of the interaction between the cholesterol
molecule and band 3 protein (144).
The nature of the side chain of a sterol has also been shown
to be of importance in determining the specificity of cholesterol
protein interaction observed in soluble proteins isolated from
r 14 ~i
cell cytosol of mouse fibroblasts. By incubating 14 Cl-25-hydroxy-
cholesterol and [3h] cholesterol with cell cytosol and subjecting
the incubation to density gradient centrifugation, Kandutsch et al.
(15) demonstrated that each sterol bound to a specific low
molecular weight protein that aggregated in its presence. Thus
the addition of a hydroxyl group at carbon 25 of cholesterol alters
its protein bi inding properties in such a way that it cannot bind
to the same protein as cholesterol.
These examples in combination with the experimental results
described in this chapter indicate that the side chain dependence
previously observed in cholesterol phospholipid systems also
operates on the interaction between cholesterol and certain proteins.
By ensuring that only cholesterol with its iso-octane side chain
exhibits tight binding to specific proteins, the chances of other
sterols especially plant sterols ergosterol and stigmasterol,
interfering with cholesterol mediated cellular processes arc almost
negligible.
Another use of the cholesterol side chain analogues could
be to investigate cholesterol protein interactions in a variety
of membrane and cell cytosol systems.
CHAPTER 7
INVESTIGATION OF THE CHOLESTEROL POOL
FOUND IN MICROSOMES
119.
Investigation of the Cholesterol Pool Found in Microsomes
Introduction
In the previous chapter the problem of the supply of
cholesterol to cholesterol 7a-hydroxylase was investigated.
That study used microsomes that had been lyophilised and treated
with butanol and acetone to remove endogenous cholesterol.
In addition to removing cholesterol, butanol-acetone treatment
removed about 25% of the phospholipids. As phosphatidyl¬
choline has been shown to be essential for optimal activation of
the liver fatty m hydroxylase enzyme (145) which like the
cholesterol 7a-hydroxylase enzyme is microsomal and cytochrome
P450 linked, this removal of phospholipid may in part account
for the inability of excess exogenous cholesterol to increase
the enzyme activity of a butanol powder. Furthermore Lu and
Coon (145) surmised that the lipid requirement for laurate
hydroxylation implied that the lipid environment of the enzymes
in the endoplasmic reticulum contributed to the substrate
specificity. Obviously a method that removes cholesterol without
affecting the rest of the microsomal components would be preferable
to the butanol acetone treatment.
In this chapter the initial attempts to manipulate the amount
I
of cholesterol in microsomes by treatment with liposomes are
described. A related procedure can also be used to replace
cholesterol by one of its side chain analogues.
The treatment of membranes with liposomes composed of phospho¬
lipid alone or a mixture of cholesterol and phospholipid is a
technique that has been widely adapted to study the role of
cholesterol in other cellular membranes. Principally the levels
of cholesterol in erythrocytes and ghosts (146) lymphocytes (147)
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and platelets (148) have been manipulated by the use of liposomes
containing varying proportions of cholesterol or cholesterol
analogues.
The erythrocyte has been the most popular membrane for
these studies due to its ready availability and its high molar
concentration of cholesterol in relation to phospholipid (1:1).
It has been shown that cholesterol added in a liposome containing
equimolar amounts of cholesterol and phospholipid can equilibrate
with the labelled cholesterol of rat erythrocyte ghosts within a
period of 24 hours at 37°C without any net transfer of cholesterol
in or out of the membrane (146). This implied that the cholesterol
content of the erythrocyte ghost was dependent on the concentration
of cholesterol present in its surrounding and that all of the
erythrocyte cholesterol was accessible to the liposomal cholesterol.
A similar conclusion regarding the exchangeability of membrane
cholesterol was arrived at for a number of other subcellular
organelles including liver plasma membranes, kidney microsomes,
liver smooth endoplasmic reticulum and liver mitochondria when the
distribution of labelled cholesterol contained in plasma lipo¬
proteins was analysed after a 37°C incubation of lipoprotein
with cell fraction (149).
i
The cholesterol exchange process is thought to be dependent
on a number of factors (a) the nature of the fatty acids in the
liposomes undoubtedly influences the exchange or the removal of
cholesterol from the membrane. Poznansky and Lange (150) and
Bloj and Zilversmit (151) among others have studied this aspect of
the exchange process and although their results differ in absolute
terms they both show that cholesterol containing liposomes prepared
from unsaturated phospholipids allow a much higher rate of exchange
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into the erythrocytes than liposomes prepared from unsaturated
phospholipids. The nature of the fatty acyl chains has no
CO
effect on the total amount of the exchangeable cholesterol in
A
the erythrocyte; (b) the ratio of liposomal cholesterol to
membrane cholesterol; (c) the existence of a non-exchangeable pool
of liposomal cholesterol. Bruckdorfer et al. (146) and Bloj
and Zilversmit (151) do not subscribe to the view of Poznansky
and Lange (150) that in vesicles of dipalmitoylphosphatidyl-
choline and cholesterol only 70% of the cholesterol is available
for exchange with the cholesterol found in the erythrocyte ghost.
Poznansky and Lange (152) account for the inability of 30% of the
labelled cholesterol to exchange by stating that it is located
in the inner membrane of the liposome and is thus unavailable for
exchange. This implies that the movement of lipid molecules
from one side of a lipid bilayer to the other (flip-flop) (153)
is slower than had been previously believed. This seems unlikely.
Perhaps the observed differences in the rate of exchange can be
rationalised in terms of differences in the sonicated liposomes
used for the exchange. This explanation would be consistent with
the data of Bloj and Zilversmit (151) who showed that the rate of
radioactive cholesterol exchange from multilayered liposomes into
the erythrocytes was 2.5 times slower, than the exchange from
unilamellar liposomes.
Another use of liposomes is to remove cholesterol from membranes
in order to discover what function the cholesterol is performing.
When erythrocyte ghosts were incubated with sonicated egg yolk
phosphatidylcholine or sonicated egg yolk phosphatidylcholine
containing 10 mole % cholesterol (the ratio of liposomal cholesterol
to erythrocyte cholesterol is 0.1) after 24 hours the membranes
lost 32-46% of their sterol. When an excess of the dispersion
was present, the ghosts lost 60% of cholesterol. A similar
picture was also obtained by Shattil et al. (148) using
liposomes to alter the cholesterol level in platelets. Platelets
were incubated for 5 hours at 37°C with sonicated dipalmitoyl-
phosphatidylcholine containing (a) equimolar amounts of
cholesterol (b) a two-fold excess of cholesterol or (c) no
cholesterol. The liposomes containing equimolar amounts of
cholesterol and dipalmitoylphosphatidylcholine had no effect on
platelet lipids or platelet function, whereas the platelets
incubated with liposomes containing excess cholesterol acquired
39.2% excess cholesterol while the protein and phospholipid
values remained unaffected. Dipalmitoylphosphatidylcholine
liposomes removed 21% of the platelet cholesterol which resulted
in an 18-fold reduction in their sensitivity to adrenaline
(39.2% excess cholesterol caused a 35 fold increase in sensitivity
to adrenaline). Thus using this technique it is^possible to
elucidate the role that cholesterol is playing in the platelet.
A similar set of experiments suggested that cholesterol in
erythrocytes was acting to strengthen the erythrocyte membrane
(154).
The results obtained for the cholesterol depletion experiments
have been explained by Lange and Alessandro (155). The exchange of
cholesterol between erythrocytes and plasma and the net movement
of cholesterol out of the membrane into the plasma are both character¬
ised by the same rate constant, and are driven by the cholesterol to
phospholipid ratios in the cells and plasma. The apparent limitation
on the extent of cholesterol depletion of membranes is thus
explicable as the consequence of an equilibrium between membrane
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cholesterol and plasma cholesterol which is reached before all
the cholesterol is removed from the membrane. It is proposed
that the exchangeable cholesterol is available for removal from
the membrane and thus there is only a single pool of erythrocyte
cholesterol. Thus the limitation on cholesterol depletion of
the erythrocyte does not imply the existence of a class of
strongly bound cholesterol molecules. Rather it is due to
the dissipation of the gradient which leads to net movement of
cholesterol out of the cells into the plasma. Cholesterol
exchange still occurs at equilibrium, between cells and plasma
leading to the equilibration of radioactive cholesterol, between
the two cellular fractions.
7.2 Preparation of liposomes for use in the cholesterol exchange and
cholesterol depletion experiments
In the previous section differences in results of different
groups working with the same biological systems was attributed
to differences in the preparation of the liposomes used to
deliver the label or to remove cholesterol from the membrane
under study. The various methods for liposome preparation
described in literature are
(1) Bruckdorfer et al. (154) prepared liposomes from dried films
of egg yolk phosphatidylcholine (20 mg) and sterol (16 mg) by
sonicating the lipid in 10 ml of 30 mM NaCl with a Branson Sonic
Power Instrument Model S125 set at position 4. During the
sonication procedure the glass vessel was cooled with an ice water
mixture. The dispersions were then centrifuged at 48,000 g for
1 hour to remove the undispersed lipid which formed 30% of the
mixture.
(2) Stevens and Green (156) found that a 5 x 90 sec burst of
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to disperse a 1.6 mg/ml (1:1) mixture of sterol and phospholipid.
(3) The description of sonication conditions by Shattil et al.
(148) is sketchy. They prepared liposomes by sonicating the
lipid film in 10 ml of buffer for 1 hour with a 70W output
sonicator.
(4) The method of Horwitz et al. (157) gives a more detailed
description of the sonication conditions. A vessel of 5.5 cm
height and diameter 2.4 cm was used to contain an undisclosed
amount of lipid which was then converted into liposomes by
sonicating for 40 minutes with a sonicator that operated at
20 kilo-cycles per second with a power output of 75W. In
addition they found that the nature of the phospholipid fatty acyl
chains influenced the uptake of cholesterol.
(5) Green and Green (158) used the sonication technique of
Stevens and Green (156) but altered the ratio of lipid to water
in order to see if there was a relationship between this ratio
and the amount of lipid dispersed. With ratios above 6 mg/ml
the maximum incorporation of cholesterol was 1:1 even when the
initial ratio of cholesterol to phospholipid was 3:1. At a
slightly lower concentration a 2:1 ratio could be obtained and
if the starting mixture contained less than 1 mg lipid per ml
I
all the sterol was dispersed.
As can be seen each sonication procedure has slight differences
from other published methods and many factors can influence the
nature of the liposomes produced by these various techniques.
Hauser (159) discussed the differences and stated that the
following factors were important. The ratio of the sample
volume to the soniprobe tip was important. A one minute
exposure of 2 ml of dispersion led to detectable decomposition,
Fig.7.2
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whereas 10 ml of dispersion gave degradation products only
after 40 minutes of sonication. Besides the instrumental
settings (power output, tuning of the probe and the sonication
time) the geometry of the tip of the soniprobe relative to that
of the sample tube, the volume, concentration, liquid depth,
and temperature of the dispersion, the depth to which the top
of the soniprobe was immersed, the characteristics of the
lipid species involved and the nature of the dissolved gas and
the atmosphere surrounding the sample were all found to
influence the extent of lipid decomposition.
Obviously t^iese sources of variation make comparison
between different methods of liposome preparation extremely
difficult. A possible method for further characterisation
of the liposomes formed by the various sonication procedures
was to compare the relative elution positions of liposomes
upon molecular sieve chromatography. This was originally
suggested by Huang (64) and has been used by Bloj and Zilversmit
(151) among others to prepare homogeneous preparations of single
walled liposomes suitable for use in exchange experiments.
The initial method of liposome preparation adopted was the
procedure described by Stevens and Green (156). Egg yolk
phosphatidylcholine (50 mg) was dispersed in 0.1 M phosphate
(5 ml) buffer pH 7.4 by vortexing the lipid for 4 minutes.
This was followed by sonication of the dispersion contained in
4.5 cm height by x 2.5 cm diameter vessel with a Branson sonicator,
equipped with a 2 mm by 6 cm titanium probe, maintained at power
level 7. The sonication consisted of 5 x 90 seconds periods
interspersed with 20 second cooling periods. The resulting
milky suspension was centrifuged at 74,000 g for 20 minutes and
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the opalescent supernatant separated from the undispersed material
which formed a white pellet. The supernatant was then
applied to a Sepharose 4B column (1.5 cm x 33 cm) when all the
material was seen to appear in the void volume. When the
procedure was repeated using the same apparatus, but with
double the period of sonication and 20 mg of egg yolk
phosphatidylcholine in 10 ml of buffer as opposed to 50 mg
in 5 ml, a similar result was obtained. If a trace of
radioactive cholesterol was added to the lipid film prior to
sonication under the second set of conditions, 69% of the
label was recovered in the supernatant and the remaining
31% remained in the pellet. A typical elution profile of
radioactive liposomes produced by this sonication procedure
is given in Figure 7.1 which shows that virtually all of the
label is located in a fraction of the lipid that appears in the
void volume. A similar picture was obtained when the vortexed
liposomes were placed in a sonicating bath similar to that
described by Huang (64) and sonicated at maximum power
setting for 3 hours. Thus neither of the sonication procedures
seems to produce single walled liposomes from the multilayered
liposomes formed by vortexing the dried lipid film in buffer.
Small single walled liposomes were eventually obtained by
following the procedure described in Chapter 2. After 40
minutes of sonication the liposomal solution became optically
clear and on centrifugation only titanium fragments from the
sonicator tip centrifuged down. Figure 7.2 shows a typical
elution profile of liposomes prepared in this manner, from the
Sepharose 4B column. Although only 56% of the liposomal
population appeared in the retained fraction which is 10% less
than that in the published figures of Huang (64) it was used
1*4 hour incubation 14 hour incubation 14 hour incubation

















1.176 0 0.133 16 0.386 6 0.197
1.161 3.6 0.059 8 0.089 0 0.104
1.151 3.6 0.104 8 0.059 0 0.104
1.137 0 0.059 0 0 0 0.114
1.127 5 0 0 0.208 0 0.044
1.113 3 0.089 5.2 0.029 0 0.074
1.104 0 0 0 0.044 0 0.074
1.084 3 0 5.3 0.176 0 0.059
1.081 0 02118 0 0.118 0 0.089
1.063 3.6 0.089 8 0.236 0 0.148
1.059 7.2 0.236 14 0.564 0 0.252
1.047 0 0.743 0 0.564 6 0.743
1.038 0 0.921 27 1.009 20 1.069
Pellet 140 3.8 90 2.820 120 3.8
Continuous sucrose density gradient profile of microsomes




without further subfractionation. Thus the sonicated lipo¬
somes prepared from egg yolk phosphatidylcholine are a mixture
of large and small vesicles. The proportions of each type
present in each preparation will differ slightly depending on
the efficiency of the sonication. The incorporation of
cholesterol analogues in a 1:1 or 1:10 ratio with the egg yolk
phosphatidylcholine has no effect on the basic profile shown
in Figure 7.2 when 3 mg lipid are dispersed in 1 ml of buffer.
Alteration of cholesterol levels in liver microsomes by treatment
with egg yolk phosphatidylcholine liposomes
In an attempt to estimate what fraction of the exchangeable
microsomal cholesterol pool described by Graham and Green (149)
could be removed by egg yolk phosphatidylcholine liposomes, a
series of preliminary experiments were performed using the
techniques described for the removal of cholesterol from the
erythrocyte (154). Basically this involved incubation of the
microsomes with liposomes for various periods of time at 37°C
and centrifuging the incubation mixture at 100,000 g for 1 hour
to separate liposomes from microsomes. When the microsomal
fraction was prepared in this way the liposomes did not appear
to be having any noticeable effect on the microsomal cholesterol
levels. A possible explanation of this result was that the
unsonicated liposomes used in the experiments were co-sedimenting
with the microsomes and were contributing to the measurement of
cholesterol in the microsomal pellets. This problem was partly
resolved by placing the incubation mixture of microsomes and
liposomes on a sucrose density gradient. Both continuous gradients
varying from a median density of 1.038 g cm ^ to a median density
of 1.176 g w/v) and discontinuous gradients
|.Y.PG XJX-otein chol. P.L chol/P.L. chol/protein
(rag) («ig) (Mg) ("ig j
0 2.4 113 1.20 0.098 0.049
3 1.92 118 1.32 0.089 0.046
O)
6 2.3 91 1.43 0.062 0.039
9 2.3 76 1.16 0.062 0.033
0 cb} b 120 1.25 0.098 0.020
An analysis of the 100,000g pellets formed by the 4°C
overnight incubation of microsomes with E.Y.PC followed by
sucrose density gradient centrifugation. (b) shows an analy¬
sis of the microsomal preparation.(P.L. = phosphlipid)
Incubation chol protein P.L chol/P.L.
conditions 0-'-S) (mg) (mg)
4°G «' 169+5 4.29±0.5 ' 1.25±0.2 0.134
4°C +E.Y.PC 100+5 3-47+0.5 0.95+0.2 0.105
(4"'g)
37°G+E.Y.PC 70+5 3-38±0.5 1.1010.2 O.O63
(4mg)
(6) 180+5 8.0 +0.5 1.3210.2 0.136
Analysis of the 100,000g pellets formed after sucrose
density gradient centrifugation. (b) describes the
microsomal preparation used fin the-'incubfe.tion. Results
are the means of 6 determinations± standard deviation.
Table 7.5
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(20,30,60% w/v) (160) were used for the separation of
liposomes from the membrane fractions. In this system the lipid
floats on the surface of the sucrose and the various microsomal
components were separated on the basis of their relative sizes.
Table 7.1 shows that overnight incubation, at 37°C or 4°C, of
unsonicated liposomes with a reconstituted freeze dried powder
of microsomes (containing 6.6 mg protein and 170 pg cholesterol)
gave a reduction in the absolute amount of cholesterol present
in the 100,000 g pellet. However there was no change in the
cholesterol:protein ratio. Table 7.1 also shows that the
microsomal protein spreads throughout the sucrose gradient with
slight differences in the exact distribution which can be
attributed to temperature effects.
If the amount of cholesterol in the 100,000 g pellets is
related to the amount of phospholipid present which is unaffected
by the liposomal phospholipid or 37°C incubation then the results
are slightly different. Table 7.2a shows that even at 4°C when
the results are expressed in relation to the phospholipid,
liposomal phosphatidylcholine removed 36% of the cholesterol
upon overnight incubation (Table 7.2b is an analysis of the
microsomal preparation that was incubated with the liposomes).
After a 14 hour incubation at 37°C the microsomal suspension
changes to a light granular suspension indicating that the
membranes have been altered by the incubation procedure.
When the experiments were repeated using sonicated egg yolk
phosphatidylcholine liposomes in a 40 fold excess over the
microsomal cholesterol the removal of cholesterol improved.
Table 7.3 shows 100,000 g sucrose density gradients pellets
obtained from four experiments contain similar amounts of protein
, protein chol. P.L. chol/P.L. chol/px-otein
(rag; (wg) (mS)
(a) 6 100 1.92 0.052 0.0167
(b) 2.5 80 1.85 0.043 0.032
(c) 2.46 180 2.16 0.083 0.073
Analysis of the 100,000g pellets formed by a 37°C overnight
incubation of the microsomes (b) alone, (c) with liposomes
containing a four fold excess of cholesterol, (a.; represents






P450 protein ( mg )
14 hour 4°C 14 hour 4°G
+S.Y.PC
14 hour 4°0 14 hour 4°c
+E.Y.P0
1 0 0 0.70 0.87
<L 0 0 0.80 0.70
3 0 0 0.92 1.12
4 0.24 0.4 0.87 1.05
5 0.4 0.5 0.87 1.02
b 0 0 0.52- 0.29
7 0 0 0.8? 0.41
8 0 0 0.87 0.85
9 1.4 1.8 3.37 3-37
Distribution of microsomal cytochrome P450 and protein in a
20,30,60% discontinuous sucrose gradient. The microsomal
suspension contained 9«64 nig protein and 4 nmole cytochrome P450.
Table 7.5
and phospholipid to those obtained before. The amount of
cholesterol removed increases with increasing incubation
temperature and the maximum reduction that was achieved was
52% of that in the intact microsome when measured relative
to the microsomal phospholipid.
Since these results showed that cholesterol can be
removed from microsomes by incubation with egg yolk
phosphatidylcholine, it was decided to try to increase the
amount of cholesterol in the microsomes by incubating them
with cholesterol containing liposomes. Unsonicated liposomes
were prepared from cholesterol (4.2 mg) and egg yolk
phosphatidylcholine (10 mg) and an aliquot containing 400 yg
of cholesterol was incubated with a microsomal suspension
containing 100 yg cholesterol. Table 7.4 shows that the
microsomes can increase their cholesterol complement by 60%
under these incubation conditions.
The treatment of microsomes with liposomes of varying
compositions seems to be a technique that should allow the
microsomal pool of cholesterol to be manipulated using mild
conditions. Unfortunately there are problems associated with
the methodology which as yet have not been completely solved.
/
The major problem concerns the fact that the microsomes sub-
fractionate when they are placed on a sucrose gradient and
thus a better method for separating the liposomes from the
microsomes will have to be developed. A sucrose medium of
some sort may still be required as even single walled liposomes
have a tendency to aggregate (159) and thus to sediment with the
microsomes. In addition the overnight incubation may have a
deleterious effect on the enzymic activity of the microsomes.
4681024682302 FractionNo.(ml) Sepharose4Beluti nprofileof3H:C24: ggyolkphosphatidylcholine(1 1) liposomes.
130.
Thus the methodology involved in trying to alter the cholesterol
levels in the microsome is more complicated than that published
for the erythrocyte and is still not entirely satisfactory.
The effect of egg yolk phosphatidylcholine on the activity of
the microsomal cholesterol 7a-hydroxylase
4
In the previous section it was shown that up to 52% of the
microsomal cholesterol expressed as a cholesterol phospholipid
ratio can be removed by treatment with egg yolk phosphatidyl¬
choline. In addition to check if this technique could be
adopted for the study of cholesterol 7a-hydroxylase the
properties of a microsomal preparation which had been treated
by egg yolk phosphatidylcholine were investigated. Fresh
microsomes containing 9 mg of protein and 4 nmoles cytochrome
P450 were incubated at 4°C for fourteen hours in the presence
or absence of egg yolk phosphatidylcholine. Table 7.5 shows
the 20, 30, 60% (w/v) discontinuous sucrose density gradient
profile of cytochrome P450. Only 50% of the cytochrome P450
added to the gradients was recovered. As can be seen in both
cases 66% of the recovered cytochrome P450 was found in the
fraction that floats on top of the 60% sucrose cushion. In
addition cytochrome b,. and NADPH cytochrome c reductase were
i
located in the pellet fraction alone and were recovered in 80-90
per cent yield. No cytochrome P420 was detected. The remaining
cytochrome P450 found at the boundary between the 20 and 30%
sucrose layers did not support 7a-hydroxylation. Thus egg yolk
phosphatidylcholine removes cholesterol from the microsome
without destroying the basic microsomal organisation, under the
described incubation conditions.
The cholesterol 7a-hydroxylase activity of these pellets with
reduced cholesterol levels was determined to see if enzyme
activity was retained after overnight incubation at 4°C and a
subsequent sucrose density gradient centrifugation. When the
results are expressed as the percentage conversion to 7a-
hydroxycholesterol per mg pellet protein, the results showed
that the enzyme activities of both the treated and untreated
microsomes were not significantly different. If the microsomes
were incubated at 37°C as stated previously this resulted in a
50% depletion of the microsomal cholesterol. Unfortunately
the procedure also destroyed the cytochrome P450 and eliminated
t
the cholesterol 7a-hydroxylase activity.
The activity of the cholesterol 7a-hydroxylase as measured
by the tracer assay is not altered by removal of 36% of the
microsomal cholesterol. Perhaps this result is not altogether
unexpected as a fully depleted preparation of microsomes (butanol
powder) still retains the cholesterol 7a-hydroxylase activity.
7.5 Comparison of the abilities of the side chain analogues to
exchange with microsomal cholesterol pool
As previously noted the erythrocyte has been the membrane
of choice for study of the role of cholesterol in membranes.
Using erythrocyte ghosts and liposomally bound steroids containing
2 to 3 times the weight of cholesterol in the erythrocyte.
Bruckdorfer et al. (154) were able to show that 30% of 7-
dehydrocholesterol, lathosterol, 3-norcholesterol and cholest-4-en-
3-one could exchange with erythrocyte cholesterol. The failure
of other sterols to exchange was attributed to their poor
incorporation into a liposome. There is no record of a similar
study in the liver microsomes where the cholesterol present is
Fraction c • p • m •
incubation residue 10,950
sucrose gradient residue 2,4M












Typical distribution of radioactivity in the various
fractions involved in the experimental procedure. 1x10^ c.p.m.
were added and 8'[% was recovered.
Table 7.6
participating in many cellular processes including the
production of steroid hormones and bile acids. As lipo¬
protein bound cholesterol has been shown to exchange with smooth
endoplasmic reticulum (149) it was decided to find out if
liposomal cholesterol was also capable of exchanging with
microsomal cholesterol.
A microsomal suspension (1 ml) containing approximately
5 mg of protein and 100 yg of cholesterol was incubated for
various intervals at 37°C with sonicated liposomes containing
a similar amount of radioactive cholesterol prepared from lipid
films containing tritiated cholesterol and egg yolk phospha¬
tidylcholine in a 1:1 molar ratio. The sonication procedure
used, incorporated 80-100% of the radioactive cholesterol into
a liposomal structure. Figure 7.3 shows a typical elution
profile of the radioactive liposomes prepared in this manner.
The profile is that of liposomes containing equimolar quantities
of the analogue and phosphatidylcholine but a similar profile
was obtained with each of the cholesterol analogues. The
exact elution volume was varied between 24 and 31 ml depending
on the precise tuning of the sonication. In some of the
initial experiments the liposomes contained N -glycerol
trioleate which Zilversmit and Hughes (161) stated to be a non-
exchangeable marker in a mixture of microsomes and liposomes.
In my hands this marker compound exchanged into the microsomes
rendering this method of measurement of the exchange useless.
After the incubation period, the incubation mixtures were
placed on top of 20 (3 ml), 30 (4 ml) and 60 (4 ml) % (w/v)
discontinuous sucrose density gradients prepared in 10 mM Tris,
1 mM EDTA pH 7.4 which were then centrifuged at 100,000 g for
Time (hr) % exchange protein cholesterol P.L.
(Ks) (»s) (mgj
0 0 2.42 100 1.40
1 34-2 2.48 100 1.52
2 40±2 2.6 100 1.34
3 45±3 2.6 100 1.42
7 70±5 3.23 120 1-54
14 feo±5 2.89 110 1.46
Time course of cholesterol exchange into
microsomes when cholesterol is presented in a
liposome containing equimolar amounts of
cholesterol and phospholipid. The microsomal




1 hour. The gradient was divided into 1 ml fractions and the
material that floated on top of the 60% sucrose cushion was
isolated, diluted with buffer and recentrifuged at 100,000 g
for 1 hour in order to determine what proportion of the
added radioactivity was tightly bound to the microsomal fraction.
The pellet thus obtained was resuspended in buffer and the
radioactivity, protein, cholesterol and phospholipid present
were determined. The only factor that was found to alter
was the radioactivity, indicating that cholesterol exchange
was occurring and that there was no movement of sterol.
The radioactivity value was corrected for losses that occurred
during the manipulation and the ability of a liposomal cholesterol
analogue to exchange with microsomal cholesterol was expressed as
a percentage of the added radioactivity. Table 7.6 shows a
typical distribution of radioactivity through the fractions
involved in the experimental procedures when liposomes containing
and phosphatidylcholine in a (1:10) molar ratio were incubated
at 37°C for 14 hours.
The initial experiments established that after 14 hours of
incubation of cholesterol containing liposomes (cholesterol:
phospholipid 1:1) with microsomes, the maximal exchange of
radioactivity had occurred. Table 7.7 gives an indication of
the time scale of the exchange process. The value of the amount
of endoplasmic reticulum cholesterol available for exchange is
considerably less than that published by Graham and Green (149)
who incubated liver smooth endoplasmic reticulum with a plasma
lipoprotein fraction containing the radioactive cholesterol. ,
The difference may be due to the ability of the lipoprotein to
deliver cholesterol to the microsomes at a faster rate than
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(a) (6) (a) (6)
The effect of altering the cholesterol side
chain and the cholesterol:phospholipid ratio on the
exchangeability of cholesterol analogues with
microsomal cholesterol. Column(a)represents the efficiency
of incorporation of each analogue into a liposome , and the












The exchange of cholesterol analogues contained
in dimyristoyl phosphatidylcholinefin a 1:10 molar ratio
with an equivalent amount of microsomal cholesterol.
Table ?.9-~
1J4,
liposome and lipoprotein was confirmed when the relative hr^Asporh
vgtrt Cowp^irtcl. S»« f\icA liposome
abilities of sonicated and unsonicated liposomes^transferred
60% of the radioactivity, whereas unsonicated liposomes only
transferred 16%.
As the preliminary experiments had shown that the
developed procedure could deliver radioactivity into the
microsomes, the ability of three side chain analogues to
exchange with microsomal cholesterol was investigated.
Each of the cholesterol analogues tested can be incorporated
in liposomes in a 1:1 ratio (162). Thus unlike
Bruckdorfer (154) the liposomes did not require a proportion
of cholesterol to ensure that the sterol and phospholipid are
present in equimolar amounts. In each experiment the
liposome and microsome contained equimolar amounts of
cholesterol or cholesterol analogues, which ensured that no
net movement of cholesterol would occur. In the exchange
experiments already quoted, the ratio of liposome cholesterol
to membrane cholesterol varied from 1:32 (151) to 1:50 (152).
This prevented net movement of cholesterol but perhaps is a
i
slightly artificial situation.
The microsomal exchange experiments were repeated with
liposomes containing the molar proportions of cholesterol
analogue and phospholipid found in the microsomes (0.1 mole
cholesterol per mole phospholipid). This ensured that any
exchange occurring was measured under equilibrium conditions.
Table 7.8 shows that more than 80% of the radioactivity added
to the lipid film is present in the liposomal fraction.
Furthermore it also shows that in both liposomal preparations
approximately 60% of the and cholesterol C^ was freely
exchangeable with the microsomal cholesterol, whereas only 40%
of the C01 and C„Q exchanged. As each sterol was equallyZL Zo
incorporated into a liposome and the Sepharose 4B profiles
(Figure 7.4) indicated that the sonication was equally
effective in the cases of all the analogues (including
then this implies that the exchange process was regulated
at the microsomal level.
When the liposomes were prepared from dimyristoyl
phosphatidylcholine, the amount of radio-labelled sterol
incorporated into the sonicated liposomes was reduced
compared with the unsaturated phospholipid (Table 7(9)).
However when the sterol exchanged into the microsomes was
expressed as a percentage of the total sterol present a similar
pattern to that previously observed was noted. This is
contrary to the picture presented by Bloj and Zilversmit (151)
that the rate of cholesterol transfer was proportional to the
degree of unsaturation of the lipids comprising the liposome
for cholesterol exchange into a red cell.
The results in this section indicate that when cholesterol
is presented to rat liver microsomes in liposomes of different
composition, the labelled cholesterol molecule can exchange
with the microsomal cholesterol. Furthermore the side chain
of cholesterol appears to be playing a role in determining the
rate of cholesterol exchange process as and cholesterol
exchange with microsomal cholesterol more readily than C00 or CZo
7.6 Conclusion
The work involved in this chapter has been concerned with
trying to alter the microsomal cholesterol pool by incubating
the microsomes with liposomes prepared from pure egg yolk
iJU,
phosphatidylcholine, or with liposomes containing the
available cholesterol side chain analogues that are radio-
actively labelled. The methodology involved the use of
discontinuous and continuous sucrose density gradients to
separate the liposomes from the microsomal fraction. In
addition to separating these two components the sucrose also
subfractionated the microsomes which is a recognised phenomenon
(163). The liver microsomal fraction results when the
supernatant fluid from the mitochondrial pellet is recentrifuged
at 100,000 g. For maximal recovery of liver microsomes,
extensive homogenisation at high speed is required to disrupt
as many of the hepatocytes as possible but such homogenisation
also results in increased damage to anJfragmentation of
cellular organelles. Thus the precise conditions used in the
homogenisation such as the speed of the pestle and the number
of passes performed during homogenisation determine the extent of
the contamination of the microsomal fraction by plasma membrane,
golgi cisternae, connective tissue cells, outer mitochondrial
membranes or lysosomes. As these details are not always
comprehensively described it is difficult to compare different
microsomal preparations.
Analysis of the continuous sucrose density gradients showed
that the main microsomal fraction has a median density greater than
or equal to 1.176 gm cm ^ and contained cholesterol 7a-hydroxylase
activity, cytochrome b,- and P450, phospholipid and at least 80 per
cent of the microsomal cholesterol. The proportion of added
protein found in the fraction was dependent on the experimental
conditions.
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The cholesterol levels in the main microsomal fraction were
a
altered by incubation with liposomes of varying compositions.
The results showed that the microsomes could be enriched with
cholesterol by treatment with cholesterol containing liposomes.
This was not achieved in Chapter 6 when butanol powders were
incubated with acetone solution of cholesterol, implying that
the butanol treatment abolished the ability of the microsomes
to sequester increased levels of cholesterol. In addition
the microsomal cholesterol was replaced by radioactive
cholesterol side chain analogues presented in liposomes.
However, after a fourteen hour incubation at 4°C of
microsomes with liposomes, when approximately 30% of the micro¬
somal cholesterol was removed, addition of tracer cholesterol
to the fraction showed that the activity of the cholesterol 7a-
hydroxylase enzyme was unaffected. This was not unexpected as
butanol treatment of the microsomes depleted the microsomal
cholesterol but the cholesterol 7a-hydroxylase activity was
retained as measured by the tracer assay. Another possible
explanation was that the cholesterol removed was not providing
substrate for the enzyme.
This chapter has also shown that a cholesterol analogue
contained in a liposome can exchange with 60% of the microsomal
cholesterol. This process required a 37°C 14 hour incubation,
which destroyed the enzyme activity and thus it was not possible
to see if the exchanged cholesterol analogues were metabolised
in a different way from that described in Chapter 6.
Although those experiments have not been able to show
whether alteration of the microsomal cholesterol pool will alter
the activity of the cholesterol 7a-hydroxylase the fact that the
138.
liposomal cholesterol pool is capable of exchanging with
microsomal cholesterol implied that at least 60 per cent of
the microsomal cholesterol could have been obtained from
plasma lipoproteins. This figure for the amount of
exchangeable cholesterol is similar to that noted by
Balasubramaniam et al. (164) for the percentage of microsomal
cholesterol that is immediately accessible to the enzyme.
Balasubramaniam also indicated that the two pools were
mutually exclusive and that the preferred substrate for the
cholesterol 7ot-hydroxylase was cholesterol synthesised in the
microsome (164). Whether in fact the lipoproteins supply a
source of substrate for the cholesterol 7a-hydroxylase enzyme
must remain a matter for conjecture due to the difficulty of
experimental design.
Summary
(1) The preparation of single bilayer liposomes suitable for
delivery of sterols into microsomes is described.
(2) The ability of liposomes of various compositions to alter
the microsomal cholesterol pool is described.
(3) The use of sucrose density gradients to separate the
microsomes from the liposomes and an analysis of the effect of
sucrose density gradient centrifugation on the microsomal
components is outlined.
(4) The effect of alteration of the cholesterol side chain
on the ability of the liposomally bound sterol to exchange with
microsomal cholesterol is described.
I
CHAPTER 8
INVESTIGATION OF THE POSSIBLE INVOLVEMENT OF A




The liver microsomal fraction contains cholesterol, which
is a structural component of membranes as well as an enzyme
substrate. The possible sources of substrate cholesterol for
cholesterol 7a-hydroxylase have been much discussed in the
literature in recent years. Balasubramaniam et al. (164)
have shown that when N -cholesterol was incubated with liver
microsomes under conditions in which 7a-hydroxylation takes
place the specific activity of the 7a-hydroxycholesterol formed
during the incubation was lower than that of the added cholesterol.
This showed that seme of the endogenous cholesterol in the
microsomes which was equilibrating with the exogenous radioactive
cholesterol was accessible to the enzyme. They have proposed
the term "substrate pool" for that fraction of the microsomal
cholesterol that acts as substrate for cholesterol 7a-
hydroxylase and they estimated that approximately 70% of the
microsomal cholesterol was accessible to the enzyme. This same
figure was reached by Van Cantfort et al. (128) using
different techniques and the same assumption that the exogenous
cholesterol equilibrated completely with the microsomal cholesterol.
In the same paper Balasubramaniam et al. (164) isolated
liver microsomes from rats shortly after they had been injected
7a-hydroxycholesterol formed by the microsomes was lower than that
of the microsomal cholesterol. They concluded that the pool of
cholesterol from which 7a-hydroxycholesterol was synthesised does
not equilibrate rapidly with plasma cholesterol and they therefore
suggested that this pool was derived preferentially from cholesterol
synthesised in the rough endoplasmic reticulum. This finding was
with noted that the specific activity of the
itu.
confirmed by Bjorkhem and Danielsson (11) who showed that the
i
specific activity of 7a-hydroxycholesterol formed from [5-^hJ
mevalonic acid during incubations of rat liver microsomes
was higher than that of the total microsomal cholesterol.
Cholesterol feeding increases cholesterol absorption by
the liver and decreases hepatic cholesterol synthesis as judged
by the activity of HMG CoA reductase (165). In addition there
is a slight increase in the excretion of endogenous neutral
steroids but it is insufficient to prevent an accumulation of
cholesterol in the liver. Under these conditions the percentage
of cholesterol formed in the liver will obviously decrease.
However when the cholesterol 7a~hydroxylase activity of the
cholesterol fed animals was measured, some workers (9,132) observed
an increase whereas others failed to notice any significant
change from control values (11). The failure to observe any
increase in formation of 7a-hydroxycholesterol could be
rationalised by postulating that the enzyme was supplied by a
pool of cholesterol that is largely unaffected by alteration
of the general hepatic cholesterol pool. Alternatively the
previously mentioned deficiencies of the tracer assay may prevent
an increase in the activity of the enzyme from being detected.
The increase in the activity of cholesterol 7a-hydroxylase
could be explained by an alteration of the source of cholesterol
for the enzyme under these conditions. As cholesterol feeding
inhibits hepatic cholesterol synthesis while at the same time
increasing 7a-hydroxylation of cholesterol newly synthesised
cholesterol cannot be the only source of substrate. Perhaps
cholesterol feeding facilitates transfer of cholesterol that
does not normally provide substrate for the enzyme from a pool
supplied by dietary sources to a pool which normally supplies
cholesterol for hydroxylation. .
The situation was further complicated by the findings of Gustafsson
et al. (166) using germ free rats. Germ free rats have a higher level
of liver cholesterol than "normal" animals and cholesterol synthesis
is decreased. In normal rats bile acids are metabolised by intestinal
microflora to a spectrum of secondary and non-steroidal derivatives,
however in germ free rats only cholic acid and chenodeoxycholic acid
are formed. When germ free rats were fed cholesterol, chenodeoxycholic
acid production was stimulated to a greater extent than cholic acid and
under these conditions the endogenous formation of cholesterol was
GvjsV-fc-f
decreased. _ explained the results by suggesting that the substrate
pools of cholesterol for chenodeoxycholic and cholic acid formation
were different, the cholic acid pool consisting of the same newly
synthesised cholesterol proposed by Balasubramaniam et al. (1964) and
the chenodeoxycholic acid substrate pool being freely available to
the endogenous cholesterol.
It should be noted that the experiments described above showed
only that cholesterol newly synthesised in the hepatic microsomes was
the preferred substrate for cholesterol 7a-hydroxylase and not that it
was the sole substrate. All the exchangeable cholesterol in the
body is potentially accessible to the enzyme (167). This is obvious
from the well known observation that the bile acids become labelled
if ring labelled cholesterol is injected intravenously. The situation
revealed by observations on the relative specific activities of
microsomal cholesterol under different experimental conditions may
perhaps be expressed most simply by saying that the pool of cholesterol
that provides substrate for cholesterol 7a-hydroxylase equilibrates
more rapidly with cholesterol molecules that have just been synthesised
in hepatic microsomes than with molecules reaching the microsomes from
other sources including lipoproteins from cholesterol fed animals.
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Another possible method for regulating the activity of the enzyme
i
by altering substrate supply would be by a specific transport mechanism
for cholesterol from the cholesterol pools to the enzyme. The presence
of a saturable carrier would be consistent with the possibility that
the rate of formation of 7a-hydroxycholesterol is regulated by the
size of the enzyme's substrate pool.
The existence of a factor that would affect the activity of
cholesterol 7a-hydroxylase was first described by Mayer (168).
Unfortunately the peptide that he isolated from rat liver 100,000 g
supernatant inhibited the enzyme. More recently Spence and Gaylor
(13) in a paper which was mainly concerned with the effect of a protein
purified from 100,000 g supernatant on the activity of HMGCoA
reductase indicated that a 40-80% ammonium sulphate treatment of rat
liver 100,000 g supernatant also contained a protein that improved
the conversion of cholesterol to 7a-hydroxycholesterol. This finding
would be consistent with the observation that other microsomal enzymes
are stimulated by, or are dependent on, the presence of a cytosolic
protein. They include the conversion of
(1) squalene to lanosterol (169)
(2) lanosterol to dehydrolanosterol (170)
(3) lanosterol to C^-j sterol (171)
(4) dihydrolanosterol to cholesterol (172)
(5) 5-cholest-7-en-3p-ol to cholesta-5, 7-dien-3f3-ol (173)
(6) tJ~ cholestenol to 7-dehydrocholesterol and of 7-dehydrocholesterol
to cholesterol (174) (175)
(7) vitamin to 25-hydroxyvitamin (176)
and (8) 7a-hydroxy-4-cholesten~3-one to 7a,12a-dihydroxy-4-cholesten-
3-one (177) among others.
microsomal cytosolic B.S.A. % recovery -1
protein (mg) protein (mg) of labell' L conversion
15 0 0 64 4r0.5
15 90 0 67 7•9-0.5
15 0 90 62 4±0.5
0 90 0 66 0
A comparison of the abilities of equivalent amounts
of bovine serum albumin (B.S.A) and unfractionated 100,000g
supernatant to enhance the activity of cholesterol T*hydroxy¬
lase. Results are the means 1'the standard error of the mean.
Tab1e 8.1
microsomal cytosolic , trypsin %
protein(mg) protein(mg) (mg) conversion
15 60 1 7.9+0.4
15 60 5 8.0+0.5
15 60 0 14.0+0.5
15 0 0 9.0±0.5
The effect of a trypsin treatment on the ability
of unf ractionated 100,00pg supernatant to increase the
activity of microsomal cholesterol ^-hydroxylase. The
trypsin solution contained lOmM CaCl^ and was incubated











The effect of the addition of differing amounts
of ammonium sulphate fractionated 10C,000g supernatant to








1 min(80°G) 30 9.1*0.2
2 min(80°C) 30 6.4*0.5
5 min(80°C) 30 6.0*0.3
none 30 8.0*0.1
The effect of different periods of heat treatment
on the stimulatory activity of an 40-80% ammonium sulphate
fraction from rat liver 100,000g supernatant. The
microsomal preparation contained 6mg protein.
Table 8.4
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The precise role that these solyble proteins play in mediating
the activity of the microsomal enzyme is a matter of conjecture.
In a recent review Scallen et al. (178) implied that each soluble
protein may be a soluble constituent of the particle-bound enzyme.
The soluble component could thus fulfil both a carrier or binding role
towards a water insoluble substrate and a catalytic role in
conjunction with the membrane bound enzyme component. However Saat
and Bloch (179) thought that this was too precise a definition of
the role of the supernatant proteins and they surmised that they were
more likely to be transporting exogenous or endogenous substrate to a
specific site or compartment within the membrane. Furthermore as enzymes
were associated with the endoplasmic reticulum they considered that
the active proteins, although isolated from the 100,000 g supernatants,
were in fact peripheral microsomal proteins. Since the microsomes
contained numerous inter-related enzymes the existence of several
"supernatant" proteins seems likely.
The following sections describe the initial attempts to confirm
the findings of Spena and Gaylor (13) regarding the involvement of
supernatant protein in microsomal cholesterol 7a-hydroxylase.
8.2 Involvement of a cytosolic protein in cholesterol 7a-hydroxylase
In order to check if the 100,000 g supernatant of rat liver
possessed the ability to stimulate the activity of microsomal cholesterol
7a-hydroxylase, the 100,000 g supernatant was obtained from cholestyramine
fed (4% w/w), female rats and lyophilised. After reconstitution in
phosphate buffer (0.1M pH 7.4) the supernatant fraction was added to a
standard 7 ml incubation containing cholesterol (described in
chapter 2) at a supernatant protein to microsomal protein ratio of 6:1
and the reaction was incubated at 37°C for 1 hour. Following a lipid
extraction and thin layer chromatography the amount of radioactivity






























The effect of ine reap toe thylamine and a
40-80% ammonium sulphate fraction of rat liver
100,000g supernatant on cholesterol '/*< hydroxy¬




corresponding to the 7a-hydroxycholesterol was expressed as a
i
ratio of the total radioactivity recovered. Table 8.1 shows
that rat liver 100,000 g supernatant can stimulate the
conversion of radioactive cholesterol to radioactive 7a-
hydroxycholesterol and that this stimulation cannot be
supported by the supernatant alone or by an equivalent amount
of bovine serum albumin. Thus the results are comparable
with Spence and Gaylor (13) who used a similar ratio of
supernatant protein to microsomal protein.
That a protein present in 100,000 g supernatant was
involved in this stimulation was confirmed by treatment of the
unfractionated supernatant (90 mg) with trypsin. Table 8.2
shows that trypsin abolished the stimulatory activity of the
100,000 g supernatant implying that the stimulation was protein
mediated.
Preparation of an ammonium sulphate extract of 100,000 g supernatant
The active cytosolic protein was collected by salt precipitation
of the 100,000 g supernatant. Solid ammonium sulphate was
added to cytosol to 40% saturation over one hour with stirring and
the pH was maintained at 7.4 with solid Tris base. The super¬
natant and salt precipitated protein were then separated by
centrifugation for 15 min at 17,000 g. The pellet was discarded
and the supernatant was brought to 80% saturation with solid
ammonium sulphate with stirring as above. The precipitate was
collected by centrifugation, dissolved in 50 mM phosphate buffer
(pH 7.4) and dialysed overnight at 4°C. The protein was then
dialysed against water for 3 hours and lyophilised. The recovery
of 100,000 g protein in the 40-80 ammonium sulphate fraction varied
between 25 and 38%. Upon addition of various amounts of the crude
protein thus obtained, the activity of cholesterol 7a-hydroxylase
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was increased over control levels (Table 8.3). It should be
noted that preincubation of radioactive cholesterol with crude
protein prior to addition to the enzyme did not improve conversion
to product. Other workers (13) have shown that the cytosolic
proteins could he further purified by heat treatment.
Grabowski et al. (177) heated 30 mg supernatant protein/ml of
solution in a boiling water bath until the temperature of the
solution reached 60°C (approximately 2 minutes) and found that
although 75% of the protein was denatured, the remaining 25%
could enhance 12a-hydroxylation of 7a-hydroxy-4-cholesten-3-one.
A similar procedure was repeated with the ammonium sulphate extract
in order to assess if the protein that possessed cholesterol 7a-
hydroxylase stimulated activity was heat labile or heat stable.
Heat treatment of the lyophilised ammonium sulphate fractionated
cytosol at 80°C for 2 or 5 minutes resulted in the denaturation
of 80-85 per cent of the protein, but Table 8.4 shows that the
cytosolic protein may be partially heat stable. The preparation
of Spence and Gaylor (13) that enhanced cholesterol 7a-hydroxylase
was seen to be heat labile under these conditions whereas the
proteins that stimulated methyl sterol oxidase and HMG-CoA reductase
were unaffected.
The effect of heat treatment on a protein which does not
possess any innate biological activity is difficult to quantify.
As the heat treatment denatures 80% of the protein but does not
result in an increase in the stimulatory activity of the remaining
20%, the heat treatment at best is not improving the stimulatory
activity of the cytosolic protein. The criteria for purification
of such a protein must be based on the minimum amount that can
cause maximum stimulation of the enzyme. Thus the apparent
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excess cytosolic protein. However fhis can be discounted in
this case as the heated supernatant does not stimulate
cholesterol 7a-hydroxylase to the same extent as an equivalent
amount of unheated cytosolic protein.
8.4 Comparison of this cytosolic protein fraction with that of
Scholan (180)
As a cytosolic factor had been implicated by Scholan in assist¬
ing metabolism of the radioactive cholesterol, its properties
were compared with the cytosol protein fraction prepared by
ammonium sulphate fractionation of the 100,000 g supernatant.
The factor of Scholan was isolated from the supernatant of
100,000 g supernatant that had been boiled for 10 minutes at 95°C.
It was non-dialysable and seemed to be acting to prevent auto-
oxidation of the radioactive cholesterol in a similar way to the
thiol 8-mercaptoethylamine. Table 8.5 shows that the crude, heat
labile, dialysable protein only partially acts as an anti-oxidant.
Furthermore, a combination of a fraction containing the heat labile
factors and 8-mercaptoethylamine could stimulate the production
of 7a-hydroxycholesterol beyond the levels observed in the presence
of 8-mercaptoethylamine alone, whereas the heat stable fraction of
Scholan could not. Although the crude heat labile protein fraction
is partially preventing autoxidation, only in the presence of an
anti-oxidant are its stimulating properties fully realised. Thus
the SF described by Scholan and the cytosolic protein fraction seem
to be playing different roles in cholesterol metabolism.
8.4 Fractionation of the crude cytosolic protein by gel filtration
The properties of the crude supernatant protein were further
investigated by gel filtration on a Sephadex G75 column prepared in
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reported purifications of cytosolic proteins and in combination
l
with the heat treatment was seen to be the most effective in
the purification scheme of Gaylor and Delwiche (181).
Various amounts of ammonium sulphate fractionated cytosol
(50-300 mg protein) were applied to a 2 x 51 cm Sephadex G75
column in 20 mM phosphate buffer pH 7.4 (5 ml), and the eluent
was collected in 5 ml aliquots. Figure 8.1 shows the elution
profile of the cytosolic protein and the percentage increase in
activity (as compared to the control values) when each fraction
was added to a standard incubation mixture. Stimulatory activity
was noted in fractions 10-12 and 19-21. When the increase in
activity was expressed per milligram of the cytosolic protein
added, maximal stimulation was associated with fractions 19-21.
This pattern was observed over five independent estimations.
If the protein eluting between 85-110 mlwas concentrated and
reapplied to the same column the elution position was unaltered.
This implied that the void volume fraction was not an aggregate
formed as a result of ionic strength effects.
Figure 8.2 shows the calibration curve of cytochrome c,
myoglobin, trypsin, and bovine serum albumin applied individually
to the Sephadex G75 column. The void volume was fixed at 51-52 ml
by blue dextran, aortas the ratio of Ve/VQ for the fractions with
high specific activity varied between 1.9 and 2.1, the molecular
weight of the protein species was estimated at between 17,300
and 20,000. Measurement of the A280^A260 for Protein in fraction
10-12 and 19-21 gave a value of 0.68-0.79 indicative of the presence
of pyridine nucleotides.
Upon the addition of varying amounts of protein obtained from











1.25 5.6+0.1 0.75 5.1*0.2
3-75 5.9*0.2 1.5 6.0*0.5
7.5 5.4*0.2 3 5.7*0.1
16 6.2*0.2 0 3.8
24 6.8±0.1
e 3.B±0.2
The effect of the addition of varying amounts of
protein isolated from the void volume fraction and the
retained fractions from Sephadex U-/3 on the cholesterol




gytosolic •% sc^tosblic %
protein(mg) conversion protein (mg,) conversion
(A) (B)
5 b.l 1.5 5.0
1.5 5.8 0.75 4.7
0.75 5.5 0.50 4.4
0.5 5.2 0.25 4.9
0.25 5.9 0 2.9
o 2.9
The effect of DSAE cellulose on the ability
of the retained fraction ( G'75 ) to stimulate cholesterol
Y«t hydroxylase. <A) represents the fraction that is eluted
by 5mM Tris HG1 pH7«4» while (B) is eluted by 5®M Sris HG1
pH7-4 containing 0.154 potassium chloride.
Sable 8.7
148.
seen to be stimulated to near maximum values which never exceed
2 fold. When the percentage increase in the activity of the
enzyme was calculated as a ratio of the cytosolic protein added,
the protein in fraction 19-21 had been purified 38 fold by
Sephadex treatment.
Ion exchange chromatography of cytosolic proteins
The protein in fraction 17-22 (30 ml) of the Sephadex G75
column was concentrated by ultracentrifugation on an Amicon
was
PM 10 membrane. This fraction (approx. 3 ml) dialysed against
A
5 mM Tris HC1 pH 7.4 (1 litre) for 12 hours at 4°C and applied
to a 1.5 x 23 cm DEAE cellulose column equilibrated in the same
buffer. The column was then washed with 5 mM Tris HC1 pH 7.4
until no more protein was eluted, followed by elution with 5 mM
Tris HC1 pH 7.4 containing 0.154 M KC1 which eluted a further
protein peak. Protein was measured in 1 ml fractions and the
two protein peaks were each pooled and concentrated by ultra¬
filtration using a PM 10 membrane in an Amicon ultrafiltration
cell. The recovery of protein from the DEAE cellulose column
varied between 50 and 60% (average of three estimations) and
70% of the recovered protein was associated with the first protein
peak which was eluted from the DEAE cellulose by 5 mM Tris HC1
pH 7.4. Although stimulatory activity seemed to be associated
with both protein fragments, the more active protein was found
in the first peak (Table 8.7).
Ion exchange chromatography thus seems to further sub-
fractionate and purify the cytosolic proteins that are associated
with stimulation of cholesterol 7a-hydroxylase. When activity
is expressed as a percentage increase of product formed per mg
of cytosolic protein the ion exchange chromatography step
produces two fractions which are 415 and 275 fold purified
containing (a) fraction 10-12 from Sephadex G75 column
(b) fraction 19-21 from Sephadex G75 (c) DEAE cellulose
eluted with 5 mM Tris HC1 pH 7.4 (d) DEAE cellulose eluted
with 5 mM Tris HC1 containing 0.154 M KC1 pH 7.4
Fig. 8.3
Mobility
S.B.S. polyaery1amide gel electrophoresis
estimation of the molecular weight of the protein
retained on Sephadex G75 by comparison with the
mobilities of standard proteins. Standard proteins
used, B.S.A. MW 68,000, cytochrome c MW 11,7000,
Y globulin MW 50,600 and 23,500, glyceraldehyde
3P dehydrogenase MW 35,000, catalase MW 60,000
and ovalbumin MW 43,600.
- Fig. 8.4
respectively as compared to the value for unfractionated
supernatant.
Sodium dodecyl sulphate-polyacrylamide disc gel electrophoresis
Each sample to be analysed was dialysed at room temperature
for 12 hours against 100 volumes of 10 mM sodium phosphate
buffer pH 7.0 containing 0.1% SDS and 0.1% mercaptoethanol
in order to ensure that the sample composition would not inter¬
fere with the electrophoresis. The protein was then denatured
by boiling in 0.01 M sodium phosphate buffer pH 7.0, 1% in
SDS and 1% in mercaptoethanol for 3 minutes. A typical solution
for application to the gel contained 5 yl of tracking dye, 1 drop
of glycerol, 5 yl of mercaptoethanol, 10 yl of protein, (0.6 mg/ml),
and 50 yl of dialysis buffer. Gel electrophoresis of the protein
preparations was done in 0.1% sodium dodecyl sulphate (SDS) on
10% acrylamide essentially as described by Weber and Osborn (60).
Figure 8.3a-d shows relative density scans for each stage
of purification. The Sephadex G75 treatment separates the
proteins of the ammonium sulphate extract by molecular size.
Analysis of the pooled fractions formed after gel filtration
revealed that the material in fraction 10-12 consists of at least
20 protein bands, whereas apart from a lightly stained area
adjacent to the origin of the gel which does not contain any
visible bands, fraction 19-21 contained 5 protein bands, one
of which migrated with the tracker dye. A similar analysis of
the pooled fractions formed after ion exchange chromatography
showed the following
(a) in the case of the protein which eluted in the equilibrating
buffer the band with a relative mobility of 0.73 has become the most
prominent of the bands and
Photograph of polyacrylamide gel electrophoresis (0.1% SDS)
of cytosolic protein partially purified by ammonium
sulphate, gel filtration, and ion exchange chromatography.
Right hand side of photograph represents the anode.
Fig. 8.5 \
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(b) that a less well defined species.with a similar relative
mobility was present in the fraction eluted with equilibration
buffer containing 0.154 M KC1. The relative mobilities of
the main protein species observed are detailed in Table 8.8.
It should be noted that the band with a mobility of 0.73 is
present in all the fractions that stimulate cholesterol 7a-
hydroxylase.
An estimate of the molecular weight of the material w.th
a relative mobility of 0.73 which constitutes the major protein
band in the pooled ion exchange fractions was estimated by
polyacrylamide gel electrophoresis by comparison with standard
proteins of known molecular weight (Figure 8.4). This procedure
gave the protein a molecular weight of 20,000-23,000 which was
slightly higher than that determined by estimating the approximate
elution position of a stimulating activity on a calibrated
Sephadex G75 column (17,000-20,000). The differences may in part
be explained by the inaccuracies in measurement of the column
elution volumes. Figure 8.5 shows a photograph of the partially
purified cytosol protein.
The purification techniques used this far have been partially
successful and have yielded a preparation which consists of one
major band MW 22,000 and five minor bands and whose activity is
400 fold greater than the 40-80% NH^SO^ fraction from 100,000 g
supernatant.
In addition molecular weight determination by SDS polyacryl¬
amide electrophoresis is unaffected by the molecular dimensions
of the protein, whereas molecular weight determinations by gel
filtration are based on the Stokes radius of the proteins.
Although further purification of the protein preparation will be
^ __
14' 16 18 20 22 24 26
mis eluant
Elution profile of an incubation of
radioactive cholesterol with cytosolic
protein, partially purified by Sephadex G75
gel filtration, from Sephadex G25.
1 ^ 8. fe>,
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required before the precise identity of the stimulatory protein
can be determined the 22,000 MW band is the major protein
present in a stimulatory fraction and may be the protein responsible
for the stimulation.
Investigation of the possible method of action of the cytosolic
protein
As the previously described cytosolic proteins have been
designated as cholesterol binding protein (182), sterol carrier
protein (174), or squalene binding protein (173), it was decided
to investigate if the partially purified preparation obtained
after Sephadex G75 chromatography could bind cholesterol.
Fractions 17-22 (30 ml) from the Sephadex G75 column were con¬
centrated to 3 ml in an Amicon filtration cell fitted with a PM
10 membrane. This concentrated protein (10 mg/ml) was then
incubated with 60 nmole cholesterol at 37°C for 1 hour
and applied to a 2 x 10.5 cm column of Sephadex G25 prepared in
20 mM phosphate buffer. Measuring the protein and radioactivity
in the eluant showed that 40% of the added radioactivity is
associated with a single void volume protein peak. The value
is comparable with the binding achieved by the cytosol protein
isolated by Grabowski et al. (177) which stimulates microsomal
12a-hydroxylase. The stimulatory activity was also seen to be
associated with the single void volume protein peak (Figure 8.6).
When the radioactive cholesterol was applied to the column in
the absence of the supernatant fraction, it could not be eluted
from the Sephadex.
In an attempt to gain some extra information regarding the
interaction of the cholesterol with the cytosolic protein a
slightly different system for measuring the interaction between
Fractionation method " Kobility




(im4)2so4 (40-80%) (B) 20 bands. 0.488 (major)
Sephadex G'/5 fraction 0.495 (major), 0.588
10-12 (major), 0.6b9 (minor)
0.749 (minor)
(NH4)2S04 (40-8056) (C) O.586 (major), 0.778•
Sephadex (175 fraction (major), 0.8d6 (major)
19-21 are the main proteins.
(NV2304 (40-80%) (D) 0.43 (minor),0.46 A
Sephadex (175 fraction (minor), 0.47 (minor)
17-22, DEAF cellulose 0.53 (minor), 0.73
eluted with 5mM Tris (major), 0.82 (minor)
HG1 pH 7.4
(E) as (i)) except that 0.509 (minor), 0.647
the 5mM Tris HOI pH 7.4 (minor), 0.715 (minor)
contains 0.154M KG1
A description of the S.D.S. polyacrylamide gels
containing partially purified cytosolic protein
Table 8.8
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Comparison of 3 cytosolic proteins
Table 8„9 shows a comparison between the best
characterised cytosolic proteins.
Note- Astruc et al. ( 141) have suggested that boiled
lOOjOOOg supernatant cannot activate the microsomal
conversion of squalene to cholesterol. Thus the
reported heat stability of the Dempsey preparation
must remain in doubt.
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cholesterol and protein was adopted., The procedure used was
that originally developed by Mester (183) for the determination
of the binding characteristics of uterine cytosol proteins with
different affinities for oestradiol and involved a 4°C overnight
incubation of the cytosol with radioactive cholesterol to allow
equilibration of the cholesterol and the cytosolic protein to
occur. After the incubation period the unbound radioactivity
was removed by treatment with a dextran-charcoal suspension.
This assay is based on the fact that the charcoal adsorbs free
but not protein-bound sterol. Provided the charcoal containing
reaction mixture is vigorously but briefly agitated and the
charcoal immediately centrifuged, a single determination of
the radioactivity is sufficient to determine the percentage of
added st erol that is bound to the cytosol protein. The degree
of specificity of the binding was determined by comparison with
boiled cytosol which measures non-specific binding. These
procedures were repeated exactly using native and heat denatured
cytosolic protein from fraction 17-21 of the Sephadex G75 gel
filtration step, but results were obtained which indicated that
there was no binding of the radioactive cholesterol to the
cytosolic fraction tested. A possible explanation of this
negative result could be that the binding of cholesterol to this
protein is of such low affinity that the charcoal can remove
bound cholesterol. This might be expected if the function of
the protein was to transport the cholesterol from its site of
synthesis to its point of metabolism.
Each method of measurement of binding gave different results
which are probably attributable to the experimental limitation of
each technique. An explanation of the ability of the protein to
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bind cholesterol may be that the 37°C incubation aggregated the
cytosolic proteins and created a molecular species capable of
binding the cholesterol. This would agree with the findings
of Ritter and Dempsey (174) that only the aggregated protein
can bind cholesterol while the monomer sterol carrier protein
will not. In their experience when a fraction from a gel
filtration column containing apo SCP was incubated with a
labelled cholesterol precursor and subjected to gel filtration,
a radioactive protein with a higher molecular weight appeared
in the void volume of the column. This observation is consistent
with the results of gel filtration of the incubation mixture
containing cytosolic protein and cholesterol that are presented
in Figure 8.6.
Thus while the inclusion of cytosolic protein was observed
to increase the production of 7a-hydroxycholesterol from
cholesterol its means of action must remain a matter of conjecture.
8.9 Comparison of properties of reported cytosoiie protein
In recent years the properties of some of the cytosolic
proteins have been investigated to determine their structure
and functional role. Ritter and Dempsey (174) have isolated
a protein (purified to homogeneity as indicated by SDS) which
has sterol carrier protein activity in the conversion of (J-
cholesterol to 7-dehydrocholesterol and of 7-dehydrocholesterol
to cholesterol. This protein was obtained by heat treatment of
rat liver 100,000 g supernatant (1000, 5 minutes) followed by
ammonium sulphate fractionation (40-80%) and passage through a
Sephadex G75 column prepared and eluted with 0.1 M phosphate
buffer pH 7.4. Table 8.13 shows some of these properties
and in addition (a) only an aggregated form of the protein with
a molecular weight in excess of 150,000 will bind substrate and
154.
(b) only a protein-bound cholesterol.will act as substrate for
the enzyme. In addition phospholipid facilitated formation
of the protein aggregate and apo HDL could replace SCP.
Scallen et al. (178) have obtained and partially purified
three cytosolic proteins designated SCP^, SCP2 and SCP^,
respectively, which function in the conversion of squalene
to cholesterol. Table 8.8 shows some of the main properties
of the proteins and indicates that SCP^ resembles SCP of
Dempsey. The molecular weight of SCP^ has been estimated to
be 28,000 (182) or 13,000 depending on the conditions employed.
Both of these protein preparations have an enzyme activating
role as their major cellular function. In the recent paper
by Erickson et al. (187) a protein was described which had no
stimulating function and was termed a cholesterol binding protein
(CBP). The protein was initially tagged with cholesterol by
intraperitoneal injection of radioactive cholesterol. The
protein associated with the administered radioactivity was purified
to homogeneity from rat liver 100,000 g supernatant by ammonium
sulphate fractionation, gel filtration and ion exchange
chromatography. Unlike the preparations of Dempsey and Scallen
the purified protein contained cholesterol (Table 8.9) and
differed in its immunochemical reactivity and could not be
replaced by apo HDL.
The results of double immunodiffusion experiments with anti
CBP antiserum and washed mitochondria, microsomes, rat liver nuclei
and several other rat cytosols including kidney, spleen and adrenal





In this chapter the involvement of a cytosolic protein
in the microsomal conversion of cholesterol to 7a-hydroxy-
cholesterol has been demonstrated. This protein can be
obtained by ammonium sulphate fractionation of the 100,000 g
supernatant and is partially heat stable. The material
possessing the stimulatory activity can be further subfractionated
by gel filtration into two fractions
(a) a fraction found at the void volume of Sephadex G75
equilibrated in 20 mM phosphate buffer pH 7.4 and
(b) a fraction eluting at approximately twice the void volume.
Reapplication of fraction (b) to the same column did not alter
the elution position of the fraction, implying that the void
volume fraction was not a simple aggregate formed by ionic
interaction of the monomers.
Both fractions have an ^280^260 ^.68 to 0*79 which is
indicative of bound pyridine nucleotide. Ion exchange chroma¬
tography of the retained fractions on DEAE cellulose prepared
in 5 mM Tris HC1 pH 7.4 and eluted with 5 mM Tris HC1 pH 7.4
and the same buffer containing 0.154 M KC1 gave a further two
protein fractions both of which stimulated enzymic activity.
The maximum stimulating activity was associated with the peak
eluted by 5 mM Tris HC1 pH 7.4 and SDS polyacrylamide gel
electrophoresis of this protein showed it to consist of one major
band with an Rf of 0.73 (estimated molecular weight 19,000-23,000)
and at least 5 minor bands. The SDS results probably provide
a better estimate of the molecular weight of the protein than
the results with the calibrated Sephadex G75 column as the molecular
weight standards were of higher quality and the protein was purer.
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These preliminary studies, although they are far from complete,
probcuv
suggest the existence of a rat liver cytosol^capable of stimulating
the activity of cholesterol 7a-hydroxylase. The protein seems to
resemble the CBP of Erickson more closely than the others due to
the fact that the ion exchange purified material contained 0.5
mole cholesterol/mole of cytosol protein whereas the more
purified preparations of SCP did not. In addition the molecular
weight of the 7a-stimulating protein by SDS gel electrophoresis
was more akin to that of CBP than the others described in the
literature. However the similarities of the ^280^260 rati°
between SCP and crude 7a-stimulating protein indicate that they
may have some properties in common. The presence of the endogenous
cholesterol in the crude preparation of cytosol protein may in
part explain the failure of the radioactive cholesterol to bind
to the protein but its presence in an inhomogeneous preparation
cannot be taken to indicate conclusively that it was acting as a
cholesterol transport protein.
Whether the protein isolated in 100,000 g supernatant is a
microsomal peripheral protein acting as a regulator of the
movement of cholesterol from the general microsomal pool to a
specific pool which provides substrate for the enzyme or is a
cytosol protein acting as a means of supply of extra microsomal
cholesterol is a question which cannot be answered at present.
























In mammalian cells cholesterol is the major sterol present.
The structure of cholesterol with its rigid ring system, its secondary
hydroxyl group at C^ and a branched chain at is thought to
determine its biochemical properties. In previous studies, the
cholesterol nucleus has been the main focus of attention with the
side chain of cholesterol only being mentioned in passing.
The object of the work described in this thesis was two-fold
(a) definition of the precise dimension of the side chain at C^
necessary to optimise the biochemical properties of the cholesterol
molecule.
(b) further investigation of the two main cholesterol systems
of the adrenal and the liver.
In the liver cholesterol is present as a membrane structural
component and as a substrate for certain microsomal oxidising enzymes.
The relative proportions of metabolically restrained cholesterol in
liver microsomes are unknown. A possible model for cholesterol
compartmentation in liver microsomes is shown in figure 9.1.
Pool (a) represents metabolically inactive (structural) cholesterol
which equilibrates at a slow rate with pool (b) which is assumed
to be metabolically active. The cholesterol in pool (b) can be
converted to bile acids or excreted as faecal neutral sterols and
can be replenished by de novo hepatic synthesis and by cholesterol
absorption from the gut.
The radiotracer assay of cholesterol la hydrolase assumes
that exogenous cholesterol equilibrates with endogenous cholesterol
in pools (a) and (b). The similar results obtained for the GLC
and radioactive tracer assays (Table 6.7) indicate that equilibration
is occurring.
The association of substrate chplesterol with cholesterol 7a-
hydroxylase might be a control step in the production of cholesterol
7a-hydroxycholesterol although it has not been possible to demonstrate
a specific in vitro interaction of cholesterol with the enzyme (184).
Alternatively the activity of cholesterol 7a-hydroxylase could be
enhanced by increasing the supply of substrate for the enzyme,
by altering the relative preparations of microsomal cholesterol in
pools (a) and (b). This may be achieved by cholesterol feeding
which is known to stimulate cholesterol 7a-hydroxylase (9), or by
the existence of a specific cholesterol transport mechanism from
pool (a) to pool (b).
The protein described in chapter 8 enhances the existing
activity of cholesterol 7a-hydroxylase but is not a prerequisite for
enzyme activity. Thus it is more likely to be providing substrate
than forming an integral part of the active site. The existence of
the protein might also explain the observation that the cholestyramine
mediated increase in activity was removed by treatment with
actinomycin D (2,3). Evidence of a direct relationship between the
synthesis of a protein which does not possess any innate catalytic
activity and the activity of cholesterol 7a-hydroxylase would be
difficult to establish.
As HMG CoA reductase and cholesterol 7a-hydroxylase are both
thought to be situated in the smooth endoplasmic reticulum (185)
and newly synthesised cholesterol is believed to be the preferred
substrate for cholesterol 7a-hydroxylase (164) then the role of the
protein might be to redistribute the microsomal cholesterol rather
than to bring cholesterol to the microsomes. Furthermore the location
of both enzymes on the same membrane would suggest that the "cytosolic"
protein could be a microsomal peripheral protein that has been removed
from the microsomes during the isolation procedure.
Cholesterol 7a-hydroxylase is thought to be cytochrome P450
linked as demonstrated by the inhibition of the enzyme by carbon
monoxide and by reversal of the inhibition with monochromatic light
at 450 nm (129,186). There is no direct correlation between the
level of hepatic cytochrome P450 and cholesterol 7a-hydroxylase.
There may be a cytochrome P450 specifically associated with
cholesterol 7a-hydroxylase which constitutes such a small
proportion of the total cytochrome P450 that its induction following
cholestyramine treatment is not observed. The results of chapter 6
involving drug pre-treatment of animals and comparison of the
metabolism of pregn-5-en-3B-ol (C^)» and 23-24-bisnor-5~cholen-3B_ol
(C22) with cholesterol showed that Pb pretreatment increased hepatic
cytochrome P450 levels and enhanced ethylmorphine demethylase activity
and the metabolism of anc^ ^2 t0 many products. The activity
of cholesterol 7a-hydroxylase was unaffected and only gave one
major product in the presence of B-mercaptoethylamine. Thus the
metabolism of the short side chain analogues seemed to be more
related to drug metabolism enzymes than to the cholesterol 7a-
hydroxylase system.
This relationship between the structure of the cholesterol analogue
and its pattern of metabolism could be due to the existence of a
hydrophobic cleft in the active site of cholesterol 7a-hydroxylase.
This cleft would be optimally adapted to fit the iso-octane side
chain of cholesterol, but not sterols with longer or shorter side chains.
The side chain cleavage enzyme system of rat adrenal mitochondria
is another cholesterol oxidising system that has been investigated
with a cholesterol side chain analogues to determine if the side
chain has a role to play in regulating the enzyme activity.
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In a recent paper Arthur et al, (141) reported that sterols
with the cholest-5-en-36-ol ring system and saturated side chains
of different lengths were converted to pregnenolone at rates
similar to cholesterol. When the experiments were repeated using
2+
ACTH pretreated rats and Ca in the incubation medium a different
result was obtained which indicated that cholesterol itself was the
optimal substrate for the adrenal side chain cleavage system.
In the mitochondria the substrate cholesterol could come from the
plasma lipoproteins or from lipid droplets present in the adrenal
cell cytoplasm or from de novo synthesis. ACTH is known to act
on the cells of the adrenal cortex to produce an almost instantaneous
stimulation of steroidogenesis. The effects of calcium on side
chain cleavage is not so well understood, although it has been
shown to increase side chain cleavage activity in rat testes
2+
mitochondria (187). Ca is also thought to bind to the phospho-
2+
diester groups of phospholipid. The affinity of Ca for PC
bilayers is such that at 5 mM approx. 1% of all phosphatidylcholine
polar groups are likely to be bound. The cation bound conformation
of the hydrophobic bilayer region may be different from the ion
free state of the bilayer (188). However this interaction between
2+
phosphatidylcholine polar groups and Ca is weak and does not
change the packing density and the molecular motion of the
hydrocarbon chains.
Phosphatidylcholine is zwitterionic over physiological pH range
2+
and the affinity of Ca is much lower than that for negatively charged
phospholipid such as phosphatidylserine and phosphatidylethanolamine.
The lipid of the internal mitochondria] membrane which constitutes
25% of the membrane mass, contains 90% phospholipids composed of
phosphatidylcholine, phosphatidylethanolamine and cardiolipin in
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appro xiimate molar ratios of 4:3:2 (189). Thus there are many sites
2+
where Ca could hind to the phospholipid head groups.
The current evidence favours the concept that the availability
of cholesterol to the enzyme regulates pregnenolone synthesis rather
than alteration in the amount of enzyme present. This concept is
2+
consistent with other properties of membranes containing Ca
2+
Results of a study involving interacting spin labels show that Ca
may increase the extent of phase separation in phosphatidic acid-
phosphatidylcholine membranes (190). This induced phase separation
is caused by formation of crystalline patches of calcium ion bound
phosphatidic acid, the phosphatidylcholine being squeezed from the
areas of rigid lipids (69). The alteration in phase separation
2+
caused by Ca could result xn the displacement of cholesterol
from one region to another, this second region being more accessible
to the enzyme complex. The differential metabolism of the various
cholesterol side chain analogues could then be explained in terms
of their relative abilities to migrate in the mitochondrial membrane.
That this property and not direct interaction with enzyme is the
determining factor in pregnenolone production from the analogues
2+
is expected, as previously m the absence of Ca , all the analogues
had been shown to act as equivalent substrates for the side chain
cleavage enzyme (141).
The possible dependence of translational mobility of the
cholesterol side chain analogues on the side chain structure correlates
with the reported necessity of an intact side chain for the optimal
sterol-phospholipid interaction described in chapter 4. The precise
role of the side chain in cholesterol phospholipid interactions
was investigated using cholesterol analogues with altered side chains
and a selection of physical techniques to monitor the interaction.
The epr studies described in chapter 4 showed that the various spin
labels were reporting on different areas of the bilayer as judged
by the differential removal of each spin label signal by ascorbate.
The results of all the spin labelling experiments indicated that
cholesterol with its iso-octane side chain was optimally adapted
for maximal interaction with the surrounding phospholipid.
That the cholesterol side chain and not the phospholipid fatty acyl
chain was determining the extent of sterol phospholipid interaction
was confirmed when alteration of the phospholipid species was seen
to have no effect on the previously observed pattern of cholesterol
phospholipid interaction (Fig. 4.15). In the case of the experiments
with the 3NC spin label 30 mole % sterol had to be present to show
the side chain effect, and in agreement with Engelman and Rothman
(191) this was the proportion of cholesterol that required to be
present to prevent the phospholipid phase transition from occurring.
The results of chapter 4 and the osmotic shrinking experiments
outlined in chapter 5 using liposomes containing the cholesterol
side chain analogues confirmed the correlation between spin labelling
and osmotic shrinking experiments as observed by other groups (122).
Furthermore they showed that the effect of cholesterol on both
physical processes was closely linked with the cholesterol iso-octane
side chain. When the interaction of the cholesterol analogues with
phospholipid was assayed using a mixed monolayer the importance of
the cholesterol side chain was not so apparent since apart from C^g
and the rest of the analogues caused the monolayer to condense
to the same extent as cholesterol. This result could be explained
by suggesting that cholesterol required to be incorporated into a
bilayer structure of fixed dimensions before the properties of the
side chain could be fully expressed. Further evidence for this
163.
interpretation came from the report pf Forge et al. (117) that
cholesterol was capable of exerting a molecular control of membrane
morphology in areas with a high radius of curvature.
The side chain of cholesterol is also important in determining
the rate of exchange of liposomally bound cholesterol analogues as
observed in chapter 7. Of the side chain analogues tested,
r>
cholesterol seemed to exchange most readily into microsomes.
The figures obtained for the percentage of liposomal sterol
available for exchange can only be used for comparison of the
series of analogues and not as an absolute index of the amount of
liposomal or microsomal cholesterol that is available for exchange.
That this is the case was shown by the different results obtained
for the amount of liposomal cholesterol that is available for
exchange into the erythrocyte membrane. As the rate of exchange
of cholesterol from a liposome is thought to be dependent on the
o+
efficiency conversion of multilayered to single layered liposomes
/V
(151) comparison of different results is difficult.
The results of both the physical measurements and the enzyme
assays reveal that the iso-octane side chain of cholesterol is
playing a major role in determining the extent of the interaction
between cholesterol and phospholipids and the specificity of
cholesterol protein interactions. A possible future use for these
side chain analogues could be to further investigate the role of
cholesterol in several other natural membranes including liver
microsomes, platelets and erythrocytes by replacing cholesterol
with liposomally delivered cholesterol analogues. Erythrocyte fusion
requires the creation of protein free, fluid areas of lipid which
form the fusion site (192). Cholesterol is thought to be important
in the formation of the protein free area. As the cholesterol side
164.
chain is involved in the interaction of cholesterol with lipid and
protein, the extent of phase separation and hence of cell fusion
may be dependent on the interaction of the cholesterol side chain
with protein or lipid. The techniques developed in this work
should be adaptable to the study of this aspect of membrane organisation.
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Summary
The specificity of the interaction between the cholesterol side chain and
egg phosphatidylcholine was precisely defined by examining the effect of
three new analogues of cholesterol with modified side chains on the ordering
of two steroid spin labels in liposomes. The complete side chain of cholesterol
was shown to be required for maximum ordering. Sterols with side chains
shorter or longer than cholesterol caused significantly less ordering.
The role of cholesterol in membrane structure has been examined by a
variety of physical techniques including NMR and ESR (for example, see refs.
1,2). The results of these and other studies are consistent with the interpreta¬
tion that cholesterol causes the membrane phospholipid to possess an inter¬
mediate fluidity between a gel and a fluid state. Many different studies have
shown that for maximum interaction with a phospholipid the sterol requires
a planar ring structure, an equatorial 3/J-hydroxyl group and an intact side
chain [3].
The role played by the side chain in this interaction has been studied in
several ways [3—5]. Stevens and Green [4] measured the incorporation of
several testosterone esters into egg phosphatidylcholine liposomes. The opti¬
mal incorporation wTas observed when the fatty acyl moiety had eight carbons,
corresponding approximately to the length of the side chain of cholesterol.
However, testosterone esters are not closely analogous to cholesterol in their
molecular shape and polarity. In this laboratory we have examined the effect,
by spin labelling, of varying the side chain lengths with sterols containing the
cholesterol ring system [5]. These analogues are more closely related to cho¬
lesterol, the only difference being the modified side chains. This work sug¬
gested that sterols with side chains shorter than cholesterol by more than
three carbons caused significantly less ordering of the spin labels in-sgg phos-
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phatidylcholine liposomes than did cholesterol. These results encouraged us
to synthesise further analogues of cholesterol to define the requirement for a
side chain in the interaction with phospholipid more precisely. In this paper
we report on the synthesis of three new analogues of cholesterol (Fig. 1) and
their effect in egg phosphatidylcholine liposomes on the ordering of the two
steroid spin labels described before, 3-spiro(2'-(Al-oxyl-4',4'-dimethyloxazoli-
dine))cholestane (3NC) and 3/3-hydroxy-26-nor-25 (2'-(iV-oxyl-4',4'-dimethyl-
oxazolidine)cholestane) (25NC) [5].
Reagents used were of standard commercial grade and purified as re¬
quired. Egg yolk phosphatidylcholine was prepared using the method of
Pangborn [6] and was pure by thin-layer chromatography. Liposomes were
prepared containing sterols, phospholipid and spin labels and ESR spectra ob¬
tained as described previously [5].
la R = H
1b R =Me
2 Ri R2
a H — C02H
b H — C02Me
c Tetrahydropyranyl — C02Me
d — CH2OH
e — CHO
f „ — CHOHCH3
g „ — CHOHCH2CH(CH3)2
h — CHOH(CH2)4CH3
i H — CH2CH3
j H — (CH2)2CH(CH3)2
K H — (CH2)5CH3
Synthesis of cholesterol analogues
Hyodeoxycholic acid (la) was esterified with diazomethane and the es¬
ter (lb) converted into 3j3-hydroxycholenic acid (2a) by the method of Bha-
ruca et al. [7]. After esterification with diazomethane the 3/3-hydroxycho-
lenic acid methyl ester (2b) was converted into its tetrahydropyranyl ether
(2c) [8]. The ether was reduced to the corresponding alcohol (2d) with li¬
thium aluminium hydride and the alcohol oxidised to the protected aldehyde
(2e) with celite-silver oxide [9]. The aldehyde was then reacted with the ap¬
propriate Grignard reagent [10] and the resulting secondary alcohol (2f, 2g,
2h) reduced via its tosylate to give a saturated side chain essentially as de¬
scribed by Arthur et al. [11]. Deprotection was effected by treatment of the
steroid with acid [8] and the product was purified by chromatography and
recrystallisation. All intermediates were characterised by infrared and NMR
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spectroscopy and mass spectrometry and were shown to be pure by thin-
layer chromatography. The product sterols were shown to be pure by thin-
layer chromatography and by gas liquid chromatography. Their physical
characteristics were as follows:
24-methyl-5-cholen-3/3-ol, m.p. 133°C,M+ 358 C2S sterol (2i);
26-nor-27,27-dimethyl-5-cholesten-3(3-ol, m.p. 128—129°C, M* 400 C28
sterol (2j);
26-nor-27-n-propyl-5-cholesten-3/3-ol, m.p. 124—125°C, M* 414 C29 sterol
(2k).
Order parameters for 3NC and 25NC
Experiments were carried out using the C25, C28, and C29 analogues
and also with cholesterol using egg phosphatidylcholine liposomes containing
0—50 mol% sterol. Order parameters for 3NC and 25NC were calculated as
described previously and the spectra and order parameters for cholesterol
were essentially the same as those previously described [5]. The values of
the order parameters for liposomes containing 40 and 50 mol% sterol are gi¬
ven in Table I. The results for cholesterol are the mean of twelve indepen¬
dent experiments and those for the analogues of at least four independent
TABLE I




3NC 40 0.34 ±0.02 0.30 +0.01 0,31 ±0.01 0.31 ±0.01
50 0.39 +0.02 0.35 ±0.01 0.36 ±0.01 0.36 ±0.01
25NC 40 0.264±0.01 0.255±0.01 0.257±0.01 0.255±0.01
50 0.29 +0.01 0.270±0.01 0.270±0,01 0.270±0.01
experiments. In every case the order parameter was found to increase with in¬
creasing sterol concentration. The presence of cholesterol caused significantly
more ordering than either the shorter (C2S) or the longer (C28 , C29 ) side
chain analogues at concentrations greater than 40 mol% with both spin labels.
The differences in order parameter at compositions below 40 mol% were too
small to be distinguishable by these methods.
These results and those reported previously agree in outline with those
of Stevens and Green [4]. They found that a testosterone ester with an eight
carbon side chain gave maximum incorporation into egg phosphatidylcholine
liposomes. They suggested that since this compound is slightly longer than
cholesterol, a cholesterol-like molecule with one extra carbon in the side
chain (i.e., our C28 analogue) would be incorporated to a greater extent than
cholesterol. Although our experimental conditions are not directly compar¬
able, the spin label results indicate that this may not be the case. Cholesterol
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itself appears to have the optimal structure for a maximum sterol-phospho¬
lipid interaction.
Recent results from X-ray and neutron diffraction studies [12,13] show
that cholesterol occupies a position in a phosphatidylcholine bilayer such
that its side chain terminates in the region of the ends of the fatty acyl chains
of the phospholipid. On this basis, the C28 catalogue and more especially the
C29 analogue, which is much longer, would be likely to penetrate into the ter¬
minal region of the adjacent half of the phospholipid bilayer. Such an inter¬
action or the change that might take place in a phospholipid bilayer to re¬
lieve the consequences of such an interaction would be likely to result in a
decrease in order of the bilayer. This is what is observed in these experiments.
The order of the liposomes containing the sterols with longer side chains is
reduced to the same level as that observed with sterols with shorter side chains.
These results confirm and extend our previous findings. Taken together,
the results obtained with all the analogues of cholesterol suggest that the
complete side chain has a specific role to play in the interaction with phos¬
pholipid and that the cholesterol molecule is the optimum size to fit into an
egg phosphatidylcholine bilayer to give the maximum possible interaction
with the phospholipid.
This work was supported by the Medical Research Council. I.F.C. ack¬
nowledges the award of a MRC Research Studentship.
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